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Abstract 
Hyperthermia, a procedure to elevate tissues temperature (3 °C - 5 °C) 
artificially above the normal body temperature, has become a potential treatment 
model for malignant diseases and is under clinical trials. However, the mode of 
action of hyperthermia is far from clear. On the other hand, tumour necrosis 
factor-alpha (TNF-a) is a proinflammatory cytokine that elicits various kinds of 
biological responses. It was reported that TNF-a induces apoptosis or necrosis in 
tumour cells. However, the actual mechanism of TNF-mediated cytotoxicity is still 
under determination. 
In this study, the cytotoxic mechanisms of hyperthermia and TNF-a were 
examined by using two cell lines, a TNF-a sensitive L929 line and its derivative 
L929-11E cells with TNF-a resistance. Cells were challenged with hyperthermia (43 
1 to 3 hr); TNF-a (50 ng/ml, 37 for various time intervals); or a combined 
treatment with hyperthermia (43 °C for 3 hr) first and subsequently with TNF-a (50 
ng/ml, 37 for 3 or 6 hr). Their effects on the mitochondrial activities and 
induction of apoptosis were examined with flow cytometry. 
When L929 cells were treated with hyperthermia (43�C, 1 to 3 hr), TNF-a (50 
ng/ml) alone, or sequentially with hyperthermia (43 °C, 3 hr) and then with TNF-a 
(50 ng/ml, 37 for 3 or 6 hr), apoptotic cells were observed. With the use of JC-1, 
mitochondrial membrane potential (A^m) was also found to collapse in a 
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time-dependent manner when cells were heated at 43 or treated with TNF-a. The 
• 2 + 
level of hydrogen peroxide H2O2 and intracellular free calcium concentration ([Ca ]i) 
were increased in a time-dependent manner after treatment. Moreover, the levels of 
apoptosis-related proteins such as Bid, pro-caspase-3, cytochrome c, p53 were 
changed after treatment. 
L929-11E cells were also treated with hyperthermia (43 ^C, 1 to 3 hr), TNF-a 
(50 ng/ml) alone, or sequentially with hyperthermia (43 3 hr) and then with 
TNF-a (50 ng/ml, 3 7 � C for 3 or 6 hr). It was found that only hyperthermia (43�C，3 
hr) but not TNF-a (50 ng/ml) elicited cell death in L929-11E cells. Apoptotic cells 
and mitochondrial membrane depolarization were observed in cells treated with 
hyperthermia only. Similarly, cytochrome c and poly(ADP-ribose) polymerase 
(PARP) were found to be released and cleaved in L929-11E cells only after 
hyperthermia treatment. 
In order to determine whether both TNF-a and hyperthermia elicit apoptosis 
through mitochondria and caspases, caspase-8 (the mitochondrial upstream caspase) 
and caspase-3 (the mitochondrial downstream caspase) activities were determined. It 
was found that TNF-a activated both caspase-8 and caspase-3 activities in L929 
cells but not in L929-11E cells. On the other hand, hyperthermia enhanced caspase-8 
activity only slightly in L929 and L929-11E cells but caspase-3 activity was greatly 
enhanced in both cell lines. Caspase-8 inhibitor, z-IETD-fmk, was able to reduce the 
activities of both caspase-8 and caspase-3 upon TNF-a and hyperthermia treatment 
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in L929 cells and L929-11E cells. 
From these results, it was found that the responses in L929-11E cells elicited by 
hyperthermia were very similar to that initiated by TNF-a in L929 cells. Moreover, 
pre-treatment of L929-11E cells with hyperthermia could partially reverse the 
TNF-a resistance, indicating that the TNF-a-resistance in L929-11E cells is not a 
result of the malfunction of the post mitochondrial apoptotic pathways. The 
discrepancy in terms of the response to TNF-a and hyperthermia between the two 
cell lines awaits further elucidation. 
























亦可令線粒體膜電位(Mitochondrial membrane potential, ATm)隨著時間下降。我 
們亦發現高溫或腫瘤壞死因子可令過氧化氫(Hydrogen peroxide, H2O2)和細胞內 
躬離子(Intracellular free calcium, [Ca2+]i)的濃度隨著時間而增加。和凋亡過程 
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1.1 Hyperthermia 
1.1.1 History of Hyperthermia 
Hyperthermia is defined as a procedure in which there is an artificial 
elevation of tissue temperature a few degrees above 37 for a period of time (Hahn 
and Li, 1982). It has been employed as a therapeutic agent over the past two decades. 
In ancient Greece, the bathing customs of the Egyptians was adapted to cure patients 
suffering from paralysis with hyperthermia. Moreover, syphilis, arthritis and gout 
were treated with hot water of temperature ranging from 45 to 53 (Molls and 
Scherer, 1987). With the therapeutic effects of hyperthermia in various diseases, 
application of hyperthermia on neoplastic tissue was then performed. In 1886, Coley 
successfully cured unresectable sarcomas and certain inoperable carcinomas by 
inducing fever in patients through inoculating of erysipelas (Molls and Scherer, 1987; 
Streffer and van Beuningen, 1987). Subsequently, Georges Lakhovsky used the 
"Short wave diathermy" machine to generate the radio waves of different 
wavelengths to treat patients with malignant tumours in 1923 (Farrell, 1982). 
Since 1930s, hyperthermia had been employed as a treatment for a number of 
infectious diseases prior to the widespread use of antibiotics (Roberts, 1979; 
Greenley et al； 1992). Generally, hyperthermia has been used in clinical trials in 
treatments of tumours since it possesses the anti-tumor effect in certain tumours, 
such as liver tumours and breast tumours (Hafstrom et aL, 1994; Yonezawa et al., 
1996) and the anti-tumour effect of heat was repeatedly demonstrated under different 
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experimental conditions. 
1.1.2 Biological Functions of Hyperthermia 
Hyperthermia has been suggested to have anti-tumour activities (Field, 1987). 
In order to achieve this purpose, several possible anti-tumour mechanisms are 
proposed and they are related to multiple effects of hyperthermia on cellular 
metabolism. First of all, hyperthermia causes conformational changes in membrane 
proteins, leading to instability of the phosopholipid bilayer and an alternation of 
membrane permeability (Konings, 1988). It also leads to the destabilization of the 
structural protein system within cells, for example, the cytoskeleton (Vaupel and 
Kallinowski, 1987; Roti Roti and Laszlo，1988). Secondly, hyperthermia inhibits the 
cellular energy metabolism (Sinensky et al., 1979). Thirdly, it causes DNA damage 
(Wateris and Henle, 1982) and induces chromosomal aberrations (Dewey et al, 
1971). It also inhibits DNA replication as well as RNA and protein synthesis 
(Remani et al., 1999). Fourthly, it can induce certain kinds of heat-shock proteins 
(hsp)，such as hsp 70 and 72 (Vaupel and Kallinowski, 1987; Yatvin and Cramp, 
1993; Nishida et al, 1997; Remani et al, 1999). 
2+ 
Recently, it is found that hyperthermia increases intracellular Ca 
concentration, which plays a crucial role in apoptosis, in the human histiocytic 
lymphoma U937 cells (Kameda et al., 2001). Moreover, it was found that the 
anti-tumour effects of hyperthermia can be achieved based on the apoptotic 
mechanisms mediated by the p53 pathway (Abe et al” 2001). 
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1.1.3 Clinical Application of Hyperthermia 
Various kinds of tumours can be treated with hyperthermia. Those tumours 
that can be treated with hyperthermia include brain tumours (Abe et al., 2001), breast 
cancer (Falk and Issels, 2001) and bladder carcinoma (Bichler et al, 1988). 
There are three treatment modalities by which tumours can be treated with 
hyperthermia clinically. These include: whole-body hyperthermia, regional 
hyperthermia and local hyperthermia. 
1.1.3.1 Whole-body Hyperthermia 
Whole-body hyperthermia refers to the elevation of the entire body 
temperature to a uniform raised temperature, usually, 41.8 using thermal 
conduction such as warm-water blankets and thermal chambers or radiant light 
techniques (Turner and Schaefermeyer, 1988). It is non-invasive and is beneficial for 
the treatment of metastatic cancers that have already spread throughout the body. 
1.1.3.2 Regional Hyperthermia 
Regional hyperthermia makes use of the electromagnetic fields to heat an 
organ or limb with depth greater than 5 cm. Another kind of such treatment modality 
employs the use of perfusion in which the blood is heated and pumped into the 
tumour region (Turner and Schaefermeyer, 1988; Stewart, 1998). 
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1.1.3.3 Local Hyperthermia 
Local hyperthermia has been used in the treatment of superficial or localized 
malignant tumours with very small area. Local hyperthermia includes both 
superficial local and interstitial local hyperthermia. Superficial local hyperthermia 
refers to the heating of tissues from the body surface down to a depth of as far as 5 
cm, with the use of electromagnetic field (Turner and Schaefermeyer, 1988; Stewart, 
1998). Interstitial local hyperthermia refers to the local heating of tumours which 
required an insertion of the heating device directly into the tumour using the 
electromagnetic heating technique (Turner and Schaefermeyer, 1988). 
Recently, the purposes of local hyperthermia can be achieved with the used 
of single microwave or ultrasound applicators. Clinically, it was found that patients 
with inoperable early-stage liver cancers can be cured with the use of microwave 
heating on tumour cells according to the Prince of Wales Hospital in Hong Kong 
(South China Morning Post，2001). 
1.1.4 Combination Therapy 
It has been suggested by many investigators that the anti-tumour effects of 
hyperthermia can be enhanced if it is used in combination with other anti-cancer 
regimes such as radiation therapy or chemotherapy. On the other hand, with the 
appropriate treatment modalities to induce hypethermia as mentioned in Section 
1.1.3, the tumours can be cured effectively. 
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1.1.4.1 Combined Treatment with Hyperthermia and Radiotherapy 
Radiotherapy refers to the treatment of cancers with radiation. Radiation 
alone on tumour cells has been found to be effective in the treatment of superficial 
local tumours of about 35% whilst the combination of radiotherapy and 
hyperthermia can be achieved to 70% (Overgaard，1989; Falk and Issels, 2001)� 
Clinical trials in Phase III studies have been performed on certain kinds of tumours 
and they include: head and neck tumours, melanoma, breast cancer, rectal cancer, 
bladder cancer and cervical cancer (Falk and Issels, 2001). 
1.1.4.2 Combined Treatment with Hyperthermia and Chemotherapy 
Chemotherapy refers to the treatment of cancers with anticancer drugs. 
Various kinds of cytotoxic agents including alkylating agents such as 
Cyclophosphamide, antitumour antibiotics such as adriamycin and folate antagonists 
such as methotrexate can be used to cure various tumours (Engelhardt, 1987). The 
major functions of these anti-cancer drugs are to inhibit nucleic acid and protein 
synthesis or to interfere with cellular metabolism of tumour cells (Johnstone et al” 
2002). Although these anti-cancer drugs have been used for more than fifty years ago 
in curing tumours such as testicular cancer and certain leukemias，the impact of 
chemotherapy on the treatment of common epithelial tumors of the breast, colon and 
lung is low (Makin and Dive, 2001; Johnstone et al., 2002). Moreover, it was found 
that prolonged treatment with anticancer agents often leads to the development drug 
resistance or multidrug resistance (MDR) among tumour cells (Castro et al., 1999; 
Larrivee and Averill, 2000). MDR refers to the state in which cells develop 
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cross-resistance towards a wide variety of structurally and functionally unrelated 
cytotoxic agents (Endicott and Ling, 1989; Ling, 1992). Most likely, it was suggested 
that over-expression of P-glycoprotein confers the resistance of tumours to 
chemotherapy (Gottesman and Pastan, 1993; Sharom, 1997). Recently, it was 
suggested that nuclear factor kappa B (NF-KB) also participated in the development 
of drug resistance in cancer cells (Barkett and Gilmore, 1999; Hanahan and 
Weinberg, 2000; Perkins, 2000). 
As drug resistance may develop when cells were treated with chemotherapy, 
other treatment modalities such as hyperthermia, has been applied in combined 
treatment with chemotherapeutic drugs so as to enhance the killing effect of tumours. 
In vitro studies have shown that combination of chemical agents such as cisplatin 
(Toyota et al., 1997) and verapamil (Shchepotin et al., 1997) with hyperthermia can 
induce apoptosis in rat mammary adenocarcinoma and human colon cancer cell line 
respectively. Moreover, recent findings suggested that the cytotoxicity of 
doxorubicin, a kind of anti-tumour agent, can be increased with elevation of 
temperatures (Ohtsuboa et a/., 2000). In addition, it was found that hyperthermia can 
reverse the MDR response of adriamycin in the multidrug-resistant Chinese hamster 
ovary cell (Larrivee and Averill, 2000). Clinical trials of combined hyperthermia and 
chemotherapy in Phase III studies have been performed on certain kinds of tumours 
and they include: oesophagus cancer, stomach cancer, pancreatic cancer and 
sarcomas (Falk and Issels, 2001). 
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The enhanced cytotoxicity of combined treatment of anti-cancer drugs with 
hyperthermia may be due to the increased drug uptake, enhanced drug reactivity, 
increased membrane fluidity, membrane and cytoplasmic protein denaturation, 
altered DNA conformation, the inhibition ofDNA repair (Hettinga et al., 1997). 
• • t 
Chapter 1. General Introduction Page 9 
1.2 Tumour Necrosis Factor 
1.2.1 History of Tumour Necrosis Factor 
Tumour Necrosis Factor (TNF) was first identified by Carswell in 1975 as it 
was a cytotoxin found to appear in the sera of endotoxin-treated mice infected with 
Bacille Calmette-Guerin (BCG) (Carswell et aL, 1975). The name of TNF was given 
as this protein can induce hemorrhagic necrotic effect on mice bearing Meth A 
sarcoma, a well-vascularized tumour (review: Legerwood et aL, 1999). 
Prior to the discovery of TNF, another cytotoxin called lymphotoxin (LT) was 
identified by Granger, Williams, Ruddle and Waksman (Turetskaya et aL, 1992) 
from the culture fluid supernatant of antigen- or mitogen-stimulated peripheral blood 
leukocytes (Meager et al., 1989). It was later found that LT showed about 30% 
homology in the amino acid sequence with TNF and also shared similar activities 
such as inducing necrosis in the Meth A sarcoma in vivo (Gray et a!., 1984), and 
activating polymorphonuclear leukocytes (Shalaby et aL, 1985). With such evidence, 
LT was later named as TNF-P and the original TNF protein was named as TNF-a. 
1.2.2 Sources of TNF-a and TNF-p 
TNF-a is a cytokine that is mainly produced from the lipopolysaccharide 
activated macrophages (Arrigo and Michel, 1991; Takahashi et al., 1995). Besides 
macrophages, many other cell types can also produce TNF-a in response to a wide 
variety of agents. These include natural killer cells, certain B-lymphoblastoid cells, 
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T-lymphocytes, mast cells, astrocytes, Kupffer's cells，granulosa cells and smooth 
muscle cells (Meager et al, 1989; Aggarwal, 1992; Takahashi et al., 1995). For 
TNF-p, it was mainly produced from activated T-lymphocytes and myeloma cells 
(Aggarwal, 1992). 
TNF-a is initially produced as a non-glycosylated integral transmembrane 
precursor protein of approximately 26 kDa in size. After post-translational 
alternations, such as glycosylations and phosphorylations, TNF-a with a molecular 
size of 17 kDa can be obtained (Aggarwal, 1992; Idriss and Naismith, 2000). The 
soluble form of TNF can then be obtained after the proteolysis of membrane 
associated TNF by membrane metalloproteinase. 
1.2.3 Biological Role of TNF 
TNF-a and TNF-(3 share similar biological activities although they only have 
30% homology in their structure. Generally, TNF-a can exert a wide range of 
inflammatory and immunomodulatory activities (Rothe et al., 1993; Rink and 
Kirchner, 1996; Kong et al., 1997). It triggers the synthesis and secretion of 
pro-inflammatory mediators, such as interleukin-1 (IL-1) and other cytokines from 
the mononuclear phagocytes and vascular endothelial cells (Neta et al., 1992). 
Moreover, it possesses anti-viral and anti-bacterial effects by activating the cytotoxic 
immune cells, such as natural killer cells and cytotoxic T cells. TNF-a also has 
effects in septic shock and certain autoimmune disease (Malik and Balkwill, 1992; 
Heller and Kronke, 1994). In addition to its inflammatory functions, TNF-a also 
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possesses cytostatic or cytotoxic effects on tumour cells. It also has the anti-tumour 
activity on certain types of tumour cells in vitro, for examples, human colon 
carcinoma, breast carcinoma, melanoma and myeloma cell lines (Saks and 
Rosenblum, 1992; Heller and Kronke, 1994). It is demonstrated in in vivo studies 
that TNF-a also possesses anti-proliferative effects on human tumour xenograft in 
nude mice including malignant melanomas and gastrointestinal cancers. Due to its 
anti-proliferative effect on tumour cells, TNF-a can be used in cancer therapy (Saks 
and Rosenblum, 1992; Rothe et al” 1993; Takahashi et al, 1995; Liong et al； 1999)� 
1.2.3.1 Receptors of TNF-a 
The effects of TNF-a can be mediated by 2 distinct cell surface receptors. 
They are TNF-Receptor 1 (TNFRl) of 55 kDa in rodents and 60 kDa in human and 
TNF-Receptor 2 (TNFR2) of 75 kDa in rodents and 80 kDa in human (Lewis et aL, 
1991； Tartaglia et al, 1991; Tartaglia and Goeddel, 1992)�Both receptors are 
glycoproteins that exhibit in the extracellular domains with homologous sequence 
but with distinct intracellular or cytoplasmic domains (Tartaglia and Goeddel, 1992; 
Heller and Kronke, 1994). This discrepancy suggests that they mediate different 
intracellular signaling pathway upon binding to TNF. 
TNFRl is constitutively expressed as cell surface receptors in cells and it is 
responsible for most of the biological activities- of TNF-a such as programmed cell 
death, antiviral activity including the protection against the infection by Listeria 
monocytogenes (Pfeffer et al., 1993; Rothe et al., 1993) and host defense against 
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microorganisms and pathogens (Sethi et al., 2000). TNFR2 expression is subject to 
both transcriptional and post-transcriptional regulation induced by external cell death 
stimuli. TNFR2 has been suggested to play a role in thymocyte proliferation 
(Tartaglia et aL, 1991; Welbom et al” 1996; Grell et aL, 1998) and tissue necrosis 
(Erickson et cd., 1994). Moreover, TNFR2 was also found to be involved in 
multiorgan inflammation and microvascular endothelial cell damage (review: 
MacEwan, 2002). 
1.2.4 Signaling Pathway ofTNF 
The signaling pathway of TNF within the cells involves the activation of 
death domain, activation of the sphingomyelin pathway and activation of N F - K B 
pathway. Prior to the activation of any of the above pathways, an interaction of TNF 
receptors with its ligands must first occur. 
1.2.4.1 Activation of Death Domain 
Generally, TNF receptors possess an extracellular pre-ligand-binding 
assembly domain (PLAD). Upon the binding of the soluble or cell-surface expressed 
TNF-a to TNF receptor, PLAD can pre-complex receptor and allow trimerization of 
the cell surface receptors (review: MacEwan, 2002). The TNF receptor 1 possesses 
death domain (DD) in which it is associated with the DD of another protein called 
"TNFRl related DD protein" (TRADD). The death domain of TRADD can recruit 
"Fas-Associated Death Domain Protein" (FADD) which then interacts with the 
pro-domain of caspase-8, leading to the activation of caspase-8 and activates the 
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apoptotic pathway (Kubota et al” 2001). 
1.2.4.2 Activation of Sphingomyelin Pathway 
Sphingomyelin pathway is an alternative pathway in death receptor signaling. 
It involves the acidic form and the neutral form of enzymes called sphingomyelinase 
(SMases) that has been demonstrated to play a role in TNF signaling (Kim et al., 
1991). SMases is a sphingomyelin-specific form of phospholipase C that catalyzes 
the hydrolysis of the membrane sphingomyelin and produces the second messenger 
ceramide and phosphorylcholine (Schwandner et al； 1998). Upon the binding of 
TNF, trimerization of receptors occurs and this activates a TNFRl adaptor protein 
adjacent to the death domain of TNF receptor called FAN and in turn activates the 
neutral SMases (Reveiwed by Adam et al, 1996; Schwandner et al., 1998). 
Ceramide can therefore be produced and it has been suggested to induce cell death 
(Spiegel et al” 1996). Ceramide can also activate several targets such as a 
membrane-bound 97 kD kinase called the ceramide-activated protein kinase cascade 
(CAPK) (Liu et al., 1994) and protein kinase C cascade (Wiegmann et al., 1992) and 
caspases. On the other hand, it was found that ceramide also activates the nuclear 
factor kappa B (NF-KB) pathway that directs cells to proliferation. 
1.2.4.3 Activation of NF-KB Pathway 
Nuclear factor kappa B (NF-KB) belongs to the family of transcriptional 
activators that is involved in the proinflammatory responses mediated by 
TNF-a (Feldmann and Maini, 2001). It resides in the cytosol complexed with its 
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inhibitor, I-KBOC. Upon the binding of T N F - a , trimerization of T N F R L will lead to 
the phosphorylation and degradation of I-KBOC from the complex. Free N F - K B can be 
released and it can then translocate to the nucleus and stimulate the transcription of 
genes (Baeuerle, 1998). 
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The signaling pathway of TNR TNF mediates two pathway after binding to its 
receptors. Binding of TNF to TNFRl triggers the intereaction with the adaptor 
proteins, TNFR-associated death domain (TRADD) protein. TRADD recruits 
Fas-associated death domain (FADD) and also receptor interacting protein (RIP). 
The death domain of FADD interacts with the death domain in caspase-8 and this 
leads to the activation of the downstream caspase cascade. Binding of TNF to 
TNFR2 and the involvement of TNF receptor-associating factors (TRAFs) triggers 
the pathway leading to cell survival (Modified from review: MacEwan, 2002). 
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1.3 Types of Cell Death: Necrosis and Apoptosis 
1.3.1 Necrosis 
Necrosis is a kind of cell death in which cells die accidentally due to their 
exposure in extreme conditions such as hypoxia, hypothermia, ischemia or during 
autolysis (Kerr et al., 1995; Cameron and Feuer, 2001). It is a pathological process 
that often results in the swelling of cytoplasm and organelles, random DNA 
degradation and lysis of plasma membrane. Due to the loss of membrane integrity, 
the cytoplasmic content together with the lysosomal enzymes can be released and 
this induces inflammation of surrounding tissues by macrophages. 
1.3.2 Apoptosis 
Apoptosis, also called programmed cell death, is a kind of physiological cell 
death that was differentiated from necrosis by Kerr and his colleagues in Edinburgh 
in 1972, based on the differences in morphological, biochemical and molecular 
changes that occurs within dying cells (Alison and Saraf, 1992; Halestrap, 1999). It 
is found that apoptosis is an active, systemic and gene-regulated process that often 
leads to self-destruction of cells. 
Generally, apoptosis is found to be beneficial to organisms as it is 
participating in controlling the cell numbers of organisms at each developmental 
stage through the elimination of unwanted cells during embryogenesis, tissue 
homeostasis and cell differentitation (Alison and Sarraf, 1992). Moreover, certain 
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damaged and potentially dangerous cells such as the self-reactive lymphocytes, virus 
infected cells and tumour cells can be eliminated by apoptosis. However, 
inappropriate activation of apoptosis is harmful to organisms and always leads to 
certain autoimmune diseases, viral infections, cancer development and neural 
degenerative diseases (review: Mignotte and Vayssiere, 1998). 
Certain characterized morphological changes are associated with apoptosis. 
Cells undergoing apoptosis possess cellular shrinkage, followed by the plasma and 
nuclear membrane blebbing and the formation of apoptotic bodies. Besides 
biochemical changes such as chromatin condensation, degradation of genomic DNA 
into high molecular weight fragments of 300 一 50 kbp or oligonucleosomal 
fragments of 180 bp in size always occurs (Kravtsov and Fabian, 1996; Denecker et 
al” 2000). Prior to the initiation of apoptosis, cells must encounter various 
apoptosis-inducing stimuli or signals from either external sources such as ionizing, 
UV radiation or cytotoxic agents; or internal sources such as cytokines, growth 
factor withdrawal，levels of intracellular calcium (Azmi et al” 1996) or ATP 
(Nicotera et al., 1998). Table 1.1 summarizes the morphological and biochemical 
features of apoptosis. 
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Table 1.1 
A list of morphological and biochemical changes occurring in the necrotic and 
apoptotic cells (summarized from Cameron and Feuer, 2001; Kook et al” 2000; 
Lupulescu, 2001). 
Morphological features Biochemical features  
1. Cellular shrinkage and cytoplasm 1. Phosphatidylserine extemalization 
condensation 
2. Membrane blebbing with no loss of 2. Oligonucleosomal fragmentation of 
integrity DNA  
3. Formation of apoptotic bodies 3. Release of various factors from 
mitochondria into cytoplasm 
4. Aggregation of chromatin at the 4. Activation of endonucleases 
nuclear membrane  
5. Mitochondria become leaky due to ‘ 5. Activation of anti-death genes 
pore formation  
6. Decrease adhesion and intercellular 6. Increase mitochondrial oxidoreduction 
contacts  
7. Phagocytosis without inflammation 7. PARP cleavage  
8. Lamin (3 Cleavage 
9. Decrease in Cellular Metabolism 
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1.4 Signaling Pathway in Apoptosis 
Apoptosis has been found to be a kind of programmed cell death in cells that 
encounter various types of stimuli. Recently, it was found that 2 pathways are 
involved in apoptotic cell death. 
The first pathway involves the receptor signaling through the TNF receptor 
family such as TNFRl or Fas receptor. After binding to the corresponding ligands, 
the cell surface receptors undergo oligomerization and activated the initiator 
caspases 2，8 or 10 in cytosol and they, in turn, activate the other effector caspases 
for the execution of apoptosis (Alnemri, 1999). 
The second pathway involves mitochondria. Various stimuli such as ceramide 
oxidants, radiation can trigger the opening of the mitochondrial permeability 
transition pore. This leads to a decline in the mitochondrial membrane potential and 
often accompanies with the release of cytochrome c, which in turn activates the 
caspases and lead to apoptosis (Green and Reed, 1998). 
1.4.1 Factors Involved in Apoptotic Pathway 
1.4.1.1 Caspases 
Caspases belong to a family of aspartate-specific cysteine proteases that are 
constitutively expressed in their zymogen form in the cytosol of cells. The caspases 
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have the structure containing the catalytic cysteine residues located within a 
conserved QACRG motif (Verhagen and Vaux, 1999). When cells are stimulated 
with various apoptotic stimuli, signals will pass along the signaling pathway and the 
pro-form of caspases are cleaved after the aspartate residues. For caspases to achieve 
their full function, the precursor caspase was first cleaved into large and small 
caspase subunits followed by the removal of the N-terminal prodomain. The 
resulting caspase is a tetramer containing 2 large, 2 small subunits and 2 active sites 
(Zimmermann and Green, 2001). 
To date, 14 different kinds of caspases have been found, namely, caspase-1 to 
caspase-14 (Cohen, 1997; Song and Steller, 1999). Caspase-2, -8，-9 and -10 were 
found to be the initiator caspases in the apoptotic pathway as they are activated in 
response to the external death signals, such as Fas molecules. They can activate the 
downstream caspases such as caspases- 3, -6 and -7 that are the executioner caspases 
(Zimmermann and Green, 2001). 
1.4.1.2 Death Substrates 
Certain death substrates have proposed to be activated by caspases and they 
have important role in the apoptotic pathway. For example, DNA fragmentation 
factor (DFF), poly-ADP-ribose polymerase (PARP) and p53 are actively involved in 
DNA fragmentation and other events in the execution phase. 
DNA fragmentation factor (DFF) is a heterodimer composing of two subunits 
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of 40 and 45 kDa, DFF40 and DFF45 (Boulares et al., 2002). DFF45 is the inhibitor 
of the DFF40 and it is required for the expression of DFF40 (Enari et al., 1998). 
DFF40 is required for the subsequent activation of endonucleases that cause DNA 
fragmentation (Nagata, 2000). 
Poly-ADP-ribose polymerase (PARP) is a DNA repair enzyme whose 
expression is triggered by DNA strand breaks (Germain et al,, 2000). It is a substrate 
that can be cleaved by active caspase-3. During apoptosis, PARP is cleaved by 
caspase-3 from a 116 kDa peptide into 25 kDa and 85 kDa peptides. The cleavage of 
PARP and the 85 kDa subunit can facilitate the degradation of DNA. 
p53 is known to be the gene product of the tumour suppressor gene. It 
induces cellular activities in response to cellular stress (Schuler and Green, 2001) 
such as DNA damage (Komarova and Gudkov, 2001). It was found that wild type 
p53 regulated the growth arrest and at the same time, the p53-regulated gadd45 • 
(growth arrest DNA damage inducible 45) protein can play a role in the repair of 
damaged DNA (Kastan et al., 1992; Smith et al” 1996). Recently, it was found that 
hyperthermia could induce an accumulation of p53 gene product in the cells shortly 
after activation before the onset of cytochrome c release and the pro-caspase-3 
activation. (Marchenko et al., 2000; Komarova and Gudkov, 2001). 
• 产. ： 
1.4.1.3 Bcl-2 Protein Family 
Bcl-2 family is a family of proteins that can be divided basically on their 
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functions into two different groups. They are anti-apoptotic and pro-apoptotic 
proteins. Their sequence homology was confined to the four specific regions of 
Bcl-2 homology (BH) domains, the BH 1 to BH 4 (Yin et al., 1994; Farrow and 
Brown, 1996). Anti-apoptotic proteins mediate their functions mainly through the 
BH4 domain whilst pro-apoptotic proteins functions to promote apoptosis through 
the BH3 domain (Chittenden et al； 1995). Examples of anti-apoptotic proteins are 
Bcl-2, Bcl-xL，Bcl-x and those of pro-apoptotic proteins include Bax, Bad and Bid 
(Desagher et al, 1999). 
Basically, there are several mechanisms regulating the Bcl-2 proteins for the 
protection against apoptosis. These include acting as scavenger of free radicals, 
binding to cyto c and preventing it from leaving mitochondria and regulating caspase 
activities. Moreover, it was suggested that the anti-apoptotic proteins and 
pro-apoptotic proteins are able to heterodimerize so as to inhibit the biological 
activity of their partners (Antonsson and Martinou, 2000). 
The pro-apoptotic protein, bax, is related to the reduction of mitochondrial 
membrane potential after it is overexpressed in the mitochondria. Recently, it was 
found that it is involved in the participation in the opening of mitochondrial 
permeability transition pore. On the other hand, the bid protein that resides in the 
cytosol was suggested to be a pro-apoptotic Bcl-2 family member that participates in 
the release of cyto c from mitochondria upon its cleavage by caspase-8 (Slee et al, 
2000). 
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1.4.1.4 Role of Mitochondria 
Mitochondria play a central role in energy metabolism within cells. Through 
the oxidative phosphorylation that occurs within the inner mitochondrial membrane, 
around 80 to 90% ATP can be generated in most mammalian tissues (Szewczyk and 
Wojtczak, 2002). Recently, scientists have demonstrated that mitochondria also play 
an active role in apoptosis. It was found that changes of the mitochondrial membrane 
integrity were accompanied with the release of soluble intermembrane proteins, such 
as cytochrome c (cyto c)，apoptosis-inducing factor (AIF) and the "second 
mitochondria-derived activator of caspase" (Smac/DIABLO) and endonuclease G 
(Endo G) into the cytosol prior to any caspase activation. 
Cyotchrome c (cyto c) is a small, soluble protein of 15 kDa in size and it is 
located within the intermembrane space within mitochondria. Originally, cyto c is 
translated from the ribosomes in the cytoplasm as an apoprotein. After this 
apoprotein is imported into the intermembrane space of mitochondria, there is a 
covalent attachment of the apocytochrome c and the heme group that is synthesized 
in mitochondria and this creates cyto c (Vander Heiden and Thompson, 1999). Cyto 
c is one of the important constituents in the mitochondrial electron transport chain. It 
is responsible for the shuttling of electrons in between the cytochrome reductase 
(complexes III) and cytochrome c oxidase (complexes IV) in the respiratory chain in 
mitochondria for the production of ATP. Upon apoptosis, cyto c is released from the 
intermembrane space of mitochondria to the cytosol due to the opening of the 
mitochondrial permeability transition pores (Green and Reed, 1998; Mignotte and 
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Vayssiere, 1998; Single et al., 1998; Skulachev, 1998). The opening of mitochondrial 
permeability transition pores may be due to the swelling of mitochondrial matrix 
during apoptosis or due to the protein-protein interaction of pro-apoptotic protein of 
the Bcl-2 family. 
Apoptosis-inducing factor (AIF) is a 57 kDa flavoprotein that resides in the 
mitochondrial intermembrane space (Hunot and Flavell，2001). During apoptosis, 
AIF is released from mitochondria and it was then translocated to the nucleus. It acts 
on DNA by causing chromatin condensation and large scale DNA fragmentation 
(Susin et al., 1999; review: Wang, 2001). 
Second mitochondria-derived activator of caspase (Smac/DIABLO) is a 25 
kDa mitochondrial protein that is released from mitochondria, together with cyto c, 
into the cytosol during apoptosis (review: Wang, 2001). It is found to interact with 
the X chromosome-encoded inhibitor of apoptosis protein (XIAP) of lAPs family 
through the conserved BIR (Baculoviral lAP repeat) domain (Chai et aL, 2000). 
Through the interaction, the inhibitory effect of lAPs on caspase-3 and caspase-9 
activity was relieved. This, in turn, can promote the activation of caspase-9 that can 
activate the primary downstream pro-caspase-3 for the apoptosis to occur (Du et al., 
2000; Verhagen et al, 2000). 
Endonuclease G (Endo G) is a 30 kDa nuclease that resides in mitochondria. 
Upon the induction of apoptosis, Endo G is released from mitochondria at the same 
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time with the other mitochondrial proteins and it migrates to the mitochondria and 
leading to the nucleosomal DNA fragmentation (review: Wang, 2001)� 
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1.5 Objectives of the Project 
In this project, the potential of hyperthermia, TNF-a and their combination in 
the induction of cell death will be investigated using two cell lines, a TNF-sensitive 
cell line L929 and a TNF-resistant cell line L929-11E cells. 
Both L929 and L929-11E cells are murine fibroblast cell lines. L929 is a 
commonly used cell line model for studying the cytotoxic effect and mechanism 
mediated by TNF. On the other hand, L929-11E cells are derived from L929 cells 
and it is resistant to TNF treatment. Thus, with the application of TNF, L929-11E 
cells can be used as a control reflecting the role of TNF in mediating its cytotoxic 
effect in L929 cells. 
Recent findings suggest that mild hyperthermia induce apoptosis in certain 
cancer cell lines (Feril Jr. et al, 2002). However, limited information is provided for 
the mechanism of how hyperthermia mediates its anti-tumour effects through 
apoptosis in cancer cells and how hyperthermia affects mitochondria during 
apoptosis. 
Therefore, the objectives of the project are: 1) to study the mechanism of how 
hyperthemia and TNF-a mediate apoptosis; 2) to compare and contrast the effect of 
TNF-a and hyperthermia on the induction of apoptosis in L929 and L929-11E cells; 
3) to study the changes in mitochondrial activities upon hyperthermia and TNF-a 
treatment; 4) to examine the changes of the level of apoptosis-related protein; 5) to 
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find out the possible upstream pathway governing apoptosis from the treatment with 
hyperthermia and TNF-a. 
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Chapter 2 
Materials and Methods 
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2.1 Materials 
Table 2.1 
A list of the common name, chemical name and formula of chemicals. 
Common name，Chemical name and formula Source Formula 
Weight 
2-mercaptoethanol 78.13 Sigma Chemical Co., 
(C2H6OS) St. Louis，MO, USA 
4-OH-TEMPO 1 7 1 2 S i g m a Chemical Co., 
(4-hydroxy-2，2，6, 6-tetramethylpiperidine-1 -oxyl) St. Louis, MO, USA 
Acetic acid 60.05 BDH Chemicals Ltd., 
(CH3COOH) Poole, England 
Acrylamide/bis-acrylamide / Sigma Chemical Co., 
(30% solution, mix ratio 37.5:1) St. Louis, MO, USA 
Agarose / Sigma Chemical Co., 
- St. Louis, MO, USA 
Albumin, Bovine / Sigma Chemical Co., 
(BSA, initial fractionation by cold alcohol St. Louis, MO, USA 
precipitation, Fraction V 96-99% albumin)  
Ammonium persulfate 228.2 BIO-RAD 
Laboratories 
Annexin-V-Fluos labeling solution / Boehringer 
Mannheim, Germany 
Anti-bid antibody / Cell Signaling 
Technology™ 
Aiiti-caspase-3/CPP32 antibody / BD Transduction 
Laboratories 
Anti-cytoch rome c antibody / Pharmingen 
Anti-Grp-75 antibody / Santa Cruz 
Biotechnology, Inc. 
Anti-mouse-HRP conjugated antibody / BIO-RAD 
(mouse horseradish peroxidase conjugated) Laboratories 
Anti-p53 antibody / Santa Cruz 
Biotechnology, Inc. 
Anti-PARP antibody 1 Santa Cruz 
(poly(ADP-ribose) polymerase) Biotechnology, Inc. 
Anti-rabbit-HRP conjugated antibody 1 “ BIO-RAD  
(rabbit horseradish peroxidase conjugated) Laboratories 
Chapter 2, Materials and Methods Page 30 
Anti-TNFRl antibody 1 Santa Cruz 
Biotechnology, Inc. 
ApoAlert Caspase-3 Fluorescent Assay Kit / Clontech Laboratories 
(Cell Lysis Buffer, 2X Reaction Buffer，1 M DTT, 1 Inc. 
mM DEVD-AFC，1 mM DEVD-CHO, 80 _ AFC)  
ApoAlert Caspase-8 Fluorescent Assay Kit / Clontech Laboratories 
(Cell Lysis Buffer, 2X Reaction Buffer, 1 M DTT, 1 Inc. 
mM lETD-AFC, 1 mM lETD-fmk, 80 mM AFC)  
Aprotinin / Sigma Chemical Co., 
(3 - 7 TIU (trypsin inhibitor unit)) St. Louis, MO, USA 
BCA / Sigma Chemical Co., 
(Bicinchoninic acid solution) St. Louis，MO, USA 
Bromophenol blue 691.9 Sigma Chemical Co., 
(Ci9H9Br405SNa) St. Louis, MO, USA 
Calcium Chloride-2-hydrate 147.02Riedel-de Haen, AG, 
(CaCl2-2H20) Germany 
CCCP 2 0 4 . 6 S i g m a Chemical Co., 
(carbonyl cyanide m-chlorophenyl-hydrazone) St. Louis, MO, USA 
(C9H5CIN4)  
Chloroform 119.38 Merck, Germany 
(CHCI3)  
Commassie brilliant blue R-250 826.0 USB (United States 
(C45H44N507S2Na) Biochemical), 
Cleveland, OH, USA 
Copper (11) sulfate pentahydrate / Sigma Chemical Co.， 
(CUSO4-5H2O) (4% (w/v) solution) St. Louis, MO，USA 
Cycloheximide 281.3 Sigma Chemical Co., 
(CHX) (C15H23NO4) St. Louis, MO, USA 
Cyclosporin A 1202.6 Sigma Chemical Co., 
(CsA) St. Louis, MO, USA 
DCF ‘ 487 Molecular Probes, 
{2\1'-dichlorofluorescin diacetate) (H2DCFDA) Eugene, Oregon, USA 
Diethyl pyrocarbonate 162.1 Sigma Chemical Co., 
(DEPC) (C6H10O5) St. Louis，MO, USA 
Digitonin 1228 Merck, Germany 
(C56H92O29)  
DMSO 78.13 BDH Chemicals Ltd., 
(dimethylsulphoxide) (CH3SOCH3) Poole, England 
DNA marker / GibcoBRL, Life 
(100 base pair) Technologies Inc. 
ECL reagents / Amersham Pharmacia 
(Enhanced chemiluminescence reagents) Biotech  
Ethanol 4 6 . 0 7 B D H Chemicals Ltd.,  
(EtOH) (C2H5OH) Poole, England 
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Ethdium bromide 394 Molecular Probes, 
(EtBr) Eugene, Oregon，USA 
Ethylenediaminetetraacetic acid 292.2 Sigma Chemical Co., 
(EDTA) (C10H16N2O8) St. Louis, MO, USA 
FCCP 2 5 4 . 2 S i g m a Chemical Co., 
(carbonyl cyanide St. Louis, MO, USA 
p-(trifluoromethoxy)phenyl-hydrazone) (C10H5F3N4O)  
Fetal Bovine Serum / GibcoBRL, Life 
(FBS) Technologies Inc. 
Fluo-3/AM i T ^ Molecular Probes, 
(Fluo-3, acetoxymethyl ester) Eugene, Oregon, USA 
Fura-red/AM 1089 Molecular Probes, 
(Fura-red, acetoxymethyl ester) Eugene, Oregon，USA 
Glucose 180.2 Sigma Chemical Co., 
(C6H12O6) St Louis, MO, USA 
Glycine 75.07 USB (United States 
(H2NCH2CO2H) Biochemical), 
Cleveland, OH, USA 
HEPES 2 3 8 . 8 S i g m a Chemical Co., 
(N-[2-hydroxyethl]piperazine-N'-[2-ethanesulfonic St. Louis, MO, USA 
acid])  
Hydrochloric acid 36.45 BDH Chemicals Ltd., 
(HCl) Poole, England 
Isoamyl alcohol 88.15 Riedel-de Haen, AG, 
(3-methyl butanol-(l)) (C5H12O) Germany 
Isopropanol 60.1 BDH Chemicals Ltd., 
((CH3)2CH0H) Poole, England 
JC-1 ^ Molecular Probes, 
(5，5，，6，.6,-tetrachloro-l，V, 3， Eugene, Oregon, USA 
3 ‘-tetraethylbenzimidazolcarbocyanine iodide)  
Leupeptin 463 Sigma Chemical Co., 
(C20H38N6O4) St. Louis，MO, USA 
Low range marker for western blot / BIO-RAD 
Laboratories 
Magnesium chloride 203.3 Sigma Chemical Co., 
(MgCli) St. Louis, MO, USA 
Magnesium sulfate-7-hydrate 246.48 BDH Chemicals Ltd., 
(MgS04-7H20) Poole, England 
Methanol 3 2 . 0 4 B D H Chemicals Ltd., 
(CH3OH) Poole, England 
Molecular sieve / Sigma Chemical Co., 
(Potassium, Sodium alumino-silicate) (nominal pore St. Louis, MO, USA  
diameter: 3 angstrom)  
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MTT 414.3 I Sigma Chemical Co” 
(3-[4,5-dimethylthiazol-2-yl]-2,5-diphenyltetrazolium St. Louis, MO, USA 
bromide; thiazolyl blue) (CisHisNsSBr)  
Non-fat milk / Carnation, Nestle 
Penicillin-streptomycin / GibcoBRL, Life 
(penicillin: 5000 U/ml protein Technologies Inc. 
streptomycin: 5000 Dg/ml)  
Phenol 9411 USB (United States 
(C6H5OH) Biochemical), 
Cleveland, OH，USA 
PMSF 1 7 4 . 2 S i g m a Chemical Co., 
(phenylmethyl-sulfonyl fluoride) (C7H7FO2S) St. Louis，MO, USA 
Potassium chloride 74.55 Sigma Chemical Co., 
(KCl) St. Louis, MO，USA 
Potassium phosphate 136.1 Sigma Chemical Co., 
(monobasic anhydrous) (KH2PQ4) St. Louis，MO，USA 
Primers / GibcoBRL, Life 
(G3PDH, NRF-1，Tfam and TNFRl) Technologies Inc. 
Propidium iodide 668.4 Sigma Chemical Co., 
St. Louis, MO, USA 
Proteinase K / Sigma Chemical Co., 
(from tritirachium album) (16 U/mg protein) St. Louis, MO, USA 
Ribonuclease A / Sigma Chemical Co., ； (RNase A) (102 U/mg protein) St. Louis, MO, USA 
RPMI 1 GibcoBRL, Life 
(with phenol red) Technologies Inc. 
RPMI —I GibcoBRL, L i f e ~ 
(without phenol red) Technologies Inc. 
RT-PCR Kit 1 GibcoBRL, L i f e ^ 
(SuperScriptTM preamplification sytem for first strand Technologies Inc. 
cDNA synthesis; with oligo(dT) primer, lOX PCR 
buffer, 25 mM MgCh, 10 mM dNTP mix, 0.1 M DTT, 
superscript II reverse transcriptase and RNase H)  
SD^ 2 8 8 . 3 8 U S B (United States 
(sodium dodecyl sulfate) (CH3(CH2)iiS04Na) Biochemical), 
Cleveland, OH，USA 
Sheath fluid / Becton Dickinson, NJ, 
USA  
Sodium chloride 58.44 USB (United States 
(NaCl) Biochemical), 
Cleveland, OH, USA 
Sodium dihydrogen phosphate 156.01 Riedel-de Haen，AG,  
(NaHsPOzQ Germany 
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Sodium hydrogen carbonate 84.01 Sigma Chemical Co., 
(NaHCOs) S t Louis，MO, USA 
Sodium hydrogen phosphate 141.96 Sigma Chemical Co., 
(Na2HP04) St. Louis, MO, USA 
Sodium hydroxide 40.00 Sigma Chemical Co., 
(NaOH) St. Louis, MO, USA 
Sodium orthovanadate 183.9 Sigma Chemical Co., 
(Na3V04) St. Louis，MO，USA 
Sucrose 342.3 Sigma Chemical Co., 
(C12H22O11) St. Louis，MO，USA 
Taq DNA polymerase / GibcoBRL, Life 
(with 1 OX PGR buffer and 25 mM MgCl�） Technologies Inc. 
or MBI, Fermantas 
TEMED 116.21 Boehringer 
(N, N, N，，N‘-tetramethyl-ethylene diamine) Mannheim, Germany 
((CH3)2NCH2CH2N(CH3)2)  
TMRE 515 Molecular Probes, 
(tetramethylrhodamine, ethylester, perchlorate) Eugene, Oregon, USA 
TNF-a / Roche Diagnostics 
(recombinant murine tumor necrosis factor-alpha)  
^ 1 2 1 . 1 4 U S B (United States 
(NH2C(CH20H)3) Biochemical), 
Cleveland, OH, USA 
Trizol reagent / GibcoBRL, Life 
Technologies Inc. 
Trypsin-EDTA / GibcoBRL, Life 
(0.25% trypsin, 1 mM EDTA) Technologies Inc. 
Tween-20 / Sigma Chemical Co., 
(polyoxyethylene-sorbitan monolaurate) St. Louis, MO, USA 
Xylene cyanol FF 538.6 Sigma Chemical Co., 
(C25H27N206S2Na) St. Louis，MO, USA 
Z-ASP-CH2-DCB 454.26 Bachem AG, 
(z-Asp-2,6-dichlQrobenzoyloxymethylketone) Switzerland 
Z-IETD-FMK ^ R & D Systems, Inc. 
(Z-I-E(Ome)-T-D(Ome)-FMK)  
z-VAD-fmk 467.5 Bachem AG, 
(z-Val-Ala-DL-Asp(OMe)-fluoromethylketone) Switzerland 
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2.1.1 Culture of Cells 
2.1.1.1 TNF-a Sensitive Cell Line, L929  
L929 cells were purchased from American Type Culture Collection (ATCC, 
Rockville, MD, USA) and they are TNF-a sensitive cell line. They were established 
from the subculture generation of the parent L strain of fibroblasts in the 
C3H/An mouse. They have adherent characteristics and were maintained in RPMI 
1640 medium supplemented with 10% (v/v) fetal bovine serum and 1% 
penicillin-streptomycin (v/v) (complete medium) at 37 5% CO2 incubator (SHEL 
LAB) with humidified atmosphere. Generally, L929 cells were kept in 25, 75 or 125 
cm^ culture flasks and were passed every 3 or 4 days after growing to confluence. In 
each passage, the spent medium was discarded. Cells were then washed with PBS 
once and trypsin was added to release adherent cells from the culture flask. 
Complete medium was then added and suspension cells were collected. 
Centrifugation was carried out at 453 x g (1,500 rpm, 16.0 cm, Eppendorf Centrifuge 
581 OR) for 3 min. Pellet of cells was then suspended in complete medium and 
passed to a new culture flask for future use. 
2.1.1.2 TNF-a Resistant Cell Line, L929-11E 
The cell line, L929-11E, is a TNF-a resistant cell line. It was kindly provided 
by Prof. K. R Fung and Prof. H. K. Cheng (Department of Biochemistry, CUHK). 
Generally, L929-11E cells were isolated as TNF resistant variants from L929 cells 
according to the methods from Zimmerman et al. (1989) with modifications (Kwan, 
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1995). L929 cells were cultured in 25 cm^ culture flask. 20 units/ml TNF-a was 
added into the culture medium. Cells were maintained in this medium for two weeks 
and spent medium with dead cells were removed and medium was refreshed for 
every 3 days. The concentration of TNF-a was then increased to 50，100，200，1,000 
and 2,000 units/ml in a stepwise manner during 20 passages and finally, L929-11E 
cells were isolated. The resistance of L929-11E cells towards TNF-a was frequently 
checked with the MTT assays. The culture of L929-11E cells was the same as the 
sensitive L929 cell line in which cells were maintained in RPMI 1640 medium 
supplemented with 10% (v/v) fetal bovine serum and 1% penicillin-streptomycin 
(v/v) at 37 ^C, 5% CO2 incubator. 
2.1.1.3 Preservation of Cells 
Generally, cells were kept in freezing mixture as the frozen stock in liquid 
nitrogen. The freezing mixture was composed of 50% FBS (v/v), 40% complete 
medium (v/v) and 10% DMSO (v/v). Cells were harvested from the culture flasks 
with the use of trypsin and were suspended with complete medium. Centrifugation 
was then carried out at 453 x g (1,500 rpm, 16.0 cm, Eppendorf Centrifuge 581 OR) 
for 3 min. 5x10^ cells were suspended in one ml of freezing mixture as mentioned 
above and one ml of cell suspension was transferred to the freezing vials. The cells 
were then cooled at -20 until it frozen and then put at -70 overnight. 
Afterwards, cells were stored in liquid nitrogen until use. To thaw the cells, cells 
were thawed quickly and diluted in excess pre-warmed complete medium. 
Centrifugation at 453 x g (1,500 rpm, 16.0 cm, Eppendorf Centrifuge 581 OR) for 3 
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min was then carried out and pellet of cells were suspended into complete medium 
and was transferred to a new culture flask. 
2.1.2 Culture Media 
2.1.2.1 RPMI 1640 (Phenol Red Medium) 
RPMI (Rosewell Park Memorial Institute) 1640 was the medium used for 
culturing of sensitive and resistant cell lines. It consisted of phenol red, L-glutamine 
and 0.5 mM HEPES. The power of RPMI was then dissolved in one liter of dHiO 
and was supplemented with 24 mM NaHCOs. The pH of the medium was adjusted to 
7.4. Then, the medium was sterile filtered with the use of 0.22 jum cellulose acetate 
membrane bottle-top filter. (7111, Falcon, Becton Dickinson, NJ, USA). The 
medium was then supplemented with 10% FBS and 1% penicillin-streptomycin for 
cell culture. The complete medium was stored at 4 
2.1.2.2 RPMI 1640 (Phenol Red-free Medium) 
Phenol red-free RPMI medium consisted of L-glutamine without phenol red 
or HEPES. The power of phenol red-free RPMI was then dissolved in one liter of 
dKtO and was supplemented with 24 mM NaHCOs and 25 mM HEPES. The pH of 
the medium was adjusted to 7.4. Then, the medium was sterile filtered with the use 
of 0.22 iLxm cellulose acetate membrane bottle-top filter. The colorless medium was 
supplemented with 1% penicillin-streptomycin only. The medium was then stored at 
4 � C . 
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2.1.3 Buffers and Reagents 
2丄3.1 Preparation of Buffers 
Buffer was prepared from dissolving chemicals in distilled water (dH20) and 
titrated to suitable pH with either HCl or NaOH，unless otherwise specified. 
2.1.3.2 Buffer for Common Use 
Phosphate buffered saline (PBS) was prepared using 2.7 mM KCl, 1.5 mM 
KH2PO4, 136 mM NaCl and 8 mM NaiKPOq and the pH was adjusted to 7.4. PBS 
was made sterilized by autoclave and was then stored at 4 
2.1.3.3 Reagents for Annexin-V-FITC/PI Assay 
Annexin-V-Fluos labeling solution was purchased from Boehringer 
Mannheim. It was produced in Saccharomyces cerevisiae as recombinant form and 
was stored as aliquots at -20 (Manual of Boehringer Mannheim). Repeated 
thawing and freezing should be avoided. 
Incubation buffer was freshly prepared with 10 mM HEPES, 140 mM NaCl 
and 5 mM CaCli. The pH was adjusted to 7.4 titrated with NaOH before use. 
2.1.3.4 Reagents for Cytotoxicity Assay 
Lysis buffer for cytotoxicity assay was prepared with 0.04 N HCl in 
isopropanol and was stored at room temperature. 
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2.1.3.5 Reagents for Molecular Biology Work 
Lysis buffer for DNA isolation was prepared with 5 mM Tris，100 mM 
EDTA and 1% (w/v) SDS. The pH was adjusted to 8.0 and the buffer was stored at 4 
OC. 
6X loading buffer was prepared with 0.25% (w/v) bromophenol blue, 0.25% 
(w/v) xylene cyanol FF and 40% (w/v) sucrose and the buffer was stored at 4 � C . 
TE buffer was prepared with 10 mM Tris and 0.5 mM EDTA. The pH was 
then adjusted to 7.4. The buffer was made sterilized by autoclave and was then 
stored at room temperature. 
DEPC-dH^O was prepared by adding 1 ml of DEPC (diethyl pyrocarbonate) 
in 1 L dH20. The mixture was stirred overnight and then autoclaved. The solution 
was then stored at room temperature. • 
2.1.3.6 Reagents for Western Blotting Analysis 
Lysis buffer for total protein extraction was prepared with 1 mM NasVCU, 
1% (w/v) SDS, 10 mM Tris. The pH was then adjusted to 7.4 and stored at room 
temperature. Prior to the lysis of cells, the lysis buffer was supplemented with 5 mM 
MgCb, 1 mM PMSF and protease inhibitors such as 21 jig/ml aprotinin and 5 jug/ml 
leupeptin. 
Chapter 2, Materials and Methods Page 39 
Lysis buffer for cytochrome c extraction was prepared with 75 mM NaCl, 
1 mM NaH2P04, 8 mM NaiHPCU, 250 mM sucrose. The buffer was stored at 4 
Prior to the lysis of cells, the buffer was supplemented with 1 mM PMSF, 21 )Lig/ml 
aprotinin, 5 jag/ml leupeptin and various concentrations of digitonin. 
4X lower gel buffer was prepared with 1.5 M Tris base and 14 mM SDS. 
The pH of the buffer was adjusted to 8.8 and stored at 4 
4X upper gel buffer was prepared with 0.5 M Tris base and 14 mM SDS. 
The pH of the buffer was adjusted to 6.8 and stored at 4 
12% separating gel buffer was freshly prepared with 40% (v/v) 
acrylamide/bis-acrylamide (30%) solution, 25% (v/v) 4X lower gel buffer, 0.05% 
(w/v) ammonium persulfate and 0.12% (v/v) TEMED. 
4.5% stacking gel buffer was freshly prepared with 15% (v/v) 
acrylamide/bis-acrylamide (30%) solution, 25% (v/v) 4X upper gel buffer, 0.07% 
(w/v) ammonium persulfate and 0.13% (v/v) TEMED. 
2X SDS loading buffer was prepared with 2% (w/v) SDS, 10% (w/v) 
sucrose, 0.002% bromophenol blue and 62.5 mM Tris. The pH of the buffer was 
adjusted to 6.8. Buffer was supplemented with 5% (v/v) 2-mercaptoethanol and 
stored at 4 
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SDS tank buffer was prepared with 25 mM Tris base, 192 mM glycine and 
0.1% (w/v) SDS and stored at room temperature. 
Electroblot buffer was freshly prepared with 48 mM Tris base, 39 mM 
glycine，20% (v/v) methanol and 0.0375% (w/v) SDS. The pH of the buffer was 
adjusted to 9.2 to 9.4. 
TBS-Tween-20 (TBS-T) was prepared with 10 mM Tris base, 0.15 M NaCl 
and 0.1% (v/v) Tween-20 and stored at room temperature. 
Commassie Blue staining solution for protein staining was prepared with 
acetic acid，methanol and dHiO with a ratio of 1:3:10. 0.05% (w/v) commassie 
brilliant blue R-250 was added and the solution was stored at room temperature. 
De-stain solution for removing commassie brilliant blue R-250 was 
prepared with 40% (v/v) methanol and 10% (v/v) acetic acid and was stored at room 
temperature. 
2.1.4 Chemicals 
2.1.4.1 Recombinant Murine TNF-a 
Recombinant murine TNF-a is produced in E. coli and purified by standard 
chromatographic techniques and has more than 95% purity as determined by 
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SDS-PAGE (Manual of Roche Diagnostics). It was dissolved in PBS with the stock 
concentration of 5 jLig/ml and was stored at -70 ^C with minimal repeated freezing 
and thawing. It has the specific activity of more than 6.0 x 10^ U/mg. The unit 
definition is that one unit is defined as the amount of TNF-a required for mediating 
half-maximal cytotoxicity with L929 cells in the presence of actinomycin D. 
2.1.4.2 Dye for Cytotoxicity Assay 
MTT powder was dissolved in PBS with a stock concentration of 5 mg/ml 
and was then filtered by filter paper (Whatman). The solution was stored at 4 
2.1.4.3 Fluorescence Dyes 
JC-1 (5, 5', 6，6'-tetrachloro-l, 1’，3, 3‘-tetraethylbenzimidazolcarbocyanine 
iodide) and TMRE (tetramethylrhodamine, ethylester, perchlorate) were used for 
mitochondrial membrane potential labeling. DCF (2', 7‘-dichlorofluorescin diacetate) 
was used for ROS determination. Fluo-3/AM and fura-red/AM were used for Ca^ "^  
studies. Propidium iodide was used to study the DNA pattern of the cells. The 
powder form of fluorescence dyes were dissolved in DMSO (excess water was 
absorbed by molecular sieve) and were stored at 4 
2.1.4.4 Chemicals Related to Mitochondria Studies 
Cyclosporin A (CsA), an inhibitor of mitochondrial permeability transition 
pore and FCCP (carbonyl cyanide p-(trifluoromethoxy)phenyl-hydrazone), an 
uncoupler of mitochondrial electron transport chain, were dissolved in absolute 
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ethanol and stored at 4 Cycloheximide (CHX), an antifungal antibiotic that 
inhibit protein synthesis, was dissolved in absolute ethanol and stored at -20 
4-Hydroxy-TEMPO, a stable, cell permeable antioxidant that acts as a free radical 
scavenger, was freshly prepared with distilled water and stored at 4 in dark. 
2.1.4.5 Inhibitors of Caspases 
z-VAD-fmk (z-Val-Ala-DL-Asp(OMe)-fluoromethylketone) and 
z-Asp-CH2-DCB (z-Asp-2,6-dichlorobenzoyloxymethylketone) were dissolved in 
absolute ethanol and stored at -20 Z-IETD-FMK (Z-I-E(Ome)-T-D(Ome)-FMK) 
was dissolved in DMSO and stored at -20 
2.1.4.6 Antibodies for Western Blotting 
Primary antibodies included anti-caspase-3 (1:200, recognizes 22 kDa), 
anti-Grp-75 (1:1000, recognizes 75 kDa), anti-cytochrome c (1:1000，recognizes 15 
kDa protein); caspase-targeted proteins such as anti-PARP (1: 200，recognizes 116 . 
and 89 kDa proteins), anti-p53 (1:200, recognizes 47 kDa protein); pro-apoptotic 
proteins such as anti-Bid (1:200, recognizes 24 kDa protein). Secondary antibodies 
included anti-mouse-HRP conjugate (1:1000), anti-rabbit-HRP conjugate (1:1000) 
and anti-goat-HRP conjugate (1:1000). All antibodies were kept at 4 and repeated 
freezing and thawing should be avoided. When the antibodies were in use, they were 
diluted in 5% non-fat milk in TBS-T or 1% (v/v) BSA. 
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2.1.4.7 Other Chemicals 
Aprotinin, leupeptin, PMSF, ammonium persulfate, agarose, proteinase K， 
RNase A, ethidium bromide were used. Aprotinin and leupeptin were dissolved in 
dHiO and stored at -20 PMSF was dissolved in absolute ethanol and stored at -20 
Ammonium persulfate was dissolved in dHiO and stored at 4 Agarose was 
dissolved in TBE buffer. Ethidium bromide solution was diluted with dHsO and kept 
at room temperature in dark. Proteinase K and RNase A were dissolved in dHzO and 
TE buffer respectively and kept at -20 
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2.2 Methods 
In this project, both L929 and L929-11E cells were treated with TNF-a or 
hyperthermia at 43 as described below. 
2.2.1 Treatment with TNF-a 
Cells (1 X lOVml) in complete medium were seeded on 6-well plates at 37 
and 5% CO2 overnight. On the day of experiment, cells were washed with 
serum-free medium twice. Cells were then treated with TNF-a (50 ng/ml) for 
various time intervals. Control cells were only treated with serum-free medium. 
After treatment, cells were collected for different assays. 
2.2.2 Treatment with Hyperthermia 
Hyperthermia treatment was applied on cells by incubating the cells at 43 
5% CO2 incubator (SHEL LAB) in humidified atmosphere for various time courses. 
Cells (1 X 10^/ml) in complete medium were seeded in 6-well plates at 37 
and 5% CO2 overnight. On the day of experiment, cells were washed with 
serum-free medium twice. Cells were then treated with hyperthermia at 43 5% 
CO2 for various time intervals. In some part of the experiments, cells were further 
incubated at 37 5% CO2. Control cells were incubated at 37 ^C with 5% CO2. 
After treatment, cells were collected for different assays. 
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2.2.3 In vitro Cell Cytotoxicity Assay 
MTT Assay 
MTT assay is a quantitative colorimetric assay for the determination of cell 
survival and proliferation (Masmann, 1983). It employs tetrazolium salts, MTT 
(3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide) that can measure 
the activity of various dehydrogenase enzymes in viable cells (Pagliacci et al； 1993). 
In living cells, the tetrazolium ring of the pale yellow MTT is cleaved to form dark 
blue formazan products in the active mitochondria and such changes allow cell 
survival determination (Masmann, 1983). 
One hundred jji of cells (3 x IcWwell) in RPMI medium were seeded in 96-well 
flat bottom microtiter plates (Coming) and were incubated at 37 5% CO2 
overnight. On the day of experiment, spent medium was discarded and cells were 
washed with serum-free RPMI medium twice and were then treated with TNF-a, 
hyperthermia or drugs in serum-free medium. Control cells were incubated with 
serum-free RPMI medium. After treatment, the medium was discarded and 100 [x\ 
fresh serum free medium and 20 j^ l MTT solution (5 mg/ml in PBS) was added to 
each well. The plates were then incubated for another 2 hr at 37 °C，5% CO2. After 
that, the medium was discarded and 100 )ji/well of acidic isopropanol was added to 
each well and incubated at 37 for 15 min. The absorbance at 540 nm was then 
recorded by a microplate reader (BIO-RAD, model 3550), using acidified 
isopropanol as the blank. 
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Statistical Calculations 
In each experiment, more than three samples were tested in each plate. 
Percentage cytotoxicity was expressed as mean 士 standard deviation (S.D.). The 
percentage cytotoxicity was defined as follows: 
Percentage cytotoxicity 
=[(Mean O.D. of control - Mean O.D. of test) / Mean O.D. of control] x 100% 
where control cells were incubated with serum-free medium only. The statistical 
significance was defined with p-value smaller than 0.005. 
2.2.4 Flow cytometry 
2.2.4.1 Introduction 
Flow cytometry is a sensitive and precise method for the measurement of 
certain physical and chemical characteristics of cells or biological particles through 
the detection and analysis of light scattered from a continuous sample of cells as they 
pass individually through the detectors by means of hydrodynamic focusing. Figure 
2.1 shows the setup of the flow cytometer (FCM) (Becton Dickinson, FacSort). 
Basically, FCM consists of four principal components: 1) a fluid system that 
transports the cells across the microscopic field, 2) an optical system which is 
responsible to emit coherent light at specific wavelength and detectors for scattered 
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A simplified diagram ofFCM (Modified from Sureda et al” 1999). 
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light, 3) electronic signal processing, and 4) sorting control (Ormerod, 1994). 
The principle of flow cytometry is that cells with hydrodynamic focusing are 
individually exposed to laser beam of different wavelength. The scattered light are 
analyzed in the forward direction (forward scatter, FSC) which correlate with the cell 
size and at right angle (side scatter, SSC) which correlate with the membrane and 
internal structure. For cells labeled with different fluorescence dyes, various kinds of 
fluorescence can be detected. (Sherwood and Schimke, 1995). Table 2.2 shows a list 
of parameters that can be measured by FCM. 
The flow cytometer can measure how a cell scatters light and emits 
fluorescence and then records and stores the data when they pass through the sample 
stream. It allows a multiple-parameter analysis. Using the information, the stream is 
able to determine the size, granularity and depending on the fluorescent stain 
employed, different parameters can be determined (Jett, 1996; Ormerod, 1994). 
2.2.4.2 Analysis by FCM 
Prior to the analysis by FCM, cells (1 x 10^/ml) in RPMI medium were 
seeded in 6-well plates and were incubated at 37 5% CO2 overnight. On the day 
of experiment, cells were washed twice with serum-free medium and were then 
treated with TNF-a, hyperthermia or drugs at various time intervals. After treatment, 
cells were harvested and the cellular activities were then determined with the 
application of different fluorescent dyes. 
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Table 2.2 
A summarized list of parameters measured by flow cytometry (Ormerod, 1994) 
Parameters Fluorescence dyes used 
RNA content Acridine orange (AO) 
DNA content Sulphorhodamine 101, 
Fluorescein isothiocyanate (FITC) 
Intracellular enzyme activity Fluorescein (FDA), 4-methylumbilliferone, 
a-naphthol 
Membrane permeability Fluorescein 
Membrane potential Rhodamine 123，JC-1 
Intracellular Dichlorofluorescin (DCFH) 
oxidative species 
Cell morphology Lucifer yellow 
Intracellular calcium ions Fura-2, Fluo-3 
Intracellular pH Carboxy-SNARF-1，BCECF 
Measurement of drug intake Anthracyclines 
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The acquisition of the cells was analyzed by "Cell Quest" program on the 
system of FACSort FCM (Becton Dickinson). An argon laser with excitation at 
488nm was used for the FCM. Prior to the analysis, the forward scatter (FSC) that 
determined the size and side scatter (SSC) that determined the granularity of a cell 
were monitored to determine the population of cells needed for the analysis. After 
the selection of the suitable region of cells, the fluorescence properties of 10,000 
cells were collected with a flow rate at around 300 cells/sec. 
After the analysis by FCM, the flow cytometric data was analyzed with the 
software called WinMDI version 2.8 that can be downloaded from internet with the 
website (http://facs.scripps.edu/software.htmn. 
2.2.4.3 Determination of Apoptotic and Late Apoptotic/Necrotic Cells with 
Annexin-V-FITC/PI Cytometric Analysis 
After cells were treated with hyperthermia, TNF-a or other chemicals, both 
floating and adherent cells were collected. Adherent cells were washed with 
serum-free medium twice and were harvested with trypsin. After centrifugation, 
pellet of cells were again washed with serum-free medium twice. 5 x 10^  cells were 
then loaded with 100 i^l of incubation buffer containing 2% (v/v) Annexin-V-FITC 
for 20 min at room temperature. After that, 400 \i\ of incubation buffer containing 
2.5 |LLg/ml PI was added and cells were further incubated at room temperature for 20 
min. 
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Analysis was then carried out with a flow cytometer (FACSort, Becton 
Dickinson) with excitation at 488 nm and fluorescence signals from annexin-V-FITC 
and PI were collected respectively with the channels of FL-1 for green fluorescence 
and FL-3 for red fluorescence in a logarithm (log) scale. The flow cytometric data 
was analyzed with WinMDI version 2.8. 
2.2.4.4 Determination of Mitochondrial Membrane Potential (A^m) 
Mitochondrial membrane (A中⑴）depolarization was suggested to be one of 
the mechanisms in the induction of apoptosis. The mitochondrial membrane 
depolarization can be determined by flow cytometry. One of the dye used in the 
determination of A^m was JC-1 dye 
(5,5，,6,6，-tetrachloro-l,l，,3,3，-tetraethylbenzimidazol-carbocyanine iodide). JC-1 
was a lipophilic cationic probe with the following structure (Reers et al., 1995): 
C凡 
/ 2 5 C2H5 
Figure 2.2: Chemical structure of JC-1 
After appropriate treatment, 250,000 cells in 400 jul serum-free medium were 
loaded with 10 juM JC-1 dye in 100 jul serum-free medium at 37 ""C for 15 min. Then, 
cells were submitted to flow cytometric analysis with excitation at 488 nm. The 
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fluorescence signals from JC-1 were collected with the channels of FL-1 and FL-3 in 
a logarithm (log) scale. 
2.2.4.5 Determination of Hydrogen Peroxide (H2O2) Release 
DCF was in a lipophilic non-fluorescent dye. It can diffuse into cells and be 
converted from the DCF-DA form by esterases into hydrophilic form. The 
hydrophilic DCF can then be oxidized by H2O2 to give green fluorescence. The 
fluorescence emitted is proportional to the amount of H2O2 release. 
After treatments, cells were loaded with 10 foM DCF and PI and incubated at 
room temperature. Flow cytometry was then carried out� 
2.2.4.6 Determination of Intracellular Free Calcium ([Ca2+]i) Level 
The intracellular free calcium levels in L929 cells can be determined with 
two calcium-sensitive dyes, fluo-3/AM and fura red/AM. The acetoxymethylester of 
fluo-3 is a hydrophobic molecule that can be admitted into the cells by simple 
diffusion across the plasma membrane. Inside the cells，esterases remove the 
acetoxymethyl group, leading to the formation of the hydrophilic and fluorescent 
form of the dye. Fluo-3 can therefore, using the flow cytometric analysis, the 
intracellular concentration of calcium can be determined. 
• � 
After treatments of cells, 250,000 cells in 400 jji serum-free medium were 
loaded with 10 \iM fluo-3 and 10 [xM fura-red in 100 jji serum-free medium and 
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incubated at room temperature for 1 hour at room temperature. Flow cytometry was 
then carried out. 
2.2.4.7 Determination of the Relationship of A^m and Level 
The relationship between A^m and [Ca^^Ji level can be studied with the use 
1 I 
of 2 fluorescent dyes. Fluo-3 is used in monitoring the [Ca ]i level whilst A^m of 
the cell can be monitored with TMRE (tetramethylrhodamine ethyl ester). TMRE is 
a potentiometric dye which can be used to monitor relative changes in membrane 
potential. 
After treatments of cells, 250,000 cells in 400 |LI1 serum-free medium were 
loaded with 10 i^M fluo-3 and 500 nM TMRE in 100 serum-free medium and 
incubated at room temperature for 15 min at room temperature. Flow cytometry was 
then carried out. 
2.2.5 Western Blotting Analysis 
2.2.5.1 Preparation of Proteins from Cells 
Total Protein Extraction 
L929 or L929-11E cells with appropriate treatments were washed with 
serum-free medium twice and then trypsinized. After centrifugation, the pellet of 
cells was washed with serum-free medium twice and the number of cells was then 
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counted. For one million of cells, 100 |LI1 of lysis buffer (1% (w/v) SDS, 1 mM 
Na3V04�10 mM Tris, 5 mM MgCl?�21 |Lig/ml aprotinin, 5 |Lig/ml leupeptin, 1 mM 
PMSF and pH = 7.4) was added and incubated at room temperature for 30 min. After 
that, samples were boiled for 10 min and centrifugation at 20,812 x g (14,000 rpm， 
9.5 cm, Eppendorf Centrifuge 5417R) for 7 min at 4 Supernatant was then 
collected and stored at -70 
Determination of Protein Amount 
The amount of protein obtained by SDS lysis method was examined by BCA 
assay. The assay was carried out in a 96-well plate. First of all, the protein standards 
with different amounts of bovine serum albumin (BSA, with 2，4，6, 8, 10 昭 per 
well) were added to each well. For the part of protein samples, 1 [il of protein 
samples were mixed with 9 \il of PBS in each well. Three replicate of samples and 
BSA standard were performed. After that, 200 jul of BCA mixture consisting of BCA 
(bicinchoninic acid) solution and CuSCU • 5H2O solution in a ratio of 50:1 was added 
to each well and the plate was then incubated at 37 ^C for 30 min. The absorbance 
was then recorded at 540 nm with a microplate reader, using BCA mixture 
containing PBS solely as a blank. The standard curve was then plotted with the 
x-axis represented the concentration of BSA and the y-axis represented the 
absorbance at 540 nm measured. The equation was developed from the standard 
curve and it was then used for the determination of the amount of protein. 
Chapter 2, Materials and Methods Page 55 
0.5 -T  
y 二 0.038X + 0.011 
0.4 - �2 = 0.997 
i -
S 0 .2 一 J ^ 
° z 0.1 - # 
0.0 - X . 
I I I 1 i 1  
0 2 4 6 8 10 12 
BSA _ 
Figure 2.3 
A standard curve for protein determination. The BCA method was used for the 
determination of protein amount in each sample. The amount of protein can be 
determined by fitting the mean optical density (O.D.) of each sample (triplicate) into 
the y-value of the equation, y = 0.038x + 0.011. The amount of protein in each 
sample can then be obtained from the x value of the equation. The r^  represented the 
linearity of the curve. 
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Cytosolic Protein Isolation 
Cytosolic protein can be isolated with the use of digitonin at various 
concentrations. L929 or L929-11E cells with appropriate treatments were washed 
with serum-free medium twice and then trypsinized. After centrifugation, the pellet 
of cells was washed with serum-free medium twice and the number of cells was then 
counted. In each sample, 50 i^l of lysis buffer (75 mM NaCl, 1 mM NaH2P04, 8 mM 
Na2HP04, 250 mM sucrose, 21 |ag/ml aprotinin, 5 jj,g/ml leupeptin, 1 mM PMSF and 
various concentrations of digitonin) was added to 4 million of cells and the mixture 
was vortex vigorously for 30 sec at room temperature. After that, samples were spun 
at 10,621 X g (10,000 rpm, 9.5 cm, Eppendorf Centrifuge 5417R) for 1 min at room 
temperature with a centrifuge (MSE, MicroCentaur, Sanyo). Subsequently, 
supernatant was then collected and 50 jiil of 2X SDS.loading buffer was added. The 
mixture was then boiled for 10 min and centrifugation was then carried out at 20,817 
X g (14,000 rpm, 9.5 cm，Eppendorf Centrifuge 5417R) at 4 for 7 min. After that, 
.supernatant was collected and the extract was stored at -70 
2.2.5.2 SDS Polyacrylamide Gel Electrophoresis (SDS-PAGE) 
The apparatus of Mini-Protean 11 cell (BIO-RAD Laboratories) for 
SDS-PAGE was set up according to the manual. 
12% SDS polyacrylamide separating gel and 4.5% stacking gel were used. In 
each experiment, 25 ^g of protein samples was mixed with equal volume of 2X SDS 
loading buffer and samples were then boiled for 3 min. Then, protein samples, 
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together with the low range protein marker were loaded on each well. The voltage 
was set at 150 V and protein samples were run for 1 hr. After that, gels were 
removed from the apparatus and were soaked in electroblot buffer. 
2.2.5.3 Electroblotting of Protein 
The electroblotting of proteins was carried out with the use of the Mini 
Trans-Blot Cell (tank transfer system, BIO-RAD Laboratories). 
Prior to the electroblotting, the dry 0.22 |am PVDF (polyvinylidene fluoride) 
membrane (Immobilon-P^^, Millipore) was rehydrated with absolute methanol and 
then immersed in electroblot buffer for 15 min. Moreover, 1 mm filter paper 
(Whatman) was also soaked in electroblot buffer before use. The tank transfer 
system for electroblotting was set up with the following sequence: cathode, fiber pad, 
3X filter paper, gel, PVDF membrane, 3X filter paper, fiber pad, anode. 
Electroblotting was then performed with the voltage of 100 V for 1 hr. 
After electroblotting, the gels were stained with commassie blue staning 
solution overnight for protein determination and then de-stained with de-stain 
solution for another day. 
2.2.5.4 Probing Antibodies for Proteins 
After blotting, the membrane was transferred to a petri dish and 20 ml of 5% 
non-fat milk (in TBS-T) was added for non-specific blocking. The membrane was 
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incubated at 4 � C overnight. After that, the membrane was washed with TBS-T twice 
for 15 min. The membrane was probed with primary antibodies for 1 hr at room 
temperature. The antibodies were then removed and the membrane was washed with 
TBS-T twice for 15 min. Secondary antibodies was then loaded to the membrane for 
another hour. After that, the membrane was washed with TBS-T twice for 15 min. 
2.2.5.5 Enhanced Chemiluminescence (ECL) Assay 
ECL assay was performed by mixing the ECL reagent 1 and reagent 2 in a 
ratio of 1:1 (Amersham Pharmacia Biotech). The membrane was then exposed to the 
ECL reagent mixture for 1 min at room temperature. After that, the membrane was 
wrapped with saran wrap and was developed on Hyperfilm ECL autoradiography 
film (Amersham Pharmacia Biotech) or Fuji Medical x-ray film (super Rx, Fuji) at 
various time period. Films were then processed in a film processor (M35 X-OMAT, 
Kodak). The band intensity was then scanned with a densitometer (Molecular 
Dynamics) and images were analyzed by an imaging software, ImageQuaNT, 
version (Molecular Dynamics). 
2.2.6 Reverse Transcriptase Polymerase Chain Reaction 
Reverse transcriptase polymerase chain reaction (RT-PCR) is the technique 
that is used for studying the gene expression in tissues and cells. The procedures 
were based on the instruction manual from Trizol reagent and the RP-PCR kit 
(superscript Preamplification System for First Strand cDNA Synthesis, GibcoBRL, 
Life Technologies Inc) with slightly modification. 
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2.2.6.1 Extraction of RNA by Trizol Reagent 
L929 or L929-11E cells (1 x 10^/well) in complete medium were seeded in 
6-well plates and incubated at 37 5% CO2 overnight. On the other day, cells were 
washed with serum-free medium twice and then treated with TNF-a (50 ng/ml) or 
hyperthermia at 43 at different period of time. After treatments, the spent medium 
was discarded and cells were washed twice with serum-free medium. Then, 1 ml of 
Trizol reagent was added to each well and the cells were lysed with pipette up and 
down for several times. The lysate was then transferred to the microcentrifuge tube 
and kept at 4 °C for 5 min to prevent the degradation of RNA. Two hundred of 
chloroform was added to the lysate, followed by vigorous vortex for 15 sec. Samples 
were then incubated for 3 min at 4 � C and centrifuged at 15,294 x g (12,000 rpm, 9.5 
cm, Eppendorf Centrifuge 5417R) for 10 min at 4 After centrifugation, the 
mixture was separated into 3 layers with a lower red, phenol-chloroform phase 
containing protein; the interphase containing DNA and the colorless upper aqueous 
phase containing the RNA. The upper aqueous phase was then transferred to the new 
microcentrifuge tube. The samples were gently mixed with 500 )al of isopropanol 
and were then incubated at 4 for 10 min. After that, centrifugation was performed 
at 15,294 X g (12,000 rpm, 9.5 cm, Eppendorf Centrifuge 5417R) for 10 min at 4 
The supernatant was then discarded and 1 ml of 75% ethanol was added to the pellet 
and mixed gently and RNA can be stored at -20 °C if not in immediate use. When in 
use, the samples were centrifuged at 8,603 x g (9,000 rpm, 9.5 cm, Eppendorf 
Centrifuge 5417R) for 5 min at 4 Ethanol was then discarded and RNA was 
air-dried for 10 min. 50 of DEPC-dH^O was then added and the samples were 
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incubated at 60 for 10 min. The samples were then stored at - 2 0 � € overnight or 
can be used immediately to determine the amount ofRNA within each sample. 
2.2.6.2 Determination of the Amount of RNA 
The amount of RNA can be determined by measuring the O.D.260 and O.D.280. 
First of all, 2 |Ltl of sample was mixed with 500 \il of DEPC-dE^O. The O.D. at 260 
nm and 280 run was then measured with the use of the UV spectrophotometer 
(Shimadzu, model UV-1601). After the measurement, the O.D.260/280 was calculated 
and the ratio should be more than 1.6. The amount of RNA in each of sample was 
then calculated with the following formula. 
\ ‘ 
Amount of RNA in each (^ig/^il) = (O.D.260 / 0.1) x (4 / 1000) x (502 / 2) 
After the amount of RNA for each sample was obtained, one jig of RNA was 
then resolved in 1% agarose gel electrophoresis in TBE buffer at 100 V to ensure the 
integrity of RNA through the observation of intact 18S and 28S rRNA from the 
agarose gel electrophoresis� 
2.2.6.3 Agarose Gel Electrophoresis 
Agarose gel electrophoresis is the method by which the DNA or RNA can be 
separated according to their molecular weight under the electric field. 
One percent of agarose gel was prepared by dissolving the agarose powder in 
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IX TBE buffer in the flask. The flask was then weighed and was put into the 
microwave oven to heat for 1 min until the agarose dissolved. The mixture was then 
cooled to around 50 and was poured into the cassette until the agarose formed 
the gel like structure. 
The DNA or RNA was then run in agarose gel for constant voltage. After the 
electrophoresis, the gel was stained with ethidium bromide for at least 30 min, 
followed by destained in dHiO for 30 min. The gel was then put onto the UV / White 
light transilluminator (Spectroline, model TVD-IOOOR). 







Determination of the integrity of extracted RNA. RNA was extracted from cells 
undergoing different kinds of treatment and the 28S and 18S rRNA was determined 
with the use of 1% agarose gel electrophoresis. 
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2.2.6.4 Reverse Transcription 
Reverse Transcription can be performed with the use of the SuperScript 
Preamplification System from GDBCO. All preparation steps were performed at 4 
Firstly, 2.5 jug of RNA of each sample were mixed with 1 ]LI1 of Oligo (dT) primer 
with a final concentration of 0.5 in a PGR tube. DEPC-dHiO was then added 
to each tube to make to a final volume of 12 )al. The samples were then incubated at 
70 for 10 min in the PGR amplification thermocycler. Samples were placed on ice 
for 1 min. Samples were then mixed gently with 4 jji of 5X cDNA buffer (final conc. 
of IX)，1 |Lil of 10 mM dNTP mix (final conc. of 0.5 mM) and 2 |LI1 ofDEPC-dHiO. 
The samples were then incubated at 42 for 5 min. One jiil of SuperScript II 
Reverse Transcriptase (200 units) was added to each tube and the samples were 
mixed gently. Samples were then incubated at 42 for 50 min and the reaction was 
terminated at 70 for 15 min. After the termination process, samples were chilled 
on ice and 1 jjl of RNase H was added to each tube. Samples were further incubated 
at 37 for 20 min and cDNA obtained was then stored at -20 until use. 
2.2.6.5 Polymerase Chain Reaction (PGR) 
PCR can be performed with the use of the cDNA obtained from reverse 
transcription. One pi of cDNA was gently mixed with 2.5 |LI1 of lOX PCR buffer 
(final conc. of IX), 1.5 [xl of 25 mM MgCl� (final conc. of 1.5 mM), 0.5 |Ltl of 10 
mM dNTP mix (final conc. of 0.2 mM), 0.5 \il of 10 [xM of primer mix of forward 
and backward primer (final conc. of 0.2 juM), 0.25 jul of Taq DNA polymerase (5 
units/|j,l, final conc. of 1.25 units/25 |LI1) and 17.75 of autoclaved dl^O. PCR was 
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then performed with the following conditions. 
Conditions Temperature Time Number of cycles 
Initial denaturation 95 ^C 3 min 1 
Denaturation 95 "C 45 sec 20, 25 or 27 cycles 
Annealing 55 "C 30 sec according to 
Elongation 72 "C 1 min 30 sec different genes 
Final elongation 72 — 10 min _J  
2.2.6.6 Design of Primers for Different Genes 
Three different types of genes were studied. They were: (1) 
Glyceraldehyde-3 -dehydrogenase (G3PDH) which was used as an internal control; 
(2) TNFRl and (3) TNFR2. The full sequences of genes were obtained from 
sequence database of GenBank in NCBI homepage 
(http://www.ncbi.nlm.nih.gov/entrez). Primers were then designed with the whole 
sequence of G3PDH, TNFRl and TNFR2 in the PrimerS Input homepage 
(http://www-genome.wi.mit.edii/cgi-bin/primer/primer3—www.cgi). The pairs of 
primers were selected and the specificity was checked by. BLAST Search in the 
NCBI homepage (http://www.ncbi.nlm.nih.gov/BLAST). The results were 
summarized in Table 2.3. 
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Table 2.3 
Primers of G3PDH，TNFRl and TNFR2. 
Genes Size of Primer Sequence Product 
genes (bp) Size 
(bp) 
G3PDH 1 228 Left Primer 651:5' AGAACATCATCCCTGCATCC 3，(20-mer) 5 0 0 
: Right Primer 1150: 5，CTGGGATGGAAATTGTCAGG 3 ’ (20-mer)  XNFRI 3 796 Left Primer 2585: 5，TTGAATCAAGATACTGGACACTTG 3，(24-mer) 5 0 0 
‘ Right Primer 1180: 5，CTAGTACAGCCATTGTTCACATCC 3’ (24-mer)  
7NFR2 1 505 Left Primer 784:5 ' CCCCATTATTGAACAAAGTACCAA 3' (24-mer) 5 0 0 
‘ Right Primer 1372: 5' GCTCTGCAGTGTCTCTGTAGTCTC 3' 
(24-mer)  
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100 bp DNA marker 
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Figure 2.5 
Determination of the number of cycles for PGR. The number of cycle of PGR 
product of G3PDH (n=2), TNFRl (n=2) and TNFR2 (n=2) and the number of 
experiments was 2. The size of PGR product for G3PDH, TNFRl and TNFR2 were 
500 bp, 514 bp and 600 bp respectively. 
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2.2.6.7 Determination of the Number of Cycles in PCR for Different Genes 
The number of cycles of different genes was determined so as to prevent 
saturation of the PCR product. Different numbers of cycle number were assigned to 
different genes and it was found that the optimal number of cycle for G3PDH was 20 
because saturation of PCR product occurred at the cycle. The optimal cycle 
numbers for TNFRl and TNFR2 were 25 and 27 respectively. 
2.2.7 Caspase Fluorescent Assay 
Caspase Fluorescent Assay was used to determine the activity of key 
caspases in mammalian cells. The procedure was based on the instruction manual of 
the ApoAlert Caspase Fluorescent Assay Kits (Clontech) with slight modification. 
2.2.7.1 Caspase-3 or -8 Assay 
The activities of caspase-3 and caspase-8 can be determined with the use of 
their corresponding substrate conjugated with 7-ainino-4-trifluoromethyl coumarin 
(AFC). The original AFC-substrate conjugate emits blue light at 400 nm and upon 
cleavage by the corresponding caspases, free AFC is released and it emits 
yellow-green fluorescence at 505 nm. With the measurement of fluorescence at 505 
nm, the activity of caspase-3 and caspase-8 can be determined. 
The L929 or L929-11E cells (1 x 10^/well) were seeded in 6-well plates and 
were incubated at 37 °C，5% CO2 for overnight. On the next day, cells were washed 
twice with serum-free medium and were treated with TNF-a (50 ng/ml) or 
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hyperthermia at 43 at different period of time. After treatment, the spent medium 
was discarded and cells were washed twice with serum-free medium. The cells were 
then trypsinized and complete medium was added. Centrifugation was then carried 
out at 425 X g (2,000 rpm, 9.5 cm, Eppendorf Centrifuge 5417R) for 3 min. The 
pellet of cells was then washed twice with serum-free medium�1 x 106 cells were 
then obtained and centrifugation at 425 x g (2,000 rpm, 9.5 cm, Eppendorf 
Centrifuge 5417R) for 3 min. The cell pellet was then lysed with 50 ]i\ of chilled cell 
lysis buffer and was then incubated on ice for 10 min. The cell lysate was then 
centrifuged at 20,817 x g (14,000 rpm, 9.5 cm, Eppendorf Centrifuge 5417R) for 3 
min at 4 to precipitate the cell debris. The supernatant was then transferred to a 
new microcentrifuge tube. 50 [xl of 2X reaction buffer/DTT mix was added to each 
sample, follow by the addition of 5 |al of 1 mM Caspase-8 substrate (lETD-AFC; 50 
jiM final concentration) or 1 mM Caspase-3 substrate (DEVD-AFC; 50 final 
concentration). The samples were then incubated at 37 for 1 hr in water bath. The 
samples were then transferred to a 96-well plate and the fluorescence signals was 
then measured with a fluormeter (CytoFluor™ Scanner, Millipore) with a 400 nm 
excitation filter and 505 nm emission filter. 
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3.1 Studies on the Characteristics of L929 and L929-11E 
Cells 
3.1.1 Determination of the Growth Curve of L929 and L929-11E 
Cells 
In this project, the mouse transformed fibroblast cell lines, L929 and 
L929-11E cells were used to study the effects of TNF-a and/or hyperthermia on the 
induction of cell death. Prior to the study of the cytotoxic effects mediated by TNF-a 
and/or hyperthermia, some of the characteristics of L929 and L929-11E cells were 
investigated. Firstly, the growth curve of both cell lines was explored with MTT 
assay. The growth curve of a cell population is usually divided into several distinct 
phases such as the lag phase, exponential phase, stationary phase and death phase. 
Figure 3.1 and 3.2 show the initial growth curve of the two cell lines, L929 
and L929-11E cells when determined by MTT assay. It was found that both L929 
and L929-1 IE cells have similar growth rate. 
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Figure 3.1 
The growth curve of L929 cells. L929 cells seeded at the density of 3 x lO'^ /well 
with complete medium in a 96-well plate were incubated at 37 5% CO2. At 
different time intervals, MTT assay was applied. Results are mean 土 SD for 26 
determinations. Data shown here are typical results of two independent experiments. 
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Figure 3.2 
The growth curve of L929-11E cells. L929-11E cells seeded at the density of 3 x 
lOVwell with complete medium in a 96-well plate were incubated at 37 5% CO2. 
At different time intervals, MTT assay was applied. Results are mean 土 SD for 26 
determinations. Data shown here are typical results of two independent experiments. 
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3.2 Effect of TNF-a on the Induction of Cell Death in L929 
and L929-11E Cells 
3.2.1 TNF-a Induced Cell Death in L929 cells but not in L929-11E 
Cells 
L929 cells have long been suggested to be a good model in studying 
TNF-a-mediated cell death. With the use of L929-11E cells, the cytotoxic effect of 
TNF-a was compared with that of their parental cells. It was found that the 
cytotoxicity increased steadily in a dose-dependent manner and about 60% of L929 
cells were killed when treated with 3.1 ng/ml TNF-a for 20 hr. Under the same 
condition, about 15% of L929-11E cells died (Figure 3.3). When cells were treated 
with TNF-a (50 ng/ml) for 9 hr, more than 70% of L929 cells were killed whilst 
TNF-a did not induce cell death in L929-11E cells as compared to the control 
(Figure 3.4). This shows that L929-11E cells had resistance towards TNF-a (50 
ng/ml). To further confirm the fact that L929-11E cells were resistant to TNF-a, the 
cell cycle pattern of both cell lines after TNF-a treatment was investigated. 
Cell cycle is the process involved in cell division and proliferation. Normally, 
cells do not undergo division unless they receive signals that direct them to enter the 
cell cycle. There are five phases in a cell cycle: Go (resting), Gi (gap 1), S (DNA 
synthesis), G2 (gap 2), M (mitosis) phase (Lupulescu, 2001). Cells in the resting or 
"dormant" state (Go phase) are resting in the cell cycle. On the other hand, 
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Figure 3.3 
TNF-a induced cell death in a dose-dependent manner in L929 cells but not in 
L929-11E cells. L929 and L929-11E cells seeded at the density of 3 x IOVwqW with 
complete medium in a 96-well plate were incubated at 37 5% CO2 overnight. 
Cells were then washed twice with serum-free medium. Cells were then incubated . 
with various concentrations of TNF-a in serum-free medium for 20 hr at 37 5% 
CO2. MTT assay was then applied. Results are mean 土 SD of 7 determinations. 
Data shown here are typical results of two independent experiments. 
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Figure 3.4 
L929-11E cells were resistant to TNF-a. L929 and L929-11E cells seeded at the 
density of 3 x lOVwell with complete medium in a 96-well plate were incubated at 
37 5% CO2, overnight. Cells were washed with serum-free medium. TNF-a (50 
ng/ml) in serum-free medium was then added and cells were incubated at 37 5% 
CO2 for 9 hr. Control was performed by incubating cells in serum-free medium for 9 
hr. MTT assay was then applied. Results are mean 土 SD of 5 determinations. Data 
shown here are typical results of two independent experiments. 
** :p<0.005, * :p 二 0.01 
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upon receiving signals for cell division, cells start to prepare the materials such as 
RNA and certain proteins necessary for the synthesis of DNA (Gi phase). After that, 
cells undergo DNA synthesis and the genome replication (S phase). They can then 
enter the G2 phase in which they prepare themselves for cell division, either mitosis 
or meiosis (M phase) (Ormerod, 2000; Lupulescu, 2001). Two checkpoints in the 
cell cycle Gi and G2 play a key role in regulating the cell cycle progression towards 
S and M phases respectively. In damaged cells, cell cycle arrest occurs at Gi or G2 
phase and the DNA replication stops and this allows the repair systems to function 
before the start of another cycle (Sorenson et al., 1990; Lowe et al., 1993). Figure 
3.5 shows the stages of the cell cycle in the cells. 
In L929 cells, the control groups at different time window possessed normal 
cell cycle pattern with Gi，S and G2/M phases (Figure 3.6a, c and e). Also, normal 
cell cycle pattern was observed in cells treated with TNF-a (50 ng/ml) at 37 °C for 3 
hr (Figure 3.6b). With the application of TNF-a (50 ng/ml) for 6 and 9 hr, an 
increase in a sub-Go/Gi peak in a time-dependent manner in L929 cells was observed 
(Figure 3.6e and f). This indicates that TNF-a induced apoptosis in L929 cells. In the 
case of L929-11E cells, both the control groups (Figure 3.7a, c and e) and 
TNF-a-treated groups (Figure 3.7b, d and f) demonstrated normal cell cycle pattern 
without sub-Go/Gi peak, suggesting that TNF-a did not induce apoptosis in 
L929-11E cells. This further confirmed that L929-11E cells were resistant to TNF-a. 
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Figure 3.5 
Stages of a cell cycle. The cell cycle consists of 4 phases: S (DNA synthesis), Gi 
(gap 1)，Gi (gap 2)，M (mitosis). (Modified from Bowen et al” 1998) 
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Figure 3.6 
TNF-a induced the occurrence of sub-Go/Gi peak in L929 cells. L929 cells were 
seeded at 1 x 10 /^well in complete medium in a 6-well plate and incubated at 37 ""C, 
5% CO2 overnight. Cells were washed with serum-free medium and were then 
treated with serum-free medium (a, c, e) or TNF-a (50 ng/ml) (b, d, f) at 3 7 � C for 3 
hr (a, b); 6 hr (c, d) or 9 hr (e, f). Cells were then harvested and fixed with 70% 
ethanol overnight. Cells were then stained with PI (43 |ig/ml) for 30 min. The cell 
cycle pattern was then determined by FCM (n=3). 
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Figure 3.7 
TNF-a did not induce the occurrence of a sub-Go/Gi peak in L929-11E cells. 
L929-11E cells were seeded at 1 x 10 /^well in complete medium in a 6-well plate 
and incubated at 37 5% CO2 overnight. Cells were washed with serum-free 
medium. In the experiment, cells were treated with serum-free medium (a, c, e) or 
TNF-a (50 ng/ml) (b, d，f) at 3 7 � C for 3 hr (a, b); 6 hr (c，d) or 9 hr (e, f). Cells were 
then harvested and fixed with 70% ethanol overnight. Cells were then stained with 
PI (43 |Lig/ml) for 30 min. The cell cycle pattern was then determined by FCM (n=3). 
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3.2.2 TNF-a Induced Apoptosis in a Time-dependent Manner in 
L929 Cells but not in L929-11E Cells 
With the previous observation that TNF-a induced cell death in L929 cells, 
we were interested in studying whether TNF-a induced apoptosis in L929 and 
L929-11E cells. To further determine whether apoptosis occurred or not after TNF-a 
treatment, cells were examined with a more sensitive assay by staining cells with 
annexin-V- FITC and PL 
Annexin-V is a 35 kDa calcium-dependent phospholipid-binding protein. It 
shows minimal binding to other phospholipids such as phosphatidylcholine and 
sphingomyeline that locate on the external leaflet of the plasma membrane but 
preferentially binds to the negatively charged phosphatidylserine (PS) (Andree et al； 
1990; Shounan et al., 1998; Aubry et al” 1999). Normally, as shown in Figure 3.8a, 
PS locates on the inner surface of the plasma membrane of viable nucleated cells due 
to the active inward transport carried out by the aminophospholipid translocase 
(Devaux, 1988; Tang et al” 1996) and bidirectional transport of phospholipids by 
scramblase (Bevers et al,, 1982; Zhou et al., 1997). During apoptosis, PS is 
translocated to the outer surface of the membrane due to the loss of 
aminophospholipid translocase activity (Verhoven et al., 1995; Bratton et al, 1997). 
The PS of the outer plasma membrane then provides a recognition signal for the 
elimination of the apoptotic cells by macrophages (Bartkowiak et al., 1999; 
Denecker et al., 2000; Bedner et al., 1999). Moreover, the exposed PS can be bound 
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both apoptotic and necrotic cells can be identified by Annexin-V, Propidium iodide 
(PI) was employed for further identification (Bartkowiak et al., 1999). 
Propidium iodide is a DNA dye. It is excluded from viable cells with an 
intact membrane whilst it enters into necrotic cells and intercalates the DNA to emit 
fluorescence (Bedner et al., 1999). With the application of the double staining 
method using Annexin V-FITC and PI, necrotic cells and apoptotic cells can be 
differentiated with FCM in terms of emitted fluorescence. Figure 3.8b shows a 
simple diagram of dot plot of how the data are analyzed. The x-axis refers to the 
Annexin-V-FITC green intensity and the y-axis refers to the PI red intensity. The 
plot is divided into 4 quadrants. The lower left quadrant with cells having negative 
staining of both types of dye (annexin-V-FITC -ve, PI —ve) refers to the viable cells. 
The lower right quadrant contains early apoptotic cells stained by annexin-V-FITC 
only (annexin-V-FITC +ve, PI -ve) as PI is restricted to enter the early apoptotic 
cells with intact membrane. Cells in the upper right quadrant stained with both types 
of dye (annexin-V-FITC +ve, PI +ve) represents the late apoptotic or necrotic cells. 
Figure 3.9 showed the results in which the viable, apoptotic, late apoptotic/necrotic 
cells can be identified with the use of Annexin-V-FITC and PL One mg/ml of 
digitonin was used to treat L929 cells for the positive control in the experiment. 
Digitonin permeabilized the cell membrane of cells so that both PI and 
Annexin-V-FITC can enter into the cells, giving red and green fluorescence 
respectively upon flow cytometric analysis. A shift of the population of cells towards 
the upper right quadrant as compared with the control can therefore be observed. 
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Figure 3.9 
Determination of quadrant gating with the positive control using digitonin. (a) 
L929 cells (1 xlO^ cells/well) were seeded in a 6-well plate and were incubated at 37 
5% CO2 overnight. On the other day, the cells were harvested with both floating 
cells and adhering cells collected for the assay, (a) 0.5 x 10^  cells were resuspended 
in serum-free medium (control) or (b) treated with 1 mg/ml digitonin for 30 min to 
permeabilize the cell membrane (positive control). After that, centrifugation was 
carried out at 425 x g (2,000 rpm, 9.5 cm, Eppendorf Centrifuge 5417R) for 3 min. 
The pellet of cells was then re-suspended in 0.5 ml of incubation buffer containing 
annexin-V-FITC (2% v/v) and PI (2.5 jag/ml)； FCM was then carried out to measure 
the fluorescence from the annexin-V-FITC and the PL Dot plots were then divided 
into four quadrants based on the positive control and the % of cells was then 
calculated. Note that nearly all of the cells in the positive control shifted to the upper 
right quadrant. 
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Separation of a dot plot into quadrants can therefore be made based on this positive 
control. 
Figure 3.10 showed the results of the annexin-V-FITC and PI cytometric 
analysis for the determination of apoptotic cells in L929 cells after treatment with 
TNF-a (50 ng/ml) at different periods of t ime�As shown in Figure 3.10a, c and e 
which represented for the control cells, only about 0.1% cells (total cell number = 
10,000) appeared in the upper left quadrant. Moreover, about 96% cells remained 
viable (lower left quadrant). Less than 1% of cells was found to be apoptotic and 
about 2 to 4% of cells were found to be late apoptotic or necrotic. When cells were 
treated with TNF-a (50 ng/ml) at 37 for 3 hr, it was found to have similar pattern 
as compared with its corresponding control (Figure 3.10a and b). However, the 
number of apoptotic cells and late apoptotic/necrotic cells increased with the 
incubation time from 3 to 9 hr after TNF-a treatment (Figure 3.10b, d and f). Also，it 
was observed that the number of apoptotic cells induced by TNF-a was far more 
than the late apoptotic/necrotic cells, indicating that the major form of cell death 
induced by TNF-a in L929 cells was apoptosis. 
In L929-11E cells, the number of viable cells was around 90 to 95% in both 
control groups (Figure 3.11a, c and e) and TNF-a-treated groups (Figure 3.11b, d 
and f) whilst the number of apoptotic and late apoptotic/necrotic cells were less than 
2% and 6% respectively. This indicates that TNF-a did not induce apoptosis in 
L929-11E cells, further illustrating that L929-11E cells had resistance towards 
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Figure 3.10 
TNF-a induced apoptosis and late apoptosis/necrosis in a time-dependent 
manner in L929 cells. L929 cells were seeded at 1 x lOVwell in complete medium 
in a 6-well plate and incubated at 37 5% CO2 overnight. On the next day, cells 
were washed twice with serum-free medium and were treated with serum-free 
medium (a, c, e) or TNF-a (50 ng/ml) (b, d, f) at 3 7 � C for 3 hr (a, b); 6 hr (c, d) or 9 
hr (e，f). Cells were then harvested and 0.5 x 10^  cells were re-suspended in 0.5 ml of 
incubation buffer containing annexin-V-FITC (2% v/v) and PI (2.5 j.Lg/ml). FCM 
was then carried out to measure the fluorescence from the annexin-V-FITC and the 
PI (n=3). 
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Figure 3.11 
TNF-a did not induce apoptosis and necrosis in L929-11E cells. L929-11E cells 
were seeded at 1 x 10^/well in complete medium in a 6-well plate and incubated at 
37 5% CO2 overnight. In the experiment, cells washed twice with serum-free 
medium and were treated with serum-free medium (a, c, e) or TNF-a (50 ng/ml) (b， 
d, f) at 37 °C for 3 hr (a, b); 6 hr (c, d) or 9 hr (e, f). Cells were then harvested and 
0.5 X 106 cells were re-suspended in 0.5 ml of incubation buffer containing 
annexin-V-FITC (2% v/v) and PI (2.5 |ag/ml). FCM was then carried out to measure 
the fluorescence from the annexin-V-FITC and the PI (n=3). 
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TNF-a (50 ng/ml). To conclude, TNF-a mainly induced apoptosis in L929 cells but 
not in L929-1 IE cells. 
3.2.3 TNF-a Induced Mitochondrial Membrane Depolarization in a 
Time-dependent Manner in L929 Cells but not in L929-11E 
Cells 
Mitochondrion, being an organelle by which ATP is produced, also plays a 
key role in the apoptotic pathway. Oxidative phosphorylation occurs in the inner 
mitochondrial membrane and electrons are passing down the electron transport chain 
by which ATP can be produced. At the same time, constant extrusion of protons 
from the mitochondrial matrix to the intermembrane space occurs, giving rise to an 
electrochemical proton gradient. A transmembrane electric potential of up to -180 
mV can then be developed inside mitochondria (Bemardi et al,, 1999). The 
transmembrane electric potential is vital to the mitochondrial activities due to the 
fact that a collapse of the membrane potential would lead to an impairment in the 
production of ATP for cell metabolisms� 
Recently, it was found that apoptosis induced a collapse of mitochondrial 
membrane potential and it was found to be associated with the opening of 
permeability transition pore and the translocations of pro-apoptotic protein Bax 
(Marzo et al., 1998; Crompton, 1999). Permeability transition pore (PTP) is 
composed of porin, adenine nucleotide trans 1 ocase and cyclophilin D (Figure 3.12) 
and it is located in the contact sites between the outer and the inner mitochondrial 
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Figure 3.12 
Molecular composition of the mitochondrial permeability transition pore (PTP). 
HK, hexokinase; ANT, adenine nucleotide translocase; CpD, cyclophilin D 
(modified from Szewczyk and Wojtczak, 2002). 
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membranes (Szewczyk and Wojtczak, 2002). Generally, the PTP only allows the 
passage of molecules of less than 1,500 Da (Mignotte and Vayssiere, 1998). 
However, during apoptosis, the association of Bax with the PTP formed a channel in 
which proteins in the mitochondrial intermembrane space such as cyto c (15 kDa) 
can be released, leading to the activation of the caspase cascade by which apoptosis 
can proceed. 
To determine whether TNF-a induced mitochondrial membrane 
depolarization, the fluorescence dye, JC-1 was used. The uptake of JC-1 into the cell 
is driven by A^m (Figure 3.13). At high A平m, JC-1 forms aggregates, giving out red 
fluorescence after being excited at 488 nm whereas at low it remains as 
monomeric form to give green fluorescence. The shift of JC-1 red fluorescence to 
green fluorescence indicates that mitochondrial membrane depolarization takes place 
(Salvioli et al., 1997; Kulkarni et al, 1998; Bedner et al., 1999). 
Figure 3.14 showed the results of changes in A^m in L929 cells after 
treatment with TNF-a (50 ng/ml). As shown in the figure, there was no significant 
alternation in the A^m when L929 cells were treated with TNF-a (50 ng/ml) at 37 
for 3 hr as compared with its corresponding control (Figure 3.14b). However, a 
significant reduction in the occurred when cells were incubated with TNF-a for 
9 hr and the degree of reduction of A甲m was found to be dependent on incubation 
time (Figure 3.14d and f). In L929-11E cells, A平m of cells treated with TNF-a at 
different period of time was similar to that of their corresponding control (Figure 
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Figure 3.13 
Investigation of the mitochondrial permeability depolarization with JC-1. L929 
cells (1 X loVwell) were seeded in a 6-well plate and were incubated at 37�C, 5% 
CO2 overnight. On the other day, adhering cells were collected for assay. 0.25 x 10^  
cells were re-suspended in serum-free medium (control) or in 10 |LIM FCCP which is 
an uncoupler of the mitochondrial electron transport chain (positive control). After 
that, centrifugation was carried out at 425 x g (2,000 rpm, 9.5 cm, Eppendorf 
Centrifuge 5417R) for 3 min. The pellet of cells was then re-suspended in 0.5 ml of 
serum-free medium containing 10 [iM of JC-1 dye. FCM was then carried out to 
measure the fluorescence from JC-1. Contour plots were then divided into two 
regions based on the positive control and the % of cells was calculated. 
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Figure 3.14 
TNF-a induced mitochondrial membrane depolarization in L929 cells. L929 
cells were seeded at 1 x lOVwell in complete medium in a 6-well plate and incubated 
at 37 5% CO2 overnight. On the next day, cells were washed twice with 
serum-free medium and were treated with serum-free medium (a, c, e) or TNF-a (50 
ng/ml) (b, d, f) at 37 for 3 hr (a, b); 6 hr (c，d) or 9 hr (e, f). Cells were then 
harvested and 0.25 x 10^  cells were re-suspended in 0.5 ml of incubation buffer 
containing JC-1 (10 |jM) and was incubated at 37 for 15 min. FCM was then 
carried out to measure the green and red fluorescence from JC-1 (n=3). 
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3.15). This result indicates that TNF-a did not induce mitochondrial membrane 
depolarization in L929-11E cells. 
3.2.4 TNF-a Induced Cytochrome c Release in a Time-dependent 
Manner in L929 Cells but not in L929-11E Cells 
With a collapse in the A^m, it is believed that PTP may form a channel in 
which the mitochondrial proteins are released into the cytosol of the cells. 
Cytochrome c (cyto c) is one of the mitochondrial intermembrane space proteins that 
is necessary for the normal functions of the mitochondrial electron transport for the 
production of ATP. Cyto c release from mitochondria to the cytosol is an early event 
in cells undergoing apoptosis, but does not occur in cells over-expressing Bcl-2 
(Halestrap, 1999). 
In order to study the relationship between cyto c and the reduction of A平m, 
Western Blotting was performed to examine the release of cyto c from the 
mitochondria in both L929 and L929-11E cells. Figure 3.16 shows the results of cyto 
c release by Western Blotting. Equal amount of proteins was loaded in each well in 
SDS-PAGE. When L929 cells were incubated with TNF-a (50 ng/ml) at 37 for 3 
hr, only a small amount of cyto c was released into the cytosol as compared with its 
corresponding control (Figure 3.16a). When the incubation time was increased, more 
cyto c was released into the cytosol. In other words, TNF-a (50 ng/ml) could 
stimulate the release of cyto c from L929 cells in a time-dependent manner. When 
L929-11E cells were incubated with TNF-a (50 ng/ml) at 37 °C for 3 or 6 hr (Figure 
Chapter 3. Results Page 93 
(a) Medium for 3 hr (b) 50 ng/ml TNF-a for 3 hr h h  fiH IT 98.76% 1.24% a 98.45% 1.55% 
10' 10� 10.3 10= 10� 10' 10' 10] 10-' •i (c) Medium for 6 hr (d) 50 ng/ml TNF-a for 6 hr 
fi o . 龙 I ： 丨. 
T3 t s\ 98.52% 1.48%| ��98 .04% 1.96% th 10� 10’ HJ^  10� ^fe w ^ W 
H 石(e) Medium for 9 hr (fjiSO ng/ml TNF-a for 9 hr 
^ • , • I I - • , , , I j : , : , 
„�98.42% 1.58% ^ 97.58% 2.42% 
1^0'： 10' 10- 10- 10- 、。：丨 10' liy 10� 10" 
JC-1 green fluorescence intensity 
Figure 3.15 
TNF-a did not induce mitochondrial membrane depolarization in L929-11E 
cells. L929-11E cells were seeded at 1 x 10 /^well in complete medium in 6-well plate 
and incubated at 37 C^, 5% CO2 overnight. On the next day, cells were washed twice 
with serum-free medium and were treated with serum-free medium (a, c, e) or 
TNF-a (50 ng/ml) (b，d, f) at 3 7 � C for 3 hr (a, b); 6 hr (c，d) or 9 hr (e, f). Cells were 
then harvested and 0.25 x 10^  cells were re-suspended in 0.5 ml of incubation buffer 
containing JC-1 (10 |LIM) and was incubated at 37 for 15 min. FCM was then 
carried out to measure the green and red fluorescence from JC-1 (n=3). 
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Figure 3.16 
TNF-a released cytochrome c from L929 cells but not from L929-11E cells. 
L929 or L929-11E cells (1 x 10^  cells/well) were seeded in a 6-well plate and were 
incubated at 37 5% CO2 overnight. On the other day, cells were washed twice 
with serum-free medium and were then incubated with either serum free medium or 
TNF-a (50 ng/ml) at 37 for 3, 6 or 9 hr. After treatment, adherent cells were 
collected and cells were incubated with lysis buffer containing digitonin (25 pg/4 x 
106 cells) for 30 sec at room temperature and then centrifuged at 10,621 x g (10,000 
rpm, 9.5 cm, Eppendorf Centrifuge 5417R) for 1 min. The supernatant was collected 
and the SDS polyacrylamide gel electrophoresis was performed. Electroblotting and 
non-specific block of proteins were done. Anti-cyto c antibodies (1:1000) was 
probed onto the membrane at room temperature for 1 hr and then with 
anti-mouse-HRP conjugated antibodies (1:1000) at room temperature for another hr. 
The ECL assay was then performed and the signal was exposed on x-ray film. The 
amount of cyto c release was determined with the densitometer (n=2). 
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3.16b), there was no significant cyto c release. This implied that TNF-a did not 
release cyto c from mitochondria in L929-11E cells further indicating their resistance 
towards TNF-a (50 ng/ml). 
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3.3 Effect of Hyperthermia on the Induction of Cell Death 
in L929 and L929-11E Cells 
3.3.1 Introduction 
Hyperthermia has been applied in the treatment of malignant diseases for a 
long period of time. The therapeutic process for the hyperthermia treatment of 
tumours are to elevate their temperature from 37 °C to 42 - 45 "^C so as to either 
directly induce irreversible biological damage in tumour cells or to indirectly 
enhance the effect of other treatment regimes such as X-radiation or chemotherapy 
(Ross and Watmough, 1986). The mechanisms of how hyperthermia acts on tumours 
are still unknown. However, it was found that hyperthermia induced apoptosis in 
human colon cancer cell line HT-29 (Shchepotin et al., 1997) or in malignant fibrous 
histocytoma cell line MFH-2NR (Yonezawa et al., 1996). Along with the evidence 
that hyperthermia induced apoptosis in cancer cell lines, further study on the effect of 
hyperthermia on the induction of cell death in L929 and L929-11E cells and also the 
mechanisms involved were performed. 
3.3.2 Hyperthermia Induced Apoptosis in L929 and L929-11E Cells 
To study whether hyperthermia could induce apoptosis in both L929 and 
L929-11E cells, the cell cycle pattern was investigated. According to Fig 3.17, it was 
observed that both L929 and L929-11E cells expressed a normal cell cycle pattern 
without the appearance of sub-Go/Gi peak after treatment with hyperthermia at 43 
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Figure 3.17 
Hyperthermia did not induce sub-Go/Gi peak in L929 and L929-11E cells. 
L929 and L929-11E cells were seeded at 1 x 1 Orwell in complete medium in a 
6-well plate and incubated at 37 C^, 5% CO2 overnight. On the next day, cells were 
washed twice with serum-free medium and were treated with serum-free medium at 
3 7 � C for 3 hr (a, b) or at 4 3 � C for 1 hr (c, d); 2 hr (e, f); 3 hr (g, h). Cells were then 
harvested and fixed with 70% ethanol overnight. Cells were then stained with PI (43 
|ig/ml) for 30 min. The cell cycle pattern was then determined by FCM (n=3). 
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from 1 to 3 hr. Although there was no significant change in the cell cycle pattern of 
both cell lines treated with hyperthermia, it did not mean that hyperthermia would 
not induce apoptosis since the appearance of sub-Go/Gi is a late event of apoptosis. 
Further confirmation on whether hyperthermia would induce apoptosis in L929 and 
L929-1 IE cells was therefore performed with the Annexin-V-FITC and PI assay. 
According to Figure 3.18, there was an increase in the number of early 
apoptotic cells from about 0.9% to 12.61% when L929 cells were treated at 43 °C 
from 1 to 3 hr. Such observed increase was about 12-fold for cells treated at 43 for 
3 hr as compared with the control group (Figure 3.18a and g). Moreover, the number 
of late apoptotic/necrotic cells also increased with the increase in the hyperthermia 
incubation time in L929 cells. When L929-11E cells were treated at 43 for 1 hr, 
most of the cells remained viable as compared to its corresponding control (Figure 
3.18d). Upon hyperthermia treatment for 2 or 3 hr, more apoptotic cells appeared in 
the lower right quadrant and it accounted for about 19% or 23%, respectively (Figure 
3.18f and h). It was found that the number of late apoptotic/necrotic cells increased 
with time after being treated at 43 °C for 3 hr in L929-11E cells. However, the 
number of apoptotic cells was far more than that of late apoptotic/necrotic cells. As 
most apoptotic cells would become late apoptotic cells after a longer time treatment 
with hyperthermia, our results suggest that hyperthermia induced apoptosis in both 
L929 and L929-11E cells. Furthermore, results in Figure 3.18 indicate that L929-11E 
cells were more sensitive to hyperthermia treatment. 
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Figure 3.18 
Hyperthermia induced apoptosis and late apoptosis/necrosis in L929 cells and 
L929-11E cells in a time-dependent manner. L929 and L929-11E cells were 
seeded at 1 x lOVwell in complete medium in a 6-well plate and incubated at 3 7 � C , 
5% CO2 overnight. On the next day, cells were washed twice with serum-free 
medium and were treated with serum-free medium at 37 for 3 hr or at 43 °C for 1 
to 3 hr as indicated. Cells were then harvested and 0.5 x 10^  cells were re-suspended 
in 0.5 ml of incubation buffer containing annexin-V-FITC (2% v/v) and PI (2.5 
|LLg/ml). FCM was then carried out to measure the fluorescence from the 
annexin-V-FITC and the PI (n=3). 
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3.3.3 Effect of Hyperthermia on Mitochondrial Membrane 
Depolarization 
In order to determine the effect of hyperthermia on the change of A平叫 a 
time-dependent assay was performed. Figure 3.19 to 3.22 showed the effect of 
different incubation time of hyperthermia on mitochondrial membrane depolarization 
in L929 and L929-11E cells. According to these figures, it seemed likely that there 
was no change in A平m when L929 (Figure 3.19a to c) or L929-11E cells (Figure 
3.21a to c) were incubated in serum-free medium at 37 for 3,6 or 9 hr. However, 
when cells were challenged with hyperthermia at 43 for different time intervals up 
to 3 hr, a time-dependent mitochondrial membrane depolarization was observed in 
both L929 (Figure 3.19d to i) and L929-11E cells (Figure 3.2Id to i). When L929 
cells (Figure 3.20) were treated at 43 °C for different time intervals and then put back 
to 37 for 3 or 6 hr, a time-dependent recovery in A平m was observed. Yet, less 
number of cells recovered after a long heating time (Figure 3.20). This suggests that 
the degree of mitochondrial membrane depolarization was dependent on the 
hyperthermia incubation time. 
In L929-11E cells, if the heating time was longer than 1.5 hr, no such 
recovery was observed (Figure 3.22). Again, L929-11E cells were more sensitive to 
43 °C treatment in terms of A^m depolarization when compared to that of their 
parental cells (Figure 3.20 and 3.22). 
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Figure 3.19 
Hyperthermia induced mitochondrial membrane depolarization in L929 in a 
time-dependent manner. L929 cells were seeded at 1 x 10 /^well in complete 
medium in a 6-well plate and incubated at 37 "^ C, 5% CO2 overnight. On the next day, 
cells were washed twice with serum-free medium and were treated with serum-free 
medium at 37 for 3, 6 or 9 hr or at 43 for 1 to 3 hr as indicated. Cells were then 
harvested and 0.25 x 10^  cells were re-suspended in 0.5 ml of incubation buffer 
containing JC-1 (10 |LIM) and was incubated at 37 for 15 min. FCM was then 
carried out to measure the green and red fluorescence from JC-1 (n=2). 
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Figure 3.20 
Hyperthermia induced mitochondrial membrane depolarization in L929 in a 
time-dependent manner. L929 cells were seeded at 1 x 10 /^well in complete 
medium in a 6-well plate and incubated at 37 5% CO2 overnight. On the next day, 
cells were washed twice with serum-free medium and were treated with serum-free 
medium at 43 for various hr and then to 37 "^C for 3 or 6 hr as indicated. Cells 
were then harvested and 0.25 x 10^  cells were re-suspended in 0.5 ml of incubation 
buffer containing JC-1 (10 |LIM) and was incubated at 37 for 15 min. FCM was 
then carried out to measure the green and red fluorescence from JC-1 (n=2). 
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Figure 3.21 
Hyperthermia induced mitochondrial membrane depolarization in L929-11E 
cells in a time-dependent manner. L929-11E cells were seeded at 1 x loVwell in 
complete medium in a 6-well plate and incubated at 37�C，5% CO2 overnight. On 
the next day, cells were washed twice with serum-free medium and were treated with 
serum-free medium at 37 for 3, 6 or 9 hr or at 43 for 1 to 3 hr as indicated. 
Cells were then harvested and 0.25 x 10^  cells were re-suspended in 0.5 ml of 
incubation buffer containing JC-1 (10 jaM) and was incubated at 37 for 15 min. 
FCM was then carried out to measure the green and red fluorescence from JC-1 
(n=2). 
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Figure 3.22 
Hyperthermia induced mitochondrial membrane depolarization in L929-11E 
cells in a time-dependent manner. L929-11E cells were seeded at 1 x 10 /^well in 
complete medium in a 6-well plate and incubated at 37 °C，5% CO2 overnight. On 
the next day, cells were washed twice with serum-free medium and were treated with 
serum-free medium at 43 for various hr and then to 37 for 3 or 6 hr as 
indicated. Cells were then harvested and 0.25 x 10^  cells were re-suspended in 0.5 ml 
of incubation buffer containing JC-1 (10 |LIM) and was incubated at 37 "^C for 15 min. 
FCM was then carried out to measure the green and red fluorescence from JC-1 
(n=2). 
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3.3.4 Hyperthermia Induced Cyto c Release in a Time-dependent 
Manner in L929 and L929-11E Cells 
The effect of hyperthermia on the cyto c release in L929 and L929-11E cells 
was also studied. There was about 10-fold increase in the level of cyto c upon 43 
treatment for 3 hr in L929 cells as compared with corresponding control at 37 
(Figure 3.23). On the other hand, the release of cyto c was more significant in 
L929-11E cells treated with hyperthermia at 43 for 3 hr when compared with the 
control. Moreover, two hours treatment at 43 released cyto c in L929-11E cells 
but not in L929 cells. Taken together, data in Fig 3.23 suggest again that L929-11E 
cells were more sensitive to the hyperthermia treatment than parental cells. 
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Figure 3.23 
Hyperthermia enhanced cyto c release in L929 and L929-11E cells in a 
time-dependent manner. L929 and L929-11E cells in complete medium were 
seeded at 1 x 10^/well in complete medium in a 6-well plate and incubated at 37 
50/0 CO2 overnight. In the experiment, cells were washed twice with serum-free 
medium and treated at 37 for 3 hr or at 43 for 1 to 3 hr as indicated. Cells were 
then harvested and were incubated with lysis buffer containing digitonin (25 i^g/ 4 x 
106 cells) for 30 sec at room temperature and then centrifuged at 10,621 x g (10,000 
rpm, 9.5 cm, Eppendorf Centrifuge 5417R) for 1 min. The supernatant was collected 
and the SD polyacrylamide gel electrophoresis was performed. Electroblotting and 
non-specific block of proteins were done. Anti-cytochrome c antibodies (1:1000) 
were probed onto the membrane at room temperature for 1 hr and then with 
anti-mouse-HRP conjugated antibodies (1:1000) at room temperature for another hr. 
The ECL assay was then performed and signal was exposed on x-ray film. Note that 
hyperthermia induced the release of cyto c of 15 kDa in L929 and L929-11E cells. 
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3.4 Relationship of Hyperthermia and TNF-a with PTP 
in L929 cells 
In the previous experiments, it was found that both hyperthermia and 
TNF-a induced apoptosis and the effect of hyperthermia on apoptosis was similar to 
that of TNF-a. In order to examine whether hyperthermia and TNF-a induce 
apoptosis through mitochondria and the release of H2O2, cyclosporin A (CsA) and 
4-OH-TEMPO were employed. CsA is an immunosuppressive drug. It exerts its 
functions by binding to the mitochondrial enzyme called peptidyl-prolyl cis-trans 
isomerase (cyclophilin) and suppresses its proline rotamase activity. Cyclophilin is 
involved in changing the shape of proteins by altering their conformation and is used 
in controlling the mitochondrial permeability pore. The CsA-cyclophilin complex 
can therefore inhibit calcineurin and inhibit the mitochondrial permeability transition 
pore opening and this preserves the mitochondrial membrane potential. For 
4-OH-TEMPO (4-hydroxy-2, 2, 6, 6-tetramethylpiperidine-1 -oxyl), it is an 
antioxidant that removes ROS (Karbowski et al., 1999). 
Figure 3.24 shows the effect of CsA and 4-OH-TEMPO on the TNF-a and 
hyperthermia-mediated cytotoxicity. As shown in the figure, it was found that 
TNF-a can induce cytotoxicity in L929 cells as compared to its corresponding 
control. The results also show that the cytotoxicity in L929 cells by TNF-a (50 
ng/ml) can be reduced with the use of either CsA (10 juM) or 4-OH-TEMPO (5 mM). 
In hyperthermia treatment in which cells were treated at 43 for 3 hr and then to 37 
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Figure 3.24 
In vitro cytotoxicity assay of L929 cells treated with TNF-a and hyperthermia in 
the presence of cyclosporin A (CsA) and 4-OH-TEMPO. L929 cells (3 x loVml) 
were treated as described below and the viability of cells was measured with MTT 
assay. In the experiment, 50 ng/ml TNF-a, 10 [iM of CsA and 5 mM of 
4-OH-TEMPO were used. Cells were treated with the following conditions: (1) 
medium at 3 7 � C for 21 hr; (2) TNF-a at 3 7 � C for 21 hr; (3) 4-OH-TEMPO at 37 
for 21 hr; (4) 4-OH-TEMPO and TNF-a at 3 7 � C for 21 hr; (5) CsA at 3 7 � C for 21 
hr; (6) CsA and TNF-a at 3 7 � C for 21 hr; (7) medium at 4 3 � C for 3hr and then at 37 
� C for 18 hr; (8) medium at 4 3 � C for 3 hr and then with TNF-a at 3 7 � C for 18 hr; (9) 
medium at 4 3 � C for 3 hr and then with 4-OH-TEMPO at 37 C^ for 18 hr; (10) 
medium at 4 3 � C for 3 hr and then with 4-OH-TEMPO and TNF-a at 3 7 � C for 18 hr; 
(11) medium at 4 3 � C for 3 hr and then with CsA at 3 7 � C for 18 hr; (12) medium at 
43 OC for 3 hr and then with CsA and TNF-a at 37 T for 18 hr (n=5). 
*: p<0.005; **: p=0.001; ***: p=0.004 
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OC for 18 hr with medium alone or with TNF-a, lower viability was observed as 
compared with the control at 37 Moreover, the hyperthermia-mediated 
cytotoxicity cannot be overcome by the use of 4-OH-TEMPO (5 mM) but the 
viability of cells can be restored with CsA (10 fiM). 
To see whether CsA can reduce the mitochondrial membrane depolarization 
in L929 cells, JC-1 assay was performed again. It was found that when L929 cells 
were treated with TNF-a (50 ng/ml), there were about 46% of cells having low A甲m 
(Figure 3.25b). With the use of CsA, the number of cells having low A^^ reduced to 
about 27% of the total cell count with FCM (Figure 3.25h). This means CsA can 
inhibit the TNF-a-mediated mitochondrial membrane depolarization. 
It has been suggested that caspase-8 are responsible for the cleavage of Bid in 
which its truncated form can act on the mitochondria and lead to PTP opening 
through the action of Bax. The relationship between caspases and A^m was then 
studied. The broad spectrum caspase inhibitors, z-VAD-fmk and z-Asp-CH2-DCB 
were used. The pre-treatment of cells with z-VAD-fmk and z-Asp-CH2-DCB alone 
did not affect the A^m as compared with the control group (Figure 3.25c and e). 
When cells were pre-treated with z-VAD-fmk and z-Asp-CH2-DCB for 15 min and 
then incubated with TNF-a (50 ng/ml) for 9 hr at 37 the number of cells having 
low A平m decreased as compared with that of cells treated with TNF-a (50 ng/ml) 
(Figure 3.25d and f). On the other hand, due to the resistance of L929-11E cells 
towards TNF-a, the treatment of cells with TNF-a and also the pre-treatment of 
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Figure 3.25 
Changes in TNF-a-mediated mitochondrial membrane depolarization with the 
use of z-VAD-fmk, z-Asp-CH2-DCB and CsA in L929 cells. L929 cells were 
seeded at 1 x 10 /^well in complete medium in a 6-well plate and incubated at 37 
5% CO2 overnight. On the next day, cells were washed twice with serum-free 
medium and were then treated with serum-free medium (a) or with TNF-a (50 ng/ml) 
(b) at 37 for 9 hr. Cells were also pre-treated with 25 \aM z-VAD-fmk, 100 |LIM 
z-Asp-CH2-DCB or 10 [xM CsA for 15 min as indicated. Cells were then harvested 
and 0.5 x 10^  cells were re-suspended in 0.5 ml of serum-free medium containing 10 
|LIM of JC-1. F C M was then carried out (n=2). 
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L929-11E cells with z-VAD-fmk and z-Asp-CH2-DCB did not affect the A T , 
(Figure 3.26). 
Figure 3.27 shows the results of mitochondrial membrane depolarization 
using cycloheximide (CHX). CHX is an anti-fungal antibiotics that can inhibit 
protein synthesis. As shown in Figure 3.27, treating cells at 43 "C for 1 hr induced 
ATm depolarization (Figure 3.27a and b). However, when the treated cells were 
incubated at 3 7 � C for another 3 hr, the A甲m returned to normal, indicating a 
recovery of A平m occurred after incubation (Figure 3.27a, b and f). 
When cells were heated at 4 3 � C with CHX for 1 hr, no significant change in 
ATm was observed (Figure 3.27a, b and c). However, a delay in the A^m 
depolarization (Figure 3.27c and g) indicates that protein synthesis is required for the 
early A^m depolarization. When the heating time was increased from 1 hr to 3 hr, 
more cells with depolarized A平m were obtained. And the re-incubation at 37 for 3 
hr could not show recovery (Figure 3.27d and h). Again, heating the cells with CHX 
for 3 hr delayed the A^m depolarization (Figure 3.27e and i). 
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Figure 3.26 
Changes in TNF-a-mediated mitochondrial membrane depolarization with the 
use of z-VAD-fmk, z-Asp-CH2-DCB and CsA in L929-11E cells. L929-11E cells 
were seeded at 1 x lOVwell in complete medium in a 6-well plate and incubated at 
37 ec, 5% CO2 overnight. On the next day, cells were washed twice with serum-free 
medium and were then treated with serum-free medium (a) or with TNF-a (50 ng/ml) 
(b) at 37 for 9 hr. Cells were also pre-treated with 25 |iM z-VAD-fmk, 100 |LIM 
z-Asp-CH2-DCB or 10 |iM CsA for 15 min as indicated. Cells were then harvested 
and 0.5 x 10^  cells were re-suspended in 0.5 ml of serum-free medium containing 10 
I^ M of JC-1. FCM was then carried out (n=2). 
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Figure 3.27 
Changes in the TNF-a-mediated mitochondrial membrane depolarization with 
CHX in L929 cells. L929 cells were seeded at 1 x loVwell in complete medium in a 
6-well plate and incubated at 37 5% CO2 overnight. On the next day, cells were 
washed twice with serum-free medium and were then treated with serum-free 
medium at 37 for 3 hr or at 43 for 1 or 3 hr with or without cycloheximide (2 
|ig/ml) as indicated. Moreover, cells were treated at 43 °C for 1 or 3 hr and then to 37 
•C for 3 hr with or without cycloheximide. Cells were then harvested and 0.5 x 10^  
cells were re-suspended in 0.5 ml of serum-free medium containing 10 |iM of JC-1. 
FCM was then carried out (n=2). 
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3.5 Effect of TNF-a and Hyperthermia on the Level of 
Hydrogen Peroxide (H2O2) in L929 and L929-11E 
Cells 
3.5.1 Introduction 
Reactive oxygen species (ROS) are oxygen-related free radicals or molecules 
that are chemically active and can cause oxidative damage to biomolecules in cells. 
The major types of ROS include superoxide radicals (O2 • ), hydrogen peroxide 
(H2O2) and hydroxyl radicals (OH • ) (Gorman et al., 1997; Goossens et al., 1999). 
It is widely believed that the major site of ROS production falls on the 
electron transport chain in mitochondria. In normal cells, electrons pass down the 
electron transport chain from a high potential upstream site to a low potential 
downstream site through four different complexes. In this way, electrons are passed 
to the molecular oxygen and at the same time, energy is generated for metabolic use. 
Occasionally, when the electron transport chain is impaired, the electrons in the 
upstream of the chains may leak out and react with the molecular oxygen at the 
ubiquinone site to form superoxide radicals. Such superoxide radicals are highly 
reactive and can cause damage to cells and lead to subsequent depletion of 
intracellular anti-oxidant levels, such as the glutathione level (Fernandez-Checa et 
“/., 1998; Goossens et al., 1999). On the other hand, superoxide radicals can be 
formed by an NADH-independent enzyme (Nohl，1987). In order to cope with an 
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increase production of superoxide radicals, an enzyme such as superoxide dismutase 
(Mn-SOD) plays a role in converging superoxides into the less harmful substances 
H2O2 (Goossens et al., 1999). 
SOD 
Or + Or + 2H+ > H2O2 + O2 
H2O2 is a less toxic ROS and its enhanced formation shows that ROS 
production is increased. It was proposed that during apoptosis, an impairment in the 
electron transport chain was associated with an increase in ROS production. To study 
whether TNF-a induced the release of ROS，the level of the H2O2 was determined. 
3.5.2 TNF-a Enhanced the Level of H2O2 in L929 Cells but not in 
L929-11E Cells 
Figure 3.28 showed the effect of TNF-a on H2O2 release in both L929 and 
L929-11E cells. The x-axis of the histogram referred to be the level of H2O2 as 
determined by a fluorescent dye DCF and the y-axis represents the number of cells. 
The curve with black in colour referred to the ones treated with serum-free medium 
only and the curve with red colour referred to be the cells treated with TNF-a (50 
ng/ml). It was observed that when L929 cells were treated with TNF-a (50 ng/ml) at 
3 7 � C for 3 hr, there was no significant increase in the H2O2 level as compared to the 
corresponding control (Figure 3.28a). However，when L929 cells were treated with 
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Figure 3.28 
TNF-a increased H2O2 level in a time-dependent manner in L929 cells but not 
in L929-11E cells. L929 or L929-11E cells (1 x 10^/well) in complete medium were 
seeded in a 6-well plate and were incubated at 37 5% CO2 overnight. On the next 
day, cells were washed twice with serum-free medium and were then treated with 
serum-free medium or TNP-a (50 ng/ml) at 37 ""C for 3，6 or 9 hr. Cells were 
harvested and 0.25 x 10^  cells were re-suspended in 0.5 ml of incubation buffer 
containing DCF (10 |aM) and was incubated at 37 ""C for 30 min. FCM was then 
carried out (n=3). 
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TNF-a (50 ng/ml) for 6 hr (Figure 3.28c) or 9 hr (Figure 3.28e), an increase in the 
H2O2 level was observed. An increase in the H2O2 level was therefore found to be 
dependent on the incubation time with TNF-a. On the other hand, when L929-11E 
cells were treated with TNF-a (50 ng/ml) for 3 hr (Figure 3.28b), 6 hr (Figure 3.28d) 
or 9 hr (Figure 3.28f), no significant increase in the level of H2O2 was observed. 
3.5.3 Hyperthermia Enhanced the Level of H2O2 in L929 and 
L929-11E Cells 
The effect of hyperthermia on the level of H2O2 in both L929 and L929-11E 
cells was examined. Figure 3.29 shows the histograms of FCM in which the x-axis 
represents the DCF green fluorescence intensity and the y-axis shows the number of 
cells. The black line is the response from control cells (incubated at 37 for 3 hr) 
and the red line refers to the one challenged with hyperthermia with different periods 
of time. It was found that the level of H2O2 increased in a time-dependent manner in 
L929 cells after hyperthermia treatment (Figure 3.29a, c and e). On the other hand, it 
was found that the level of H2O2 in L929-11E cells did not change much in the 1 hr 
or 2 hr of hyperthermia treatment (Figure 3.29b and d) but the level of H2O2 seemed 
to decrease. To examine this discrepancy, further assay on simultaneous 
measurement of H2O2 and A平m was performed and our findings suggested that the 
release of H2O2 was related to a decrease in the A^m in both L929 and L929-11E ^ 
cells respectively (Figure 3.30 and 3.31). It was found that there was an increase in 
the release of H2O2 in the cells with polarized A^m after hyperthermia treatment. 
Those with a drop in the carried less DCF fluorescence. Moreover, the change 
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Figure 3.29 
Hyperthermia enhanced H2O2 release in L929 cells and L929-11E cells in a 
time-dependent manner. L929 or L929-11E cells were seeded at 1 x 10 /^well in 
complete medium in a 6-well plate and incubated at 37 5% CO2 overnight. On 
the next day, cells were washed twice with serum-free medium and were treated with 
serum-free medium at 37 for 3 hr or at 4 3 � € for 1 to 3 hr as indicated. Cells were 
then harvested and 0.5 x 10^  cells were re-suspended in 0.5 ml of incubation buffer 
containing DCF (10 \xM). FCM was then carried out (n=3). 
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Figure 3.30 
Hyperthermia released H2O2 at low A^m in L929 cells in a time-dependent 
manner. L929 cells were seeded at 1 x 10Well in complete medium in a 6-well 
plate and incubated at 37 5% CO2 overnight. On the next day, cells were washed 
twice with serum-free medium and were treated with serum-free medium at 37 
for 3 hr or at 43 for 1 to 3 hr as indicated. Cells were then harvested and 0.5 x 10^  
cells were re-suspended in 0.5 ml of incubation buffer containing 500 nM TMRE 
and fluo-3 (10 piM). FCM was then carried out (n=3). 
Chapter 3. Results Page 120 
was obvious in L929-11E cells than the one found in L929 cells (Figure 3.30 and 
3.31). This observation explains why more cells with less DCF fluorescence were 
found in Figure 3.3 Ih. 
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Figure 3.31 
Hyperthermia released H2O2 at low AT^ in L929-11E cells in a time-dependent 
manner. L929 cells were seeded at 1 x 10^/well in complete medium in a 6-well 
plate and incubated at 3 7 5 % CO2 overnight. On the next day, cells were washed 
twice with serum-free medium and were treated with serum-free medium at 37 
for 3 hr or at 43 for 1 to 3 hr as indicated. Cells were then harvested and 0.5 x 10^  
cells were re-suspended in 0.5 ml of incubation buffer containing 500 nM TMRE 
and fluo-3 (10 |aM). FCM was then carried out (n=3). 
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3.6 Effect of TNF-a and Hyperthermia on the Level of 
Intracellular Calcium in L929 and L929-11E Cells 
3.6.1 Increase in the Intracellular Calcium Level Induced by TNF-a 
Was Related to the Mitochondrial Membrane Depolarization 
in L929 Cells but not in L929-11E Cells 
It is demonstrated that oligonucleosomal DNA fragmentation occurred in 
isolated nuclei from a variety of tissues incubated with millimolar concentrations of 
Ca2+ and Mg2+ (Vanderbilt et al,, 1982; Cohen and Duke, 1984; Wyllie et al., 1984). 
Figure 3.32 was a contour plot showing the relationship between the 
intracellular calcium level and mitochondrial membrane depolarization in L929 cells 
after treatment with TNF-a (50 ng/ml). The x-axis represented the fluo-3 intensity 
and the y-axis represented the TMRE intensity. Fluo-3 is a fluorescent dye that can 
be used to determine the calcium level whilst TMRE can be used to determine A平m.‘ 
As shown in Figure 3.32a, c and e, about 96% of cells were found to have normal 
ATm and [Ca^^ji. On the contrary, when cells were treated with TNF-a (50 ng/ml) for 
3，6 and 9 hr, the number of cells having low A^m and high [Ca^'^Jiwere increasing 
from about 9% at 3 hr of the treatment to 24% at 9 hr of the treatment (Figure 3.32b, 
d and f). These observations suggest that polarized mitochondria might take up Ca^^ 
ions in the cytosol and become less polarized in terms of A中m. After reaching a limit, 
^ I 
cells could not absorb more Ca ions and eventually showed a high [Ca^ ^^ Ji and 
depolarized A^m (Figure 3.32b, d and f). In the case of L929-11E cells, about 96% 
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Figure 3.32 
TNF-a induced calcium release and mitochondrial membrane depolarization in 
a time-dependent manner in L929 cells. L929 cells were seeded at 1 x 10 /^well in 
complete medium in a 6-well plate and incubated at 37 5% CO2 overnight. On 
the next day, cells were washed twice with serum-free medium and were then treated 
with serum-free medium at 3 7 � C for 3 hr (a); 6 hr (c); 9 hr (e) or TNF-a (50 ng/ml) 
at 3 7 � C for 3 hr (b); 6 hr (d); 9 hr (f). Cells were then harvested and 0.25 x 10^  cells 
were re-suspended in 0.5 ml of incubation buffer containing TMRE (500 nM) and 
fluo-3 (10 iiM) and was incubated at 3 7 � € for 15 min. FCM was then carried out 
(n=2). 
Chapter 3. Results Page 124 
of cells had normal A中m and [Ca^^ji in both the control (Figure 3.33a, c and e) and 
TNF-a-treated groups (Figure 3.33b, d and f). 
3.6.2 Hyperthermia Increased the Level of [Ca^+h in L929 and 
L929-11E Cells in a Time-dependent Manner 
The effects of hyperthermia on the level of [Ca^ '^Ji was investigated. As 
shown in Figure 3.34, it was observed that there was an increase in the percentage of 
cells in the left region with hyperthermia from 1 to 3 hr in both cell lines, implying 
that the level of was increased with hyperthermia incubation time. On the 
other hand, it was found that such increase was about 2-fold in L929-11E cells as 
compared to that in L929 cells treated at 43 for 3 hr； The relationship between 
level of [Ca2+]i and A^m was also investigated. According to Figure 3.35 and Figure 
3.36, it was observed that cells with a median high level had a relatively high 
A^m while cells with a very high possessed depolarized A平 
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Figure 3.33 
TNF-a induced calcium release and mitochondrial membrane depolarization in 
a time-dependent manner in L929-11E cells. L929-11E cells were seeded at 1 x 
10Well in complete medium in a 6-well plate and incubated at 37 5% CO2 
overnight. On the next day, cells were washed twice with serum-free medium and 
were then treated with serum-free medium at 37 ""C for 3 hr (a); 6 hr (c); 9 hr (e) or 
TNF-a (50 ng/ml) at 3 7 � C for 3 hr (b); 6 hr (d); 9 hr (f). Cells were then harvested 
and 0.25 x 10^  cells were re-suspended in 0.5 ml of incubation buffer containing 
T M R E (500 NM) and fluo-3 (10 |LIM) and was incubated at 3 7 � �f o r 15 min. F C M 
was then carried out (n=2). 
Chapter 3. Results Page 126 
L929 cells L929-11E cells 
(a) 3 7 � C for 3 hr (b) 3 7 � C f o r 3 h r 
-5.42% 7 1 ij 7.25% Z 
V::: / : 鎮 : : / 
94.58% : • 92.75% 
•二 � "23 "r 
a (c) 4 3 � C for 1 hr (d) 43 «C for 1 hr ^  
巨 7.68% 7 1 'I 10.68% 7 
i : . / ^ ：,： • ； / S . Z 92.32% .：；. .： 89.32%. ^ / X 
u ‘ - X . •• -.',.‘、’.， . 
3 {^―“一“— w丨一 
^ “ (e) 43 oc fo r 2 h厂 "(f) 43 «C for 2 hr 
0> si ： 71 sj~- • •. ~~~ 7 2 - 6.98% / / ' 12.70% Z 
3 � / 93.02% / 87.30% 
' . y ^ ‘ . ‘ 放叙 
" ( g ) 4 3 � C for 3 h r " (h) 43 «C for 3 hr 
目 9.73% . 目I 咖 ％ 、 y 
X 90.27%. Z 81.35% 
t ; / �、 為 Z 、 ; ： ％ 
0 1023 "o^ ~ 1023 
F u r a - r e d red f l u o r e s c e n c e i n t e n s i t y 
Figure 3.34 
Increase in [Ca!.]丨 in L929 and L929-11E cells upon hyperthermia treatment. 
L929 or L929-11E cells were seeded at 1 x 10^/well in complete medium in a 6-well 
plate and incubated at 37 5% CO2 overnight. On the next day, cells were washed 
twice with serum-free medium and were treated with serum-free medium at 37 
for 3 hr or at 43 for 1 to 3 hr as indicated. Cells were then harvested and 0.25 x 
106 cells were re-suspended in 0.5 ml of incubation buffer containing fura-red (10 
IxM) and fluo-3 (10 j^ iM). FCM was then carried out (n=3). 
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Figure 3.35 
Hyperthermia enhanced intracellular calcium level and mitochondrial 
membrane depolarization in L929 cells in a time-dependent manner. L929 cells 
were seeded at 1 x 1 Orwell in complete medium in a 6-well plate and incubated at 
37 5% CO2 overnight. On the next day, cells were washed twice with serum-free 
medium and were treated with semm-free medium at 37 for 3 hr or at 4 3 � �f o r 1 
to 3 hr as indicated. Cells were then harvested and 0.5 x 10^  cells were re-suspended 
in 0.5 ml of incubation buffer containing 500 NM TMRE and fluo-3 (10 |LIM) for 15 
min. FCM was then carried out (n=2). 
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Figure 3.36 
Hyperthermia enhanced intracellular calcium level and mitochondrial 
membrane depolarization in L929-11E cells in a time-dependent manner. 
L929-11E cells were seeded at 1 x 10 /^well in complete medium in a 6-well plate 
and incubated at 37 5% CO2 overnight. On the next day, cells were washed twice 
with serum-free medium and were treated with serum-free medium at 37 ""C for 3 hr 
or at 43 for 1 to 3 hr as indicated. Cells were then harvested and 0.5 x 10^  cells 
were re-suspended in 0.5 ml of incubation buffer containing TMRE (500 nM) and 
fluo-3 (10 |iM) for 15 min. FCM was then carried out (n=2) 
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3.7 Effect of Combined Hyperthermia and TNF-a 
Treatment on the Induction of Apoptosis in L929 and 
L929-11E Cells 
3.7.1 Combined Treatment with Hyperthermia and TNF-a Induced 
Apoptosis in Both L929 and L929-11E Cells 
Combined treatment of hyperthermia with chemotherapy was not a new topic 
in anticancer therapy. Phase I/II clinical data supported that hyperthermia combined 
with chemotherapy was effective in malignant germ cell tumours (Wessalowski et al., 
1998). Moreover, it was found that combined treatment with interleukin-la (IL-la) 
‘ and TNF-a potentiated the antitumour effect of hyperthermia in SCK mammary 
adenocarcinoma (Lin et al., 1996) whilst combined treatment of hyperthermia with 
TNF-a in L929 cells (Yuen et al., 2000) or verapamil in U937 cells (Kameda et al., 
2001) was found to induced apoptosis. In the previous Sections 3.2 and 3.3, it was 
found that TNF-a can induce apoptosis in L929 cells but not in L929-11E cells whilst 
hyperthermia can induce apoptosis in both cell lines. It is of interest to examine the 
combined treatment with hyperthermia (43 °C，3 hr) and TNF-a (50 ng/ml) on the 
induction of apoptosis in L929 and L929-11E cells. Combined treatment was then 
performed by treating cells at 43 °C for 3 hr and then with TNF-a at 37 °C for different 
periods of time. This treatment protocol was used because we would like to examine 
the effect of hyperthermia on reversing the TNF-resistance in L929-1 IE cells. 
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Figure 3.37 and 3.38 show the cell cycle pattern in which both L929 and 
L929-11E cells were challenged with hyperthermia at 43 for 3 hr and then with 
TNF-a (50 ng/ml) for 3 or 6 hr at 37 It was found that cell cycle arrest in S-phase 
appeared in L929 cells as more cells were accumulated in the S phase (Figure 3.37) as 
compared with the one treated with 50 ng/ml TNF-a alone in Figure 3.6. Moreover, 
similar results were observed in L929-11E cells (Figure 3.38). When L929-11E cells 
were further incubated for 6 hr at 37 after hyperthermia treatment, similar 
sub-Go/Gi peak were found after TNF-a treatment whereas no sub-Go/Gi peak was 
observed in the TNF-a treated group (Figure 3.6). Interestingly, the G2/M phase peak 
was disappeared 6 hr after hyperthermia treatment in L929-11E cells (Figure 3.38). 
On the other hand, in Figure 3.39, the number of late apoptotic cells was found 
to increase in L929 cells as the temperature was stepped down to 37 after heating 
(Figure 3.39c and e). From the same figure, the number of early apoptotic cells was 
more than that of late apoptotic/necrotic cells, suggesting that apoptosis was the majcH： 
form of cell death after hyperthermia treatment. When TNF-a (50 ng/ml) was added to 
the cells during 37 incubation after hyperthermia treatment, the number of 
apoptotic cells, as well as the necrotic cells increased slightly with incubation time as 
compared with a single treatment with hyperthermia only (Figure 3.39c and d, e and 
f). However, apoptosis was still the major form in the hyperthermia-induced cell death 
(Figure 3.39). For the L929-11E cells, previous study demonstrated that hyperthermia 
but not TNF-a induced apoptosis in this cell line (Figure 3.11 and 3.25). Interestingly, 
as can be seen in Figure 3.40, it was observed that combined treatment with 
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Figure 3.37 
Combined treatment with hyperthermia and TNF-a induced cell cycle arrest in 
L929 cells. L929 cells were seeded at 1 x lOVwell in complete medium in a 6-well 
plate and incubated at 37 5% CO2 overnight. Cells were washed twice with 
serum-free medium and were treated with the condition as indicated. Cells were then 
harvested and fixed with 70% ethanol overnight. Cells were then stained with PI (43 
|Lig/ml) for 30 min. The cell cycle pattern was then determined by FCM (n=3). 
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Figure 3.38 
Combined treatment with hyperthermia and TNF-a induced cell cycle arrest in 
L929-11E cells. L929-11E cells were seeded at 1 x 10^/well in complete medium in a 
6-well plate and incubated at 37 "^ C, 5% CO2 overnight. Cells were washed twice with 
serum-free medium and were treated with the condition as indicated. Cells were then 
harvested and fixed with 70% ethanol overnight. Cells were then stained with PI (43 
fag/ml) for 30 min. The cell cycle pattern was then determined by FCM (n=3). 
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Figure 3.39 
Hyperthermia and combined treatment with TNF-a induced apoptosis and 
necrosis in L929 cells. L929 cells were seeded at 1 x 10^/well in complete medium in 
a 6-well plate and incubated at 37 5% CO2 overnight. Cells were then treated with 
hyperthermia in the presence or absence of TNF-a (50 ng/ml) as indicated. Cells were 
then harvested and 0.5 x 10^  cells were re-suspended in 0.5 ml of incubation buffer 
containing annexin-V-FITC (2% v/v) and PI (2.5 |Lig/ml). FCM was then carried out to 
measure the fluorescence from the annexin-V-FITC and the PI (n=3). 
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Figure 3.40 
Hyperthermia and its combined treatment with TNF-a induced apoptosis and 
necrosis in L929-11E cells. L929-11E cells were seeded at 1 x 10^/well in complete 
medium in 6-well plate and incubated at 37 5% CO2 overnight. Cells were then 
treated with hyperthermia in the presence or absence of TNF-a (50 ng/ml) as 
indicated. Cells were then harvested and 0.5 x 10^ cells were re-suspended in 0.5 ml of 
incubation buffer containing annexin-V-FITC (2% v/v) and PI (2.5 j_Lg/ml). FCM was 
then carried out to measure the fluorescence from the annexin-V-FITC and the PI 
(n 二 3). 
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hyperthermia at 43 and TNF-a at 37 increased the number of cell death (early 
apoptotic plus late apoptotic/necrotic) slightly in L929-11E cells. Figure 3.40c to f 
showed that most of the cells appeared in the upper right quadrant in the diagram, 
suggesting that most of the cells were late apoptotic or necrotic after incubation at 37 
after heating. 
To conclude, apoptosis was found to be the major form of cell death induced by 
hyperthermia and TNF-a in L929 cells. The results also told us that hyperthermia and 
its combined treatment with TNF-a sensitized L929-11E cells towards cell death. 
3.7.2 Hyperthermia and Its Combined Treatment with TNF-a 
Induced Mitochondrial Membrane Depolarization in L929 and 
L929-11E Cells 
Mild hyperthermia has been shown to induce mitochondrial membrane 
depolarization in a time-dependent manner (Figure 3.26 to 3.29). The effects of the 
combined treatment of hyperthermia and TNF-a on the change of A平m in L929 and 
L929-11E cells were also examined. Figure 3.41c and 3.41 e showed that only about 
6% of L929 cells underwent mitochondrial membrane depolarization upon treatment 
at 37 for 3 or 6 hr in medium after hyperthermia (43 °C，3 hr) treatment. With the 
addition of TNF-a (50 ng/ml) after heating, the A乎m dropped greatly, 14% more as 
compared with the corresponding control (Figure 3.41c and d, e and f). Such decrease 
was found to be higher than the one by treating the cells with TNF-a alone for 3 or 6 hr 
(Figure 3.14b and d). On the other hand, mitochondrial membrane depolarization 
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Figure 3.41 
Hyperthermia and its combined treatment with TNF-a induced mitochondrial 
membrane depolarization in L929 in a time-dependent manner. L929 cells were 
seeded at 1 x 10 /^well in complete medium in a 6-well plate and incubated at 37 "C， 
5% CO2 overnight. Cells were then treated with serum-free medium at 37 for 3 hr 
or at 4 3 � € for 1 to 3 hr as indicated. Cells were then harvested and 0.25 x 10^  cells 
were re-suspended in 0.5 ml of incubation buffer containing JC-1 (10 |iM) and was 
incubated at 37 ""C for 15 min. FCM was then carried out to measure the green and red 
fluorescence from JC-1 (n=3). 
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Figure 3.42 
Hyperthermia and its combined treatment with TNF-a induced mitochondrial 
membrane depolarization in L929-11E in a time-dependent manner. L929-11E 
cells were seeded at 1 x lOVwell in complete medium in a 6-well plate and incubated 
at 37 5% CO2 overnight. Cells were then treated with serum-free medium at 37 
for 3 hr or at 43 for 1 to 3 hr as indicated. Cells were then harvested and 0.25 x 10^  
cells were re-suspended in 0.5 ml of incubation buffer containing JC-1 (10 |LIM) and 
was incubated at 37 for 15 min. FCM was then carried out to measure the green and 
red fluorescence from JC-1 (n=3). 
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occurred in L929-11E cells treated at 37 for 3 or 6 hr (Figure 3.42a, b, c and e). 
However, further treatment of cells with TNF-a (50 ng/ml) did not increase the 
mitochondrial membrane depolarization (Figure 3.42 c and d, e and f). 
With the observation that there was mitochondrial membrane depolarization in 
L929 and L929-11E cells upon combined treatment with both hyperthermia and 
TNF-a (50 ng/ml), we next investigated the release of cyto c from mitochondria. 
Previously, it was found that both hyperthermia and TNF-a could induce cyto c 
release. As shown in Figure 3.43a, when L929 cells were treated at 43 for 3 hr and 
then incubated at 37 °C in either serum-free medium or with TNF-a (50 ng/ml) for 
another 3 or 6 hr, cyto c was released from mitochondria. Moreover, cyto c was also 
released from L929-11E cells after challenge with hyperthermia at 43 for 3 hr and 
then at 3 7 � C for 3 hr in either serum-free medium or with TNF-a (50 ng/ml) (Figure 
3.43b). 
On the other hand, it was found that the reduction in the A平m was accompanied 
with an increase in the after treating L929 cells at 43 for 3 hr and then at 37 
°C for another 3 or 6 hr with or without TNF-a (Figure 3.44). In the presence of 
n I 
TNF-a, more cells had depolarized A^m and high [Ca ]i. Similar results can also be 
observed in L929-11E cells after hyperthermia treatment (Figure 3.45). However, 
TNF-a could not increase the damage in L929-11E cells (Figure 3.45). 
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Combined treatment with hyperthermia and TNF-a released cytochrome c from 
L929 cells and L929-11E cells as determined by Western Blotting. L929 or 
L929-11E cells (1 x 10^  cells/well) were seeded in a 6-well plate and were incubated at 
37 5% CO2 overnight. Cells were then washed twice with serum-free medium and 
were then incubated with either serum free medium or TNF-a (50 ng/ml) at 3 7 � C for 
3, 6 or 9 hr. On the other hand, cells in semm-free medium were first incubated at 43 
•C for 3 hr and then incubated with serum-free medium or TNF-a (50 ng/ml) for 
another 3 or 6 hr. After treatment, adherent cells were collected and cells were 
incubated with lysis buffer containing digitonin (25 |ig/4 x 10^  cells) for 30 sec at 
room temperature and then centrifuged at 10,621 x g (10,000 rpm, 9.5 cm, Eppendorf 
Centrifuge 5417R) for 1 min. The supernatant was collected and the SDS 
polyacrylamide gel electrophoresis was performed. ECL assay was then performed 
and the amount of cyto c release can be determined with the densitometer. 
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Figure 3.44 
TNF-a induced calcium release and mitochondrial membrane depolarization in 
a time-dependent manner in L929 cells. L929 cells were seeded at 1 x 10^/well in 
complete medium in a 6-well plate and incubated at 37 5% CO2 overnight. Cells 
were then treated with serum-free medium at 3 7 � C for 3 hr (a); 43 for 3 hr (b); 43 
for 3 hr and then at 3 7 � C for 3 hr in medium (c) or with TNF-a (50 ng/ml) (d); 43 
� C for 3 hr and then at 37�C for 6 hr in medium (e) or with TNF-a (50 ng/ml) (f). Cells 
were then harvested and 0.25 x 10^  cells were re-suspended in 0.5 ml of incubation 
buffer containing T M R E (500 nM) and fluo-3 (10 |LIM) and was incubated at 3 7 � C for 
15 min. FCM was then carried out (n=2). 
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Figure 3.45 
TNF-a induced calcium release and mitochondrial membrane depolarization in 
a time-dependent manner in L929-11E cells. L929-11E cells were seeded at 1 x 
10^/well in complete medium in a 6-well plate and incubated at 3 7 � C , 5% CO2 
overnight. Cells were treated with serum-free medium at 37 "^C for 3 hr (a); 43 for 3 
hr (b); 4 3 � C for 3 hr and then at 3 7 � C for 3 hr in medium (c) or with TNF-a (50 ng/ml) 
(d); 4 3 � C for 3 hr and then at 37 C^ for 6 hr in medium (e) or with TNF-a (50 ng/ml) 
(f). Cells were then harvested and 0.25 x 10^  cells were re-suspended in 0.5 ml of 
incubation buffer containing TMRE (500 nM) and fluo-3 (10 |LIM) and was incubated 
at 37 for 15 min. FCM was then carried out (n=2). 
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3.8 Investigation of the Apoptotic Pathway in L929 and 
L929-11E Cells Upon Hyperthermia and TNF-a 
Treatment 
3.8.1 Introduction 
As shown in the previous sections, it was found that TNF-a induces apoptosis 
in a time-dependent manner in L929 cells but not in L929-11E cells whilst 
hyperthermia or its combined treatment with TNF-a induces apoptosis in both L929 
and L929-1 IE cells. 
3.8.2 Effect of TNF-a and Hyperthermia on p53 Expression 
p53 is a tumour suppressor gene that is found to be involved in the apoptotic 
pathway. Its functions are to mediate cellular response to DNA damage and to 
maintain genomic stability. 
Figure 3.46 showed the effect of TNF-a (50 ng/ml) on p53 expression in L929 
and L929-11E cells. With the use of Western Blotting, it was observed that the level of 
p53 increased after TNF-a (50 ng/ml) treatment in L929 and L929-11E cells. The 
increase in the p53 protein level suggested that TNF receptors in both cell lines were 
functional and were able to transmit the signals from the receptor to the subcellular 
levels. Figure 3.47 showed the effect of hyperthermia on p53 expression in L929 and 
L929-11E cells. Both L929 and L929-11E cells were challenged with hyperthermia at 
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Figure 3.46 
Effect of TNF-a on p53 expression in L929 and L929-11E cells. L929 and 
L929-11E cells in complete medium were seeded at 1 x 10^/well in complete medium 
in a 6-well plate and incubated at 37 5% CO2 overnight. Cells were then washed 
twice with serum-free medium and treated with serum-free medium or with TNF-a at 
37 °C for 3, 6 or 9 hr as indicated. Cells were then harvested and 1 x 10^ cells were 
re-suspended in 100 |LI1 of lysis buffer for 30 min to extract protein. Samples were 
boiled and centrifugation was then carried out at 20,817 x g (14,000 rpm, 9.5 cm, 
Eppendorf Centrifuge 5417R) for 7 min. The supernatant was then collected and 
stored at -70 The protein content was determined with BCA assay. 25 |Lig of 
proteins were loaded for gel electrophoresis. Electroblotting and non-specific block of 
proteins were done. Anti-p53 antibodies (1:200) was probed onto the membrane at 
room temperature for 1 hr and then with anti-rabbit-HRP conjugated antibodies 
(1:1000) at room temperature for another hr. The ECL assay was then performed and 
signal was exposed on x-ray film. 
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Figure 3.47 
Effect of hyperthermia on p53 expression in L929 and L929-11E cells. L929 and 
L929-11E cells in complete medium were seeded at 1 x 1 Orwell in complete medium 
in a 6-well plate and incubated at 37 5% CO2 overnight. Cells were then washed 
twice with serum-free medium and then treated at 37 for 3 hr or at 43 for 1 to 3 
hr as indicated. Cells were then harvested and 1 x 10^ cells were re-suspended in 100 
of lysis buffer for 30 min to extract protein. Samples were boiled and centrifugation 
was then carried out at 20,817 x g (14,000 rpm, 9.5 cm, Eppendorf Centrifuge 5417R) 
for 7 min. The supernatant was then collected and stored at -70 The protein content 
was determined with BCA assay. 25 x^g of proteins were loaded for gel 
electrophoresis. Electroblotting and non-specific block of proteins were done. 
Anti-p53 antibodies (1:200) was probed onto the membrane at room temperature for 1 
hr and then with anti-rabbit-HRP conjugated antibodies (1:1000) at room temperature 
for another hr. The ECL assay was then performed and signal was exposed on x-ray 
film. 
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L929 cells L929-1IE cells 
T i^ tment 37。C 43。C 43。C 43 ®C 37。C 43 ®C 43 "C 43�C 
3 hr 1 hr 2 hr 3 hr 3 hr 1 hr 2 hr 3h r 
Band Gel 1 16.70 10.30 85.79 87.84 72.20 60.50 59.90 68.67 
intensity of 
p53  




Band Gel 1 81.00 90.80 84.10 84.60 86.40 87.00 87.00 91.50 
intensity of 
Grp75 




Band Ce l l 0.206 0.113 1.020 1.040 0.840 0.700 0.690 0.750 
i n t � sity  
Gel 2 0.130 0.360 0.380 0.370 0.630 0.440 0.440 0.520 
(p53/Grp 75) 
Figure 3.48 
The calculated band intensity ratio of p53 in L929 and L929-11E cells after 
hyperthermia treatment. The band intensity of p53 and Gip 75 from Figure 3.44 
(Gel 1) was determined with the software “Image Quant". The band intensity ratio of 
p53 to Grp 75 from two different experiments (Gel 1 and Gel 2) was determined with 
the following equation and shown in the table above. 
Band intensity ratio for p53 
=Band intensity of p53/Band intensity of Grp 75 
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43 for 1 to 3 hr. There was an increase in the p53 expression in L929 cells 
challenged with hyperthermia. On the contrary, a slight decrease in the p53 expression 
was observed in L929-11E cells treated with hyperthermia as calculated from results 
of two different experiments (Figure 3.48). In Figure 3.47, the level of 
glucose-regulated protein (Grp 75) was determined. Grp 75 is highly conserved 
protein and it is abundantly expressed in cells and can therefore be used as an internal 
control for determining the amount of protein loaded in each well in Western blotting. 
3.8.3 Effect of Hyperthermia and TNF-a on PARP 
Poly (ADP-Ribose) Polymerase (PARP) is an endogenous DNA break sensor 
enzyme synthesizing a homopolymer of ADP-ribose after DNA damage. Its major 
functions involve the maintenance of genomic integrity and promotion of cell survival 
following DNA damage (Germain et al., 2000). It is one of the targets of activated 
caspase-3 in which it is cleaved from a 116 kDa peptide into 85 kDa fragment. 
Figure 3.49 shows the results of L929 and L929-11E cells after hyperthermia 
on PARP cleavage. L929 and L929-11E cells were treated at 4 3 � € for 1, 2 and 3 hr. 
From the results, it was found that PARP cleavage increased with the increase in the 
hyperthermia incubation time in both cell lines. 
Figure 3.50 shows the results for TNF-a and its combined treatment with 
hyperthermia at 43�C for 3 hr and then to 3 7 � �f o r another 3hrin L929 and L929-1 IE 
cells. It was observed that PARP cleavage was increased in a time-dependent manner 
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Figure 3.49 
Hyperthermia enhanced PARP cleavage in L929 and L929-11E cells in a 
time-dependent manner. L929 and L929-11E cells in complete medium were seeded 
at 1 X 10^/well in complete medium in a 6-well plate and incubated at 37 5% CO2 
overnight. Cells were then washed twice with serum-free medium and treated at 37 
for 3 hr or at 43 for 1 to 3 hr as indicated. Cells were then harvested and 1 x 1 c e l l s 
were re-suspended in 100 |LL1 of lysis buffer for 30 min to extract protein. Samples were 
boiled and centrifugation was then carried out at 20,817 x g (14,000 rpm, 9.5 cm, 
Eppendorf Centrifuge 5417R) for 7 min. The supernatant was then collected and 
stored at -70 The protein content was determined with BCA assay. 25 |Lig of 
proteins were loaded for gel electrophoresis. Electroblotting and non-specific block of 
proteins were done. Anti-PARP antibodies (1:200) was probed onto the membrane at 
room temperature for 1 hr and then with anti-rabbit-HRP conjugated antibodies 
(1:1000) at room temperature for another hr. The ECL assay was then performed and 
signal was exposed on x-ray film. Note that the presence of 85 kDa is an indicator for 
PARP cleavage. 
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Figure 3.50 
PARP cleavage in L929 and L929-11E cells treated with TNF-a and 
hyperthermia. L929 and L929-11E cells in complete medium were seeded at 1 x 
lOVwell in complete medium in a 6-well plate and incubated at 37 5% CO2 
overnight. Cells were washed twice with serum-free medium and treated at 37 °C for 
3, 6 or 9 hr with serum-free medium or TNF-a (50 ng/ml). On the other hand, cells 
were undergone combined treatment with hyperthermia at 43 °C for 3 hr and then to 37 
for further 3 hr with serum-free medium or TNF-a (50 ng/ml). Cells were then 
harvested and 1x10^ cells were re-suspended in 100 |LI1 of lysis buffer for 30 min to 
extract protein. Samples were boiled and centrifugation was then carried out at 20,817 
X g (14,000 rpm, 9.5 cm, Eppendorf Centrifuge 5417R) for 7 min. The supernatant 
was then collected and stored at -70 The protein content was determined with BCA 
assay. 25 \ig of proteins were loaded for gel electrophoresis. Electroblotting and 
non-specific block of proteins were done. Anti-PARP antibodies (1:200) was probed 
onto the membrane at room temperature for 1 hr and then with anti-rabbit-HRP 
conjugated antibodies (1:1000) at room temperature for another hr. The ECL assay 
was then performed and signal was exposed on x-ray film. Note that the presence of 85 
kDa is an indicator for PARP cleavage. 
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in L929 cells treated with TNF-a (50 ng/ml) whilst on the other hand, no 85 kDa of 
PARP fragment was significantly observed when L929-11E cells were treated with 
TNF-a as compared with their corresponding control. 
When L929 cells were challenged with hyperthermia at 43 for 3 hr and then 
at 37 °C for 3 hr with serum-free medium, cleavage of PARP was observed. When 
L929-11E cells were incubated at 43 °C for 3 hr and then at 37 for 3 hr with TNF-a 
(50 ng/ml) or with serum-free medium, PARP cleavage was observed as well. 
3.8.4 Effect of Hyperthermia and TNF-a on Caspase-3 Activity 
Caspase-3 is one of the executioner caspases in the apoptotic pathway. It is 
located in the cytosol as an inactive form and becomes activated upon apoptotic 
stimulus. Figure 3.51 shows the results of the level of pro-caspase-3 after 
hyperthermia in L929 and L929-11E cells with Western blotting. L929 cells and 
L929-11E cells were treated at 37 for 3 hr or 43 for 1，2 or 3 hr. The proteins of 
cells after treatment were probed with two different antibodies, anti-pro-caspase-3 and 
anti-Grp 75 antibodies. According to the results, it was found that the level of 
pro-caspase-3 decreased slightly in L929 cells treated with hyperthermia at 43 for 3 
hr whilst there was about 1.7-fold decrease in the level of pro-caspase-3 in L929-11E 
cells treated with same condition of hyperthermia (Figure 3.52). The decrease in the 
level of pro-caspase-3 represents an increase in the level of activated caspase-3. Figure 
3.53 and 3.54 showed the results of pro-caspase-3 in L929 cells after treatment with 
TNF-a and hyperthermia. It was observed that the level of 
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Figure 3.51 
Level of pro-caspase-3 in L929 and L929-11E cells. L929 and L929-11E cells in 
complete medium were seeded at 1 x 10^/well in complete medium in a 6-well plate 
and incubated at 37 5% CO2 overnight. Cells were then washed twice with 
serum-free medium and treated at 37 for 3 hr or at 4 3 � C for 1 to 3 hr as indicated. 
Cells were then harvested and 1 x 10^  cells were re-suspended in 100 |LI1 of lysis buffer 
for 30 min to extract protein. Samples were boiled and centrifugation was then carried 
out at 20,817 x g (14,000 rpm, 9.5 cm, Eppendorf Centrifuge 5417R) for 7 min. The 
supernatant was then collected and stored at -70。(：. The protein content was 
determined with BCA assay. 25 ^g of proteins were loaded for gel electrophoresis. 
Electroblotting and non-specific block of proteins were done. Anti-caspase-3 
antibodies (1:200) was probed onto the membrane at room temperature for 1 hr and 
then with anti-mouse-HRP conjugated antibodies (1:1000) at room temperature for 
another hr. The ECL assay was then performed and signal was exposed on x-ray film. 
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The calculated band intensity ratio of pro-caspase-3 in L929 and L929-11E cells 
after hyperthermia treatment. The band intensity of pro-caspase-3 and Grp 75 from 
Figure 3.44 was determined with the software "Image Quant". The band intensity ratio 
of pro-caspase-3 of each sample was determined with the following equation. 
Band intensity ratio for pro-caspase-3 
=Band intensity of pro-caspase-3/Band intensity of Grp 75 
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Figure 3.53 
Level of pro-caspase-3 in L929 cells treated with TNF-a and hyperthermia. L929 
cells in complete medium were seeded at 1 x lOVwell in complete medium in a 6-well 
plate and incubated at 37 °C, 5% CO2 overnight. Cells were washed twice with 
serum-free medium and treated at 37 for 3, 6 or 9 hr with serum-free medium or 
TNF-a (50 ng/ml). On the other hand, cells were undergone combined treatment with 
hyperthermia at 43 for 3 hr and then to 37 for further 3 hr with TNF-a (50 
ng/ml). Cells were then harvested and 1 x 10^  cells were re-suspended in 100 of 
lysis buffer for 30 min to extract protein. Samples were boiled and centrifugation was 
then carried out at 20,817 x g (14,000 rpm, 9.5 cm, Eppendorf Centrifuge 5417R) for 7 
min. The supernatant was then collected and stored at -70 The protein content was 
determined with BCA assay. 25 [ig of proteins were loaded for gel electrophoresis. 
Electroblotting and non-specific block of proteins were done. Anti-caspase-3 
antibodies (1:200) was probed onto the membrane at room temperature for 1 hr and 
then with anti-mouse-HRP conjugated antibodies (1:1000) at room temperature for 
another hr. The ECL assay was then performed and signal was exposed on x-ray film. 
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The calculated band intensity ratio of pro-caspase-3 in L929 cells. The band 
intensity of pro-caspase-3 and Grp 75 from Figure 3.44 was determined with the 
software “Image Quant". The band intensity ratio of pro-caspase-3 of each sample was 
determined with the following equation. 
Band intensity ratio for pro-caspase-3 
二 Band intensity of pro-caspase-3/Band intensity of Grp 75 
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pro-caspase-3 decreased upon treatment with TNF-a (50 ng/ml) for 9 hr. On the other 
hand, no significant decrease in the level of pro-caspase-3 was observed in L929 cells 
treated with hyperthermia at 43 for 3 hr and then to 37 for 3 and 6 hr with TNF-a 
(50 ng/ml) (Figure 3.54). In L929-11E cells, there was no significant decrease in the 
level of pro-caspase-3 in cells treated with TNF-a for 3, 6 or 9 hr (Figure 3.55 and 
3.56). However, when L929-11E cells were challenged with hyperthermia at 43 for 
3 hr and then incubated with TNF-a (50 ng/ml) at 37 for 3 and 6 hr, significant 
decrease in the po-caspase-3 level was observed in a time-dependent manner. 
With the application of the ApoAlert caspase-3 fluorescent assay, the activity of 
caspase-3 can be further determined. The principle of the assay makes use of the 
caspase-3-specific substrate, DEVD-AFC. Upon the induction of apoptosis, 
pro-caspase-3 is activated and converted to the active caspase-3 which in turn cleaves 
the substrate, DEVD-AFC that normally emits blue fluorescence to a free form AFC 
that emits yellow-green fluorescence. It can be observed ia Figure 3.57 that the 
activity of caspase-3 increased in a time-dependent manner in L929 cells upon 
treatment of TNF-a (50 ng/ml) from 3 to 9 hr (bars 2 to 4) or hyperthermia at 43 °C 
from 1 to 3 hr (bars 7 to 9). On the other hand, no caspase-3 activation was observed in 
L929-11E cells after treatment with TNF-a (50 ng/ml) at different periods of time 
(bars 12 to 14). However, a time-dependent increase in the caspase-3 activity was 
observed in L929-11E cells after hyperthermia treatment (bars 17-19). It was also 
observed that when L929 or L929-11E cells were challenged with hyperthermia at 43 
and then at 37 for 3 hr with serum-free medium or TNF-a, the activity of 
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Figure 3.55 
Level of pro-caspase-3 in L929-11E cells treated with TNF-a and hyperthermia. 
L929-11E cells in complete medium were seeded at 1 x 10^/well in complete medium 
in a 6-well plate and incubated at 37 5% CO2 overnight. Cells were washed twice 
with serum-free medium and treated at 3 7 � C for 3, 6 or 9 hr with serum-free medium 
or TNF-a (50 ng/ml). On the other hand, cells were undergone combined treatment 
with hyperthermia at 43 for 3 hr and then to 37 for further 3 hr with TNF-a (50 
ng/ml). Cells were then harvested and 1 x 10^  cells were re-suspended in 100 of 
lysis buffer for 30 min to extract protein. Samples were boiled and centrifugation was 
then carried out at 20,817 x g (14,000 rpm, 9.5 cm, Eppendorf Centrifuge 5417R) for 7 
min. The supernatant was then collected and stored at -70 ""C. The protein content was 
determined with BCA assay. 25 |ag of proteins were loaded for gel electrophoresis. 
Electroblotting and non-specific block of proteins were done. Anti-caspase-3 
antibodies (1:200) was probed onto the membrane at room temperature for 1 hr and 
then with anti-mouse-HRP conjugated antibodies (1:1000) at room temperature for 
another hr. The ECL assay was then performed and signal was exposed on x-ray film. 
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The calculated band intensity ratio of pro-caspase-3 in L929-11E cells. The band 
intensity of pro-caspase-3 and Grp 75 from Figure 3.44 was determined with the 
software "Image Quant". The band intensity ratio of pro-caspase-3 of each sample was 
determined with the following equation. • 
Band intensity ratio for pro-caspase-3 
二 Band intensity of pro-caspase-3/Band intensity of Grp 75 
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Figure 3.57 
Increase in caspase-3 activity with TNF-a and hyperthermia treatment in L929 
and L929-11E cells. L929 and L929-11E cells in complete medium were seeded at 1 
X 10^ /well in complete medium in a 6-well plate and incubated at 3 7 5 % CO2 
overnight. Cells were then washed twice with serum-free medium and treated at37®C 
for 9 hr with serum-free medium (1 and 11); 37。C for 3 hr (2 and 12), 6hr(3 and 13), 
9 hr (4 and 14) with 50 ng/ml TNF-a. Cells were also treated with hyperthermia at 43 
OC for 3 hr and then at 37 ""C for another 3 hr with serum-free medium (5 and 15) or 
TNF-a (50 ng/ml) (6 and 16). Moreover, cells were incubated at 43 for 1 hr (7 and 
17), 2hr(8 and 18) and 3 hr (9 and 19). Cells were then harvested and 1 x 10^ cells 
were taken and centrifuged at 425 x g (2,000 rpm, 9.5 cm, Eppendorf Centrifuge 
5417R) for 3 min. The pellet of cells was then re-suspended in 50 |LI1 of chilled lysis 
buffer and incubated at 4 for 10 min. Centrifugation was then carried out at 20,817 
X g (14,000 rpm, 9.5 cm, Eppendorf Centrifiige 5417R) for 3 min and the supernatant 
of each sample was then mixed with 50 \x\ of 2X reaction buffer containing 10 m M 
DTT. After that, 5 of 1 m M caspase-3 substrate (DEVD-AFC) was then added. The 
samples were then incubated at 37 ""C for 1 hr in a water bath. Samples were then 
transferred to a 96-well plate and fluorescence was determined by a fluorometer with 
360/40 nm excitation filter and 460/40 nm emission filter. Bars 1-9 represented the 
results from L929 cells and bars 11-19 represented the one for L929-11E cells (n=2). 
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caspase-3 was higher when compared to that of their corresponding control�In 
general, L929-11E cells were more sensitive to hyperthermia treatment than parental 
cells. 
3.8.5 Effect of Hyperthermia and TNF-a on Bid Protein 
Bid protein is a member belongs to the Bcl-2 family and it was a kind of 
pro-apoptotic protein in which it promotes apoptosis in cells. Bid protein is located in 
cytosol of cells and it is suggested that it can be cleaved by activated caspase-8 located 
in the upstream of the apoptotic pathway. Upon cleavage, the truncated Bid protein 
acts on mitochondria and promotes the release of cyto c from mitochondria and 
initiates apoptosis. 
The level of Bid protein was investigated with the use of Western Blotting. It was 
found that there is no significant decrease in the level of full length Bid protein in 
L929 cells whilst significant decrease was observed in L929-11E cells 3 hr after 
hyperthermia treatment (Figure 3.58 and 3.59). On the other hand, it was found that 
the level of full length Bid protein was decrease after the treatment of L929 cells 
(Figure 3.60) and L929-11E cells (Figure 3.62) with TNF-a (50 ng/ml). Moreover, 
significant decrease in the level of full length Bid protein was observed in L929-11E 
cells after treatment with hyperthermia at 43 for 3 hr and then to 37 for 3 hr with 
serum-free medium or TNF-a (50 ng/ml) as shown in Figure 3.62 and 3.63. This 
evidence was not observed in L929 cells (Figure 3.60 and 3.61). 
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Figure 3.58 
Level of Bid protein in L929 and L929-11E cells after hyperthermia treatment. 
L929 and L929-11E cells in complete medium were seeded at 1 x 1 Orwell in 
complete medium in a 6-well plate and incubated at 37 5% CO2 overnight. Cells 
were then washed twice with serum-free medium and treated at 37 °C for 3 hr or at 
43 for 1 to 3 hr as indicated. Cells were then harvested and 1 x 10^  cells were 
re-suspended in 100 ]i\ of lysis buffer for 30 min to extract protein. Samples were 
boiled and centrifugation was then carried out at 20,817 x g (14,000 rpm, 9.5 cm, 
Eppendorf Centrifuge 5417R) for 7 min. The supernatant was then collected and 
stored at -70 The protein content was determined with BCA assay. 25 i^ ig of 
proteins were loaded for gel electrophoresis. Electroblotting and non-specific block 
of proteins were done. Anti-Bid antibodies (1:1000) was probed onto the membrane 
at room temperature for 1 hr and then with anti-rabbit-HRP conjugated antibodies 
(1:1000) at room temperature for another hr. The ECL assay was then performed and 
signal was exposed on x-ray film. 
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The calculated band intensity ratio of Bid for L929 and L929-11E cells after 
hyperthermia treatment. The band intensity of Bid and Grp 75 from Figure 3.44 
was determined with the software "Image Quant". The band intensity ratio of Bid of 
each sample was determined with the following equation. 
Band intensity ratio for Bid 
=Band intensity of Bid/Band intensity of Grp 75 
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Figure 3.60 
Decrease in Bid level in L929 cells treated with TNF-a and hyperthermia. L929 
and L929-11E cells in complete medium were seeded at 1 x 1 Orwell in complete 
medium in a 6-well plate and incubated at 37 5% CO2 overnight. Cells were 
washed twice with serum-free medium and treated at 37 for 3, 6 or 9 hr with 
serum-free medium or TNF-a (50 ng/ml). On the other hand, cells were undergone 
combined treatment with hyperthermia at 43 for 3 hr and then to 37 for further 
3 hr with serum-free medium or TNF-a (50 ng/ml). Cells were then harvested and 1 
X 106 cells were re-suspended in 100 \il of lysis buffer for 30 min to extract protein. 
Samples were boiled and centrifugation was then carried out at 20,817 x g (14,000 
rpm, 9.5 cm, Eppendorf Centrifuge 5417R) for 7 min. The supernatant was then 
collected and stored at -70 The protein content was determined with BCA assay. 
25 |ag of proteins were loaded for gel electrophoresis. Electroblotting and 
non-specific block of proteins were done. Anti-Bid antibodies (1:1000) was probed 
onto the membrane at room temperature for 1 hr and then with anti-rabbit-HRP 
conjugated antibodies (1:1000) at room temperature for another hr. The ECL assay 
was then performed and signal was exposed on x-ray film. 
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The calculated band intensity ratio of Bid for L929 cells. The band intensity of 
Bid and Grp 75 from Figure 3.44 was determined with the software "Image Quant". 
The band intensity ratio of Bid of each sample was determined with the following 
equation. 
Band intensity ratio for Bid 
=Band intensity of Bid/Band intensity of Grp 75 
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Figure 3.62 
Decrease in Bid level in L929-11E cells treated with TNF-a and hyperthermia. 
L929 and L929-11E cells in complete medium were seeded at 1 x lOVwell in 
complete medium in a 6-well plate and incubated at 37 5% CO2 overnight. Cells 
were washed then twice with serum-free medium and treated at 37 for 3, 6 or 9 hr 
with serum-free medium or TNF-a (50 ng/ml). On the other hand, cells were 
undergone combined treatment with hyperthermia at 43 °C for 3 hr and then to 37 
for further 3 hr with serum-free medium or TNF-a (50 ng/ml). Cells were then 
harvested and 1 x 10^  cells were re-suspended in 100 jul of lysis buffer for 30 min to 
extract protein. Samples were boiled and centrifugation was then carried out at 
20,817 X g (14,000 rpm, 9.5 cm, Eppendorf Centrifuge 5417R) for 7 min. The 
supernatant was then collected and stored at -70 The protein content was 
determined with BCA assay. 25 |Lig of proteins were loaded for gel electrophoresis. 
Electroblotting and non-specific block of proteins were done. Anti-Bid antibodies 
(1:1000) was probed onto the membrane at room temperature for 1 hr and then with 
anti-rabbit-HRP conjugated antibodies (1:1000) at room temperature for another hr. 
The ECL assay was then performed and signal was exposed on x-ray film. 
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Figure 3.63 
The calculated band intensity ratio of Bid for L929-11E cells. The band intensity 
of Bid and Grp 75 from Figure 3.44 was determined with the software "Image 
Quant，,. The band intensity ratio of Bid of each sample was determined with the 
following equation. 
Band intensity ratio for Bid 
=Band intensity of Bid/Band intensity of Grp 75 
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3.8.6 Effect of Hyperthermia and TNF-a on Caspase-8 Activity 
Caspase-8 is believed to be the initiator caspases in the apoptotic pathway. It 
is believed that signals from the death receptor is transmitted through the activation 
of caspase-8 so that the apoptotic pathway will be stimulated. The activity can be 
determined with the ApoAlert caspase-8 fluorescent assay with the use of the 
caspase-8-specific substrate lETD-AFC. 
Figure 3.64 shows the results of caspase-8 activity after treatment with 
TNF-a (50 ng/ml) or hyperthermia in L929 and L929-11E cells. The y-axis 
represents product's fluorescence and the x-axis shows the different treatment 
conditions. It can be seen that there was an increase in caspase-8 activity with 
TNF-a (50 ng/ml) treatment in L929 cells but not in L929-11E cells. Moreover, it 
was found that hyperthermia alone can cause an increase in the caspase-8 activity in 
L929-1 IE cells. 
To study whether the increase in caspase-8 activity was due to the effect of 
TNF-a (50 ng/ml) in L929 cells, the caspase-8 inhibitor, z-IETD-fmk, was 
employed. Prior to the treatment, cells were treated with 10 juM of z-正TD-fmk for 
15 min. Figure 3.65 shows the results for caspase-8 and also caspase-3 activity of 
L929 ceils treated with TNF-a (50 ng/ml) for 9 hr. It was found that there was an 
increase in both caspase-8 and caspase-3 activities after treatment with TNF-a for 9 
hr in L929 cells. With the application of z-EETD二fftik, the activities of both caspase-3 
and caspase-8 were reduced. When L929 cells were challenged with hyperthermia at 
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Figure 3.64 
Determination of caspase-8 activity with TNF-a and hyperthermia treatment in 
L929 and L929-11E cells. L929 and L929-11E cells in complete medium were 
seeded at 1 x 10^  / well in complete medium in a 6-well plate and incubated at 37 ^C, 
5% CO2 overnight. Cells were then washed twice with serum-free medium and 
treated at 37 ""C for 9 hr with serum-free medium or at 37 ""C for 3, 6 or 9 hr with 50 
ng/ml TNF-a. Moreover, cells were incubated at 43 for 1, 2 and 3 hr. Cells were 
then harvested and 1 x 10^  cells were taken and centrifuged at 425 x g (2,000 rpm, 
9.5 cm, Eppendorf Centrifuge 5417R) for 3 min. The pellet of cells was then 
re-suspended in 50 jul of chilled lysis buffer and incubated at 4 for 10 min. 
Centrifugation was then carried out at 20,817 x g (14,000 rpm, 9.5 cm, Eppendorf 
Centrifuge 5417R) for 3 min and the supernatant of each sample was then mixed 
with 50 [i\ of 2X reaction buffer containing 10 mM DTT. After that, 5 |li1 of 1 mM 
caspase-3 substrate (DEVD-AFC) was then added. The samples were then incubated 
at 37 for 1 hr in a water bath. The samples were then transferred to the 96-well 
plate and the fluorescence was determined by a fluorometer with 360/40 nm 
excitation filter and 460/40 nm emission filter. The bars 1-7 represented the results 
from L929 cells and bars 8-14 represented the one for L929-11E cells (n=2). 
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Figure 3.65 
Determination of caspase-8 and caspase-3 activity with TNF-a and z-IETD-fmk 
in L929 cells. L929 cells in complete medium were seeded at 1 x 10^/well in 
complete medium in a 6-well plate and incubated at 37 5% CO2 overnight. Cells 
were then washed twice with serum-free medium and pre-treated with 10 i^M 
z-IETD-fmk for 15 min prior to the TNF-a treatment. Cells were then incubated at 
37 for 9 hr with serum-free medium or with 50 ng/ml TNF-a. Cells were then 
harvested and 1 x 10^  cells were taken and centrifiiged at 425 x g (2,000 rpm, 9.5 cm, 
Eppendorf Centrifiige 5417R) for 3 min. The pellet of cells was then re-suspended in 
50 |j,l of chilled lysis buffer and incubated at 4 for 10 min. Centrifugation was 
then carried out at 20,817 x g (14,000 rpm, 9.5 cm, Eppendorf Centrifuge 5417R) for 
3 min and the supernatant of each sample was then mixed with 50 \x\ of 2X reaction 
buffer containing 10 mM DTT. After that, 5 of 1 mM caspase-3 substrate 
(DEVD-AFC) or caspase-8 substrate (lETD-AFC) were then added. The samples 
were then incubated at 37 for 1 hr in a water bath. Samples were then transferred 
to the 96-well plate and the fluorescence was determined by a fluorometer with 
360/40 nm excitation filter and 460/40 nm emission filter. The bars 1-4 represented 
the results from caspase-8 activity and bars 5-8 represented the one from caspase-3 
activity (n=2). 
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Determination of caspase-8 and caspase-3 activity with z-IETD-fmk in L929 
cells after hyperthermia treatment. L929 cells in complete medium were seeded at 
1 X 10^ /well in complete medium in a 6-well plate and incubated at 37。C, 5% CO2 
overnight. Cells were then washed twice with serum-free medium and pre-treated 
with 10 [iM z-IETD-fmk for 15 min prior to the TNF-a treatment. Cells were then 
incubated at 37 T or 43 for 3 hr. Cells were then harvested and 1 x 10^  cells were 
taken and centrifuged at 425 x g (2,000 rpm, 9.5 cm, Eppendorf Centrifuge 5417R) 
for 3 min. The pellet of cells was then re-suspended in 50 \x\ of chilled lysis buffer 
and incubated at 4 ®C for 10 min. Centrifugation was then carried out at 20,817 x g 
(14,000 rpm, 9.5 cm, Eppendorf Centriftige 5417R) for 3 min and the supernatant of 
each sample was then mixed with 50 jiil of 2X reaction buffer containing 10 m M 
DTT. After that, 5 |LI1 of 1 m M caspase-3 substrate (DEVD-AFC) or caspase-8 
substrate (lETD-AFC) were then added. The samples were then incubated at 37。。 
for 1 hr in a water bath. Samples were then transferred to the 96-well plate and the 
fluorescence was determined by a fluorometer with 360/40 nm excitation filter and 
460/40 nm emission filter. The bars 1-4 represented the results from caspase-8 
activity and bars 5-8 represented the one from caspase-3 activity (n=2). 
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43 for 3 hr, only slight increase in the caspase-8 activity was observed whereas a 
sharp rise in the caspase-3 activity was observed (Figure 3.66). With the application 
of z-IETD-fmk, the activities of both caspase-3 and caspase-8 were reduced. Similar 
finding was observed in L929-11E cells with hyperthermia treatment (Figure 3.67). 
As hyperthermia mediates non-receptors induced apoptosis as from the 
previous results. It is of interest to examine whether a physical increase in 
temperature is able to activate caspase-8. As shown in Figure 3.68, both intact and 
cell lysate of L929-11E cells were treated at 37 for 3 hr or at 43 for 3 hr and 
the caspase-8 activity was then determined (Figure 3.68). It was found that the 
caspase-8 activity increased only in intact cells treated at 43 for 3 hr but not in 
cell lysate. This observation suggests that the integrity of cells is needed for the 
caspase-8 activation. In light of this, L929-11E cells pre-treated with CHX before 
hyperthermia treatment to see whether newly synthesized molecules are needed 
(Figure 3.69). Data in Figure 3.69 indicate that hyperthermia increased the activity of 
caspase-8 in L929-11E cells and cycloheximide reduced the caspase-8 activity. 
3.8.7 Effect of TNF-a on TNFRl Expression 
TNF-a has been found to increase caspase-8 and also caspase-3 activities. 
Caspase-8 is the initiator caspase that lies upstream of the mitochondria. In order to 
activate caspase-8, signals from TNF-a must be transduced through the signaling 
pathway from the receptor level. Two types of TNF receptors have been found to 
play a role in mediating the signaling pathway of TNF-a. They include TNF receptor 
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Figure 3.67 
Determination of caspase-8 and caspase-3 activity with z-IETD-fmk in 
L929-11E cells after hyperthermia treatment. L929-11E cells in complete medium 
were seeded at 1 x 10^ /well in complete medium in a 6-well plate and incubated at 
37 OQ 5% CO2 overnight. Cells were then washed twice with serum-free medium 
and pre-treated with 10 |LIM z-IETD-fmk for 15 min prior to the TNF-a treatment. 
Cells were then incubated at 37 ""C or 43 for 3 hr. Cells were then harvested and 1 
X 106 cells were taken and centrifuged at 425 x g (2,000 rpm, 9.5 cm, Eppendorf 
Centrifuge 5417R) for 3 min. The pellet of cells was then re-suspended in 50 |al of 
chilled lysis buffer and incubated at 4 � € for 10 min. Centrifugation was then carried 
out at 20,817 x g (14,000 rpm, 9.5 cm, Eppendorf Centrifuge 5417R) for 3 min and 
the supernatant of each sample was then mixed with 50 |LI1 of 2X reaction buffer 
containing 10 mM DTT. After that, 5 fil of 1 mM caspase-3 substrate (DEVD-AFC) 
or caspase-8 substrate (lETD-AFC) were then added. The samples were then 
incubated at 37 ""C for 1 hr in a water bath. Samples were then transferred to the 
96-well plate and the fluorescence was determined by a fluorometer with 360/40 nm 
excitation filter and 460/40 nm emission filter. The bars 1-4 represented the results 
from caspase-8 activity and bars 5-8 represented the one from caspase-3 activity 
(n=2). 
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Figure 3.68 
Determination of caspase-8 activity with intact L929-11E cells or its cell lysate. 
L929-11E cells in complete medium were seeded at 1 x 10^ /well in complete 
medium in a 6-well plate and incubated at 37。(：，5% CO2 overnight. Cells were then 
washed twice with serum-free medium and treated at 37 ""C for 3 hr with serum-free 
medium or at 43。〇 for 3 hr. Subsequently, 1 x 10^ cells were collected and lysed 
with 50 III of chilled lysis buffer at 4。€ for 10 min. Centrifugation was carried out at 
20,817 X g (14,000 rpm, 9.5 cm，Eppendorf Centrifuge 5417R) for 3 min. 
Supernatant was then collected and incubated at 37。C or at 43 for 3 hr. After 
treatment with hyperthermia, intact cells were then harvested and 1 x 10^ cells were 
taken and centrifiiged at 425 x g (2,000 rpm, 9.5 cm, Eppendorf Centrifuge 5417R) 
for 3 min. The pellet of cells was then re-suspended in 50 |al of chilled lysis buffer 
and incubated at 4 for 10 min. Centrifugation was then carried out at 20,817 x g 
(14,000 rpm, 9.5 cm, Eppendorf Centrifuge 5417R) for 3 min and the supernatant of 
each sample was then mixed with 50 jil of 2X reaction buffer containing 10 m M 
DTT. After that, 5 |LI1 of 1 m M caspase-8 substrate (lETD-AFC) was then added. The 
samples were then incubated at 37 for 1 hr in water bath. The samples were then 
transferred to the 96-well plate and the fluorescence was determined by a 
fluorometer with 360/40 nm excitation filter and 460/40 nm emission filter (n=2). 
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Figure 3.69 
Determination of caspase-8 activity with hyperthermia and cycloheximide 
treatment in L929-11E cells. L929-11E cells in complete medium were seeded at 1 
X lOVwell in complete medium in a 6-well plate and incubated at 37 5% CO2 
overnight. Cells were then washed twice with serum-free medium and treated at 37 
。C or 43。C for 3 hr with serum-free medium with or without cycloheximide as 
indicated. Cells were then harvested and 1 x 10^ cells were taken and centrifuged at 
425 X g (2,000 rpm, 9.5 cm，Eppendorf Centrifuge 5417R) for 3 min. The pellet of 
cells was then re-suspended in 50 [il of chilled lysis buffer and incubated at 4 ^ C for 
10 min. Centrifugation was then carried out at 20,817 x g (14,000 rpm, 9.5 cm, 
Eppendorf Centrifuge 5417R) for 3 min and the supernatant of each sample was then 
mixed with 50 pil of 2X reaction buffer containing 10 m M DTT. After that, 5 |li1 of 1 
m M caspase-8 substrate (lETD-AFC) was then added. The samples were then 
incubated at 37 for 1 hr in water bath. The samples were then transferred to the 
96-well plate and the fluorescence was determined by a fluorometer with 360/40 nm 
excitation filter and 460/40 nm emission filter. 
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1 (TNFRl) and TNF receptor 2 (TNFR2). 
The mRNA expression of both TNF receptors in L929 and L929-11E cells 
was studied. Cells were treated at 37 for 9 hr with or without TNF-a. G3PDH 
was used as an internal control. It was observed that there was no significant changes 
in the expression level of both TNFRl and TNFR2 upon TNF-a treatment in both 
cell lines (Figure 3.70). 
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Figure 3.70 
Determination of T N F R l and T N F R 2 m R N A expression in L929 and L929-11E 
cells after TNF-a treatment. L929 and L929-11E cells in complete medium were 
seeded at 1 x lOVwell in complete medium in a 6-well plate and incubated at 37 
5% CO2 overnight. Cells were then washed twice with serum-free medium and 
treated at 3 7 � C for 9 hr with serum-free medium (C) or with 50 ng/ml TNF-a (T). 
After treatment, cells were washed twice with PBS and 1 ml of Trizol Reagent. The 
extraction RNA and RT-PCR was performed with the method described in Section 
2.26. Pairs of primers of TNFRl, G3PDH and TNFR2 were used for PCR reaction 
(n=2). 
Chapter 4. Discussion Pagel75 
Chapter 4 
Discussion 
Chapter 4. Discussion Pagel75 
4.1 TNF-a Induced Apoptosis and Changed the 
Mitochondrial Activities in L929 Cells 
TNF-a is a proinflammatory cytokine that has been involved in eliciting large 
number of biological responses such as inflammation, immune modulation 
(Osthoff et al., 1992; Rothe et al” 1993; Sethi et al； 2000) and thymocyte 
proliferation (Wellborn et al, 1996). The effects of TNF-a in immunomodulation 
were later found to be mediated by two cell surface receptors, TNFRl and TNFR2. 
Evidence showed that the cytotoxic effect of TNF-a was highly mediated by TNFRl 
as a result of its high affinity and slow dissociation rate after binding to 
TNF-a (Grell et aL, 1998). Although TNFR2 was also found to induce apoptosis 
through the process of ligand-passing or membrane TNF expression (review: 
MacEwan, 2002)，TNFRl was believed to engage, mainly in the induction of cell 
death. However, the detailed mechanisms of how TNF-a induces cell death through 
TNFRl in tumour cell lines are still not fully understood. Therefore, the effects of 
TNF-a on the induction of cell death in L929 cells were investigated. 
The contribution of TNF-a in the induction of apoptosis or necrosis remains a 
hot topic for debate. It was found that TNF-a induced apoptosis in cultured cardiac 
myocytes (Krown et al” 1996) and in TNF-a transgenic mice (Kubota et al., 2001). 
Moreover, TNF-a induced apoptosis in L929 cells treated with TNF plus 
actinomycin D (Shoji et al., 1995). On the other hand, studies by Vercammen's 
group showed that TNF-a induced necrosis in murine L929 fibrosarcoma cells 
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(Grooten et al,, 1993; Vercammen et al., 1998). Our results show that TNF-a can 
induce both apoptotic and late apoptotic/necrotic cell death in L929 cells (Figure 
3.10). Treatment with TNF-a (50 ng/ml) for 3 hr did not enhance the number of 
early apoptotic or late apoptotic/necrotic cells in L929 cells (Figure 3.10b). 
Moreover, cells with TNF-a treatment appeared to have an increase in the number of 
both early apoptotic and late apoptotic/necrotic cells along with the increase in the 
incubation time. However, apoptosis seemed to be the major form of cell death after 
TNF-a treatment since the number of early apoptotic cells was greater than that of 
late apoptotic/necrotic cells. Cell cycle analysis indicates a sub-Go/Gi peak appeared 
6 and 9 hr after TNF-a treatment in L929 cells (Figure 3.6). All these results suggest 
that TNF-a induced apoptosis in L929 cells. 
With the evidence from our results that TNF-a induced apoptosis, we next 
focused on the apoptotic pathway which TNF-a mediates. It becomes widely 
accepted that 2 pathways are important to initiate apoptosis. They are the 
mitochondrial and the death receptor pathway (Garrido et al., 2001). Mitochondria 
are major organelles in cells to generate ATP through the oxidative phosphorylation 
of ADP catalyzed by ATP synthase (FoFi-ATPase) in the electron transport chain 
(Huser et al., 1998). The driving force for such phosphorylation comes from the 
proton electromotive force brought about by the mitochondrial membrane potential 
(A乎m) of approximately —180 mV and the H+ concentration gradient (ApH) across 
the inner mitochondrial membrane (Huser et al,, 1998; review: Tatton and Olanow， 
1999; Szewczyk and Wojtczak, 2002). As A^m is the main contributor to the proton 
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electromotive force for ATP generation, collapse of A^m often prevents ATP 
synthesis that may be as a result of the opening of the mitochondrial permeability 
transition pore (MPTP) (Tatton and Olanow, 1999). 
MPTP is found to be responsible for the mitochondrial permeability transition 
(MPT) that controls cell death (Halestrap, 1999). MPTP is composed of several 
components including adenine nucleotide translocator (ANT), a voltage-dependent 
anion channel (a porin) and cyclophilin D (review: Tatton and Olanow, 1999; 
Szewczyk and Wojtczak, 2002). MPTP only allows the transport of molecules less 
than 1500 daltons. Decrease in the A^m is often associated with the opening of 
permeability transition pore (PTP) in the presence of high level of intramitochondrial 
Ca2+ (Scorrano et al, 1997), high level of oxidative radicals or partial failure of the 
respiratory complexes (Richter, 1993). 
Our results indicated that TNF-a induced mitochondrial membrane 
depolarization 3 hr after TNF treatment and the degree of collapse of A^m increased 
in a time-dependent manner in L929 cells (6 or 9 hr) (Figure 3.14) (Yuen et al., 
2000). Similar evidence was observed in Polla's group in which TNF-a altered the 
mitochondrial membrane potential in L929 cells (Polla et al” 1996). To study 
whether the collapse of A平m was related to MPTP, the MPTP inhibitor, cyclosporin 
A (CsA), was applied. Our results showed that CsA could reduce the number of cells 
with depolarized mitochondria (Figure 3.25) and also the cytotoxic effect mediated 
by TNF-a (Figure 3.24) (Yuen et al., 2000) in L929 cells. This suggests that MPTP 
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plays a role in mitochondrial depolarization mediated by TNF-a. The result is 
consistent with other research groups in that MPTP played a role in apoptosis 
(Pastorino et aL, 1996; Marzo et al., 1998; Tanfani et al., 2000). 
In addition to the proteins that reside in the mitochondrial electron transport 
chain, mitochondria also harbor other molecules that are essential in the induction of 
cell death. These include apoptotic inducing factor (AIF) (Susin et al； 1999), 
Smac/Diablo (Du et al., 2000) and endonuclease G (Li et al., 2001). Opening of 
MPTP usually leads to the uncoupling of respiration and mitochondrial swelling in 
additional to the mitochondrial membrane depolarization (Blattner et al” 2001). 
Findings suggested that opening of MPTP led to the outer membrane rupture and 
cyto c release (Lemasters, 1999). However, others suggested that cyto c release 
occurred without the loss of A平m (Liu et al, 1996). Exogenous cyto c added to the 
cytosol in a cell-free system triggered apoptosis (Kluck et al., 1997). Cyto c released 
to the cytosol is believed to bind to apoptotic protease activating factor-1 (Apaf-1) 
and it activates caspase-9 by forming apoptosome with dATP (Li et al., 1997). 
Our results indicated that cyto c was released when L929 cells were treated with 
TNF-a for 3 hr at 37 ''C and more cyto c was released upon treatment of TNF-a for 
6 or 9 hr (Figure 3.16) (Yuen et al., 2000). Our results also indicated that cyto c was 
released more or less at the same time with the mitochondrial membrane 
depolarization (starting from the 3 hr of TNF-a treatment). These results suggested 
that cyto c release may be related to the mitochondrial membrane depolarization. 
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Mitochondria have been found to play a major role in the caspase-dependent 
apoptotic pathway. It is suggested that caspases play an important role in apoptosis 
(Henkart, 1996; Martins and Eamshaw, 1997; Nagata, 1997). To study whether 
caspase activity was correlated with the collapse of A平m, two broad-range 
caspase-blocking agents such as z-VAD-fmk and Z - A S P - C H 2 - D C B have been 
applied. It was observed that both pre-treatment of caspase inhibitors in L929 cells 
reduced the collapse of A^m after TNF-a treatment for 9 hr (Figure 3.25). These 
results were in contradictory to the others who suggested that z-VAD-fmk failed to 
block the depolarization of mitochondrial membrane induced by resveratrol in 
leukemia cells (Dorrie et al., 2001). More interestingly, it was reported that 
application of broad-range caspase-blocking agents such as z-VAD-fmk can sensitize 
L929 cells to necrosis after TNF-a treatment (Vercammen et al； 1998). 
Several lines of evidence suggested that TNF-a induced cytotoxicity in TNF-a 
sensitive cells due to the generation of ROS (Wong and Goeddel, 1988; Zimmerman 
et al., 1989) or superoxide anion (O2") (Hennet et al., 1993) and the cytotoxicity can 
be reduced with the use of antioxidant (Yamauchi et al., 1989; Zimmerman et al., 
1989). ROS are byproducts that are generated from the mitochondrial electron 
transport chain in aerobic cells at the time of electron transport to the molecular 
oxygen (Goossens et al” 1999). ROS are suggested to take part in the defence 
against microorganisms, acting as secondary messengers in the activation of N F - K B 
or cause cell injury such as lipid peroxidation (Goossens et al., 1995). Our results 
indicated that TNF-a did not increase the level of H2O2 in L929 cells in the 3 hr 
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treatment whilst the H2O2 level increased 6 or 9 hr after the treatment (Figure 3.28). 
The antioxidant, 4-OH-TEMPO, has been applied to study the involvement of ROS 
in TNF-a treatment. It was found that 4-OH-TEMPO can reduce the cytotoxicity 
mediated by TNF-a (50 ng/ml) (Figure 3.24). The results therefore suggested that 
ROS played a role in the TNF-mediated cytotoxicity in L929 cells. 
Ca2+ has been suggested to play a crucial role in apoptosis. Incubating tissues 
with millimolar concentrations of Ca^^ and Mg2+ was found to induce 
oligonucleosomal DNA fragmentation in isolated nuclei (Vanderbilt et al., 1982; 
Cohen and Duke, 1984). Mitochondrial Ca^ "" loading has been suggested to be one 
of the stimuli to open the MPTP and release cyto c in apoptotic cells (Richter, 1993). 
It was found that TNF-a caused a slow increase in the cytosolic and intranuclear 
Ca2+ in L929 cells (Kong et al., 1997). Our results indicated that the level of 
intracellular Ca^ "^  ([Ca2+]i) increased 3 hr after TNF-a treatment and such increase 
preceded the mitochondrial membrane depolarization in L929 cells (Figure 3.32). 
I 
Afterwards, there was a time-dependent increase in the [Ca ]i simultaneously with 
mitochondrial membrane depolarization. 
With the evidence that mitochondria have played a major role in the apoptotic 
pathway induced by TNF-a in L929 cells. We next tried to trace out the 
mitochondrial pathway so as to find out the possible mechanism of TNF-a induced 
apoptosis. Many different kinds of proteins are involved in the apoptotic pathway. In 
this part, 2 different kinds of proteins have been studied. The first protein to be 
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studied was the tumour suppressor gene product, p53. p53 is a key mediator in DNA 
damage and abnormal growth. Upon the induction of apoptosis, p53 was found to 
accumulate in the mitochondria preceding the changes in mitochondrial membrane 
potential, cyto c release and pro-caspase-3 activation. p53 then acted as a nuclear 
transcription factor that modulates the expression of other p53-responsive gene 
(Marchenko et al., 2000; Komarova and Gudkov, 2001). It was shown that p53 
participated in the regulatory feedback signaling loop in decreasing the expression of 
Bcl-2 and increasing the expression of pro-apoptotic proteins such as Bax and Bak 
which involve in the induction of the release of apoptogenic factor (cyto c or smac) 
from mitochondria (Miyashita et al., 1994; Shimizu et al., 1999; Marchenko et al” 
2000; Schuler and Green, 2001). However, Li's group suggested that cyto c release 
was absent in the p53-induced apoptosis (Li et al., 1999). Our results showed that 
expression of p53 was observed in L929 cells after exposed to TNF-a for 6 or 9 hr 
(Figure 3.46). The late expression of p53 and the early release of cyto c suggest that 
p53 does not take part in the induction of the early cyto c release in L929 cells. 
The second protein to be studied was the caspase-targeted protein, PARP. PARP 
is an endogenous nuclear enzyme that is involved in scanning for DNA damage and 
participated in base-excision repair (Chiamgi, 2002). It was found that PARP was 
cleaved by active capase-3 from a 116 kDa peptide into 25 kDa and 85 kDa peptides. 
Our results showed that PARP cleavage appeared in L929 cells treated with TNF-a 
for 6 and 9 hr, implying that caspase-3 was activated. Similar findings in PARP 
cleavage were observed in neuroblastoma apoptosis (Smyth et al., 2002). Cleavage 
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of PARP therefore becomes a marker in the reflection of caspase-3 activation in 
apoptotic pathway. However, some findings showed that PARP knock-out mice can 
develop normally, suggesting that PARP cleavage represented only as a marker of 
caspase-3 activation and active caspase-3 must act on some other substrates to bring 
about the apoptotic changes in nuclei (Nicholson et al., 1995). 
As mentioned above, cleavage of PARP occurred after TNF-a treatment. We 
next investigated the possible role of caspase-3 in the activation of the apoptotic 
pathway. Caspase-3 is one of the executioner caspases that actively participates in 
the caspase-dependent apoptotic pathway. Caspase-3 is located downstream of the 
apoptotic pathway and has been found to be the central effector of apoptosis in many 
cell lines (Susin et al., 1997). As shown from the results, TNF-a decreased the level 
of pro-caspase-3 in a time-dependent manner in L929 cells (Figure 3.55). The 
decrease in the level of pro-caspase-3 corresponds to the activation of caspase-3. 
Thus, it illustrates that caspase-3 is activated upon TNF-a treatment in L929 cells. 
Further analysis confirmed that there was a time-dependent increase in the activity of 
caspase-3 in L929 cells having TNF-a treatment (Figure 3.57). 
Evidence from our results also suggested that there were changes in the 
pathway involving mitochondria through which apoptosis took place. In order to 
study more about the mechanisms by which signals from TNF-a outside cells was 
transduced to mitochondria in L929 cells, the mitochondrial upstream pathway was 
studied. 
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It was proposed that Bid protein has been one of the intermediates that involved 
in the apoptotic upstream pathway. Bid is a member of pro-apoptotic Bcl-2 family 
and it resides in the cytosol of cells. It can be cleaved by activated caspase-8 upon 
cell surface receptors activation. The truncated Bid (tBid) can then translocate from 
the cytosol to mitochondria through the interaction with cardiolipin on the 
mitochondrial membrane (Lutter et al., 2000) and it, in turn, promotes the release of 
cyto c (Li et al., 1998; Luo et al, 1998), smac (Du et al., 2000) and endonuclease G 
(Li et al., 2001) from mitochondria. Mechanistically, cyto c release was related to the 
conformational change in Bax after interacting with Bid. On the other hand, it was 
suggested that Bid could be cleaved by caspase-3 or granzyme B (review: Wang, 
2001). Our results showed that the level of Bid decreased significantly in L929 cells 
treated with TNF-a for 9 hr (Figure 3.60). Similar cleavage of Bid protein was 
observed in Jurkat cells after treatment with apoptosis-promoting stimuli such as 
staurosporine and UV radiation (Slee et al., 2000). Moreover, cultured hepatocytes 
from mice deficient in Bid protein were found resistant to Fas-induced apoptosis 
(Yin et al., 1999). Others showed that the extent of Bid cleavage but not caspase-8 
was correlated with the cyto c release in cell-free extracts (Slee et al., 2000). 
Caspase-8 is the initiator caspase that connects the signaling pathway from cell 
surface receptors to the mitochondrial apoptotic pathway. Upon the trimerization of 
receptors, TRADD, FADD and pro-caspase-8 are recruited to the receptors and this 
promotes the cleavage of caspase-8 and thereby facilitates the activation of the 
downstream apoptotic pathway (Seol et al., 2001). Our results suggested that there 
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was an increase in the activity of caspase-8 in L929 cells upon TNF-a treatment for 
6 or 9 hr. The increase in the caspase-8 activity might be required for the 
TNF-induced apoptosis. For example, the caspase-8 inhibitor, z-IETD-fmk was 
found to reduce the activity of caspase-8 in L929 cells with TNF-a treatment for 9 hr 
(Figure 3.65). z-IETD-fmk was also found to block TRAIL-induced apoptosis in 
HeLa cells (Seol et al., 2001). All these results suggested that caspase-8 was 
important in the death receptor signaling. 
To study the relationship between the participation of caspase-8 with the 
downstream apoptotic pathway, caspase-3 activities was also monitored with the use 
of z-IETD-fmk. Interestingly, it was found that z-IETD-fmk reduced the activities of 
caspase-3 in L929 cell treated with TNF-a for 9 hr (Figure 3.65). Zhuang' group 
found that cleavage of caspase-8 preceded that of caspase-3 since the blockade of 
caspase-8 by z-IETD-fmk inhibited the cleavage of pro-caspase-3 and reduced cyto c 
release in HL-60 cells (Zhuang et al” 1999). It was observed that the activities of 
caspase-3 were far more than that of caspase-8 in L929 cells (Figure 3.66). This may 
be explained by the fact that cyto c release during apoptosis leads to an amplification 
in the signal pathway (Kuwana et al., 1998). 
The possible involvement of TNF receptors in the TNF-a-mediated apoptosis in 
L929 cells was studied. TNF-a mediates its effect through TNFRl and TNFR2. 
TNFRl is found to mediate the cytotoxic cell death. On the other hand, TNFR2 
stimulates the signaling pathway leading to the activation of nuclear factor kB and 
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Jun kinase (Liu et al., 1996; Kelliher et al” 1998). TNF-a was found to induce 
apoptosis in lymphocytes from aged human through the upregulation of TNFRl and 
TRADD expression and the downregulation of TNFR2 and TRADD expression 
(Aggarwal et al., 1999). In contradiction to these results, our results indicated that 
TNF-a did not upregulate the expression of TNFRl and TNFR2 in L929 (Figure 
3.70). Taken together, TNF-a induced apoptosis in L929 cells through the 
dysfunction of mitochondria and the activation of caspases. 
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4.2 L929-11E cells Possessed Resistance Towards TNF-a 
Stepwise increase in the dose of TNF-a in culturing L929 cells generated a 
TNF-a resistance cell line, L929-11E cells (Kwan, 1995) as described in Section 
2.1.1.2. However, the possible mechanism by which TNF-a resistance developed in 
L929-11E cells was not clear. Hence, the resistance of L929-11E cells towards 
TNF-a was studied. 
With the application of the Annexin-V-FITC/PI assay, it was found that TNF-a 
did not induce early apoptosis and late apoptosis/necrosis in L929-11E cells (Figure 
3.11), implying that L929-11E cells were resistant to TNF-a. The result was 
consistent to the MTT assay (Figure 3.4). Moreover, no sub-Go/Gi peak was 
observed at different time course in L929-11E cells (Figure 3.7). All these results 
suggest that L929-11E cells were resistant to TNF-a. 
To further study whether the resistance to TNF-a developed in L929-11E cells 
was due to defects in the apoptotic pathway, we next determined the role of 
mitochondria in L929-11E cells after TNF-a treatment. It was found that neither 
mitochondrial membrane depolarization nor cyto c release occurred in L929-11E 
cells (Figure 3.16). Similar evidence was observed in Polla's group that TNF-a did 
not alter the A^m in TNF-a-resistant L929.12 cells (Polla et al., 1996). Moreover, it 
was found that TNF-a did not increase the level of H2O2 (Figure 3.28) and [Ca ]i 
(Figure 3.33) at different periods of time in L929-11E cells. All these lines of 
evidence suggest that defects occurred in the mitochondrial apoptotic pathway. And 
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such evidence did not occur in TNF-a-mediated cytotoxicity in L929 cells as 
mentioned in Section 4.1. In order to find out the possible mechanisms of TNF-a 
resistance, we next focused on whether defects would occur in the apoptotic pathway. 
It was found that TNF-a did not activate caspase-3 (Figure 3.55 and 3.57), and cause 
a decrease in 116 kDa band of PARP (Figure 3.50) in the apoptotic pathway 
downstream of mitochondria in L929-11E cells. Interestingly, a time-dependent 
increase in the expression of p53 occurred in L929-11E cells after exposure to 
TNF-a for 3, 6 or 9 hr (Figure 3.46). The increase of p53 protein expression may 
suggest that TNF receptors of L929-11E cells are functional and are able to transmit 
signals from TNF-a outside cells to subcellular level. However, the mechanism by 
which signals are transduced from TNF receptors to subcellular level to cause p53 
protein expression without the involvement of mitochondria is still unknown. On the 
other hand, it was proposed that overexpression of the wild-type p53 gene induced 
apoptosis in various cancers (Harris, 1996; Rothe et al., 1996). The mechanisms in 
which L929-11E cells can still maintain its resistance in the overexpression of p53 
upon TNF-a treatment is still a mystery. 
Similar to that of L929 cells, we have found that TNF-a did not significantly 
change the expression of TNFRl and TNFR2 in L929-11E cells (Figure 3.70). 
However, no significant increase in the caspase-8 activity (Figure 3.64) but slight 
decrease in the level of Bid protein (Figure 3.62) occurred in L929-11E cells. All of 
the results suggested that the apoptotic pathway in L929-11E cells was functional. It 
is understood that in the apoptotic pathway upstream mitochondria, TNF-a binds to 
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its surface receptors which interact with the adaptor protein，TRADD, which can 
then activate pro-caspase-8 and subsequently leads to Bid cleavage and its 
translocation to mitochondria and cyto c release (Green and Kroemer, 1998). It was 
observed that the level of Bid protein decreased after treatment with TNF-a for 9 hr 
(Figure 3.62). It is possible to propose that the TNF-resistance in L929-11E cells 
may be due to the problem in transducing signals from Bid protein to mitochondria 
as TNF-a can partly change the subcellular proteins in L929-11E cells or due to the 
missing of molecules in the signal transduction pathway. 
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4.3 Hyperthermia Triggered Apoptosis and Changed 
Mitochondrial Activities in L929 and L929-11E cells 
Hyperthermia is found to be an effective modality in the treatment of cancers 
(Schechter et al., 1978; Homback, 1989; Coil et al., 1992; Nishida et al., 1997). The 
therapeutic design for the treatment of tumours are to elevate their temperature from 
42 to 45 so as to produce multiple effects on cellular metabolism in tumour 
cells (Ross and Watmough, 1986; Nishida et aL, 1997). Certain findings indicate that 
mild hyperthermia induces apoptosis in tumours (Allan and Harmon, 1986; Takano 
et al., 1991). For example, hyperthermia at 44 °C induces apoptosis in human 
histiocytic lymphoma cells (U937) (Feril Jr. et al； 2002). Moreover, apoptotic cells 
of about 10% and 8% were respectively found in the margin and center of solid 
nodules of murine gliosarcoma (T9) after heating for 30 min at 43 (Moroi et aL, 
1996). However, necrosis was also found in the tumour nodules in murine 
gliosarcoma (T9) 3 or 6 hr after hyperthermia treatment (Moroi et al., 1996). The 
mode of cell death induced by hyperthermia and the underlying mechanism are still 
not clear. Hence, studies on how hyperthermia induces cell death in L929 and 
L929-11E cells are examined in this project. 
Our studies showed that hyperthermia at 43 °C can induce apoptosis and late 
apoptosis/necrosis in L929 and L929-11E cells. Results indicate that hyperthermia 
did not induce apoptosis at 43 for 1 hr in both L929 and L929-11E cells (Figure 
3.18). Increase in the hyperthermia incubation time at 43 from 1 to 3 hr increased 
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the number of apoptotic cells and also the late apoptotic/necrotic cells in both L929 
and L929-11E cells (Figure 3.18). However, the proportion of apoptotic cells was 
more than that of late apoptotic/necrotic cells, implying that apoptosis may be the 
major type of cell death mediated by hyperthermia. It was also found that more 
apoptotic cells appeared in L929-11E cells after hyperthermia treatment at 43 for 
2 or 3 hr as when compared to that of L929 cells (Figure 3.18). This may be 
explained by the increased sensitivity of L929-11E cells towards hyperthermia. 
Findings suggested that the sensitivity of apoptosis to hyperthermia varies between 
different types of tumour cells. In Burkitt's lymphoma cell line, WWl, apoptosis was 
induced in more than 95% of cells by heating at 43 for 30 min while apoptosis is 
rarely induced in human melanoma cells, MM961L or MM170 under the same 
condition (Harmon et al” 1991). 
To determine whether the induction of apoptosis by hyperthermia was highly 
related to mitochondria，the change in ATm and cyto c release were investigated. Our 
results show that hyperthermia induced mitochondrial membrane depolarization in a 
time-dependent manner in both L929 (Figure 3.19 and 3.20) and L929-11E cells 
(Figure 3.21 and 3.22). Moreover, recovery of A?m occurred when cells were 
incubated at 43 for 1 hr and then to 3 7 � C for 6 hr in L929 cells (Figure 3.20) and 
at 4 3 � C for 0.5 hr or 1 hr and then to 3 7 � C for 6 hr in L929-11E cells (Figure 3.22). 
With a collapse in the A平m, cyto c was found to be released in a time-dependent 
manner from both cell lines (Figure 3.23). As mitochondrial membrane 
depolarization and cyto c release are evidence of apoptosis in relation to 
Chapter 4. Discussion Pagel75 
mitochondria, we can confirm that mitochondria have been involved in the 
hyperthermia-mediated apoptosis. 
Studies also showed that the level of H2O2 was increased upon hyperthermia 
treatment in L929 and L929-11E cells (Figure 3.29). However, a decrease in the 
level of H2O2 was observed in L929-11E cells after treatment with hyperthermia for 
3 hr. The possible reason may be due to the fact that hyperthermia destroyed the 
fluidity of the plasma membrane, leading to the leakage of the H2O2 from the cells. It 
was also found that more H2O2 was released with a collapse in the A平m in L929 cells 
(Figure 3.30) and L929-11E cells (Figure 3.31). This can be explained by the fact 
that ROS takes a role in governing the opening of the mitochondrial megachannels 
and thereby, lowering the A^m of cells (Salvioli et al., 2001). 
Hyperthermia also increased the level of [ C s ? \ With the application of fluo-3 
and fura-red, it was found that there was a time-dependent increase in the 
intracellular Ca^ "" level in both L929 and L929-11E cells with a larger extent (Figure 
3.34). In the human histiocytic lymphoma U937 cells, an increase in [Ca^ ^^ li 
concentration by hyperthermia played a crucial role in causing apoptosis (Kameda et 
al., 2001). Our results also indicated that increase in the level of [Ca2+]i preceded the 
mitochondrial membrane depolarization upon hyperthermia treatment in both cell 
lines (Figure 3.35 and 3.36). Moreover, there was a time-dependent increase in the 
level of [Ca2+]i simultaneously with the collapse of mitochondrial membrane 
potential. Similar findings was also observed in Stridh's group in which tribuytltin, a 
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kind of pesticide, can induced mitochondrial hyperpolarization, followed by a rise in 
•Ca2+]i and subsequently a loss of A平m (Stridh et aL, 1999). The possible mechanism 
can be explained by the findings from Kindmark's group (Kindmark et aL, 2001). 
Kindmark's group demonstrated that glucose caused a rise in the level of 
With the activation of calcium dehydrogenases and li influx into mitochondria, 
a transient hyperpolarization of mitochondria occurred and this was followed by a 
depolarization in mitochondria. This gave a time lag in which an increase in the level 
of [Ca2+]i preceded the mitochondrial membrane depolarization. 
Studies on the mitochondrial apoptotic pathway showed that hyperthermia 
enhanced the level of p53 in L929 cells in a time-dependent manner whereas it 
seemed to have a slight decrease in the level of p53 in L929-11E cells (Figure 3.47). 
Moreover, hyperthermia cleaved PARP in both L929 and L929-11E cells after 
incubation for 1, 2 or 3 hr (Figure 3.49). With the indication of PARP cleavage, the 
level of pro-caspase-3 was found to be slightly reduced in L929 cells but significant 
decrease in L929-11E cells after hyperthermia treatment (Figure 3.51). These results 
were consistent with the ApoAlert Caspase assay in which a time-dependent increase 
in the activity of caspase-3 in both L929 and L929-11E cells was observed (Figure 
3.57). The activity of caspase-3 was higher in L929-11E cells upon hyperthermia 
treatment, suggesting again that L929-11E cells were more sensitive to 
hyperthermia. 
On the other hand, studies also showed that the level of Bid decreased 
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significantly in L929-11E cells but not in L929 cells after incubation at 43 for 3 
hr (Figure 3.58). Increase in the caspase-8 activity was also found in L929 and 
L929-11E cells upon hyperthermia treatment for 3 hr (Figure 3.67 and 3.68). On the 
other hand, it was observed that the level of active caspase-8 was reduced upon 
pre-treatment with z-IETD-fmk in L929 and L929-11E cells after hyperthermia for 3 
hr (Figure 3.66 and 3.67). All these results suggest that hyperthermia can activate the 
apoptotic pathway through caspase-8, Bid protein, mitochondria and the downstream 
pathway in L929-11E cells. At the moment, why hyperthermia induced apoptosis 
and mitochondrial depolarization in L929 cells without alternation in Bid level are 
currently unknown. 
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4.4 Combined Treatment of Hyperthermia and TNF-a 
Induced Cell Death and Changed Mitochondria 
Activities in L929 and L929-11E cells 
Chemotherapy has been successful in the treatment of testicular cancer and 
certain leukemias for more than 50 years. However, treatment with anticancer drugs 
usually lacks specificity and causes systemic toxicity in both tumor cells and normal 
cells (Johnstone et al., 2002). Moreover, resistance to chemotherapeutic drugs 
becomes a major concern in the failure of cancer treatment. Thus, other treatment 
modalities have been suggested to combine with chemotherapy to enhance the 
killing effect of anti-cancer agents. Hyperthermia has been applied in combination to 
chemotherapeutic drugs to treat tumors. The possible mechanisms of how the 
combination of hyperthermia and chemotherapeutic drugs in killing tumors are 
unknown. 
It was found in our project that combined treatment of hyperthermia and TNF-a 
induced cell death in both L929 and L929-11E cells in a very similar way through 
the mitochondrial pathway. Our results showed that the combined treatment of 
hyperthermia and TNF-a induced apoptosis or late apoptosis/necrosis in both L929 
and L929-11E cells (Figure 3.39 and 3.40). Results also indicated that the number of 
late apoptotic/necrotic cells increased upon combined treatment of hyperthermia and 
TNF-a in L929-11E cells (Figure 3.40). This suggested that most of the cells 
underwent late apoptosis/necrosis upon combined treatment. Results from our study 
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also showed that more depolarized mitochondria were found in L929 cells when 
treated with combined treatment (Figure 3.41) whereas the number of depolarized 
mitochondria in L929-11E cells with combined hyperthermia and TNF-a treatment 
was similar to that of the corresponding control (Figure 3.42). CsA was found to 
reduce the cytotoxicity in L929 cells upon combined hyperthermia and TNF-a 
treatment, implying that PTP has taken a role in the combined treatment in L929 
cells (Figure 3.24). Moreover, release of cyto c was observed in both L929 and 
I 
L929-11E cells (Figure 3.43). Increase in the [Ca ]i level together with the collapse 
of the A^m was also observed in combined treatment in both cell lines (Figure 3.44 
and 3.45). 
Also, the combined treatment of hyperthermia and TNF-a was found to change 
the level of apoptosis-related proteins in L929 or L929-11E cells. PARP cleavage 
(Figure 3.50), reduction of the level of pro-caspase-3 (Figure 3.55) and Bid protein 
(Figure 3.62) occurred in L929-11E cells whereas enhancement of caspase-3 
activities occurred in both L929 and L929-11E cells after the combined treatment 
(Figure 3.57). Although both cell lines exhibit similar patterns of cell death 
machinery, it was observed that L929-11E cells have a higher sensitivity towards 
hyperthermia through a yet undefined mechanism. 
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4.5 Reversal of TNF-a Resistance in L929-11E Cells by 
Hyperthermia 
As mentioned in Section 4.2, treatment of L929-11E cells with TNF-a did not 
induce the early apoptosis and late apoptois/necrosis (Figure 3.11) and not changed 
the mitochondrial activities (Figure 3.15 and 3.16). Studies also showed that TNF-a 
did not upregulate the expression of TNFRl and TNFR2 in both cell lines (Figure 
3.70). Although resting L929-11E cells possessed certain basal level of caspase-3 
and caspase-8 activity as shown in Figure 3.67, the resistance towards TNF-a in 
L929-11E cells did occur. Findings from other studies suggested that TNF-a 
resistance in L929.12 cells might be due to an increased activity of SOD and was not 
a result of the expression of hsp 70，grp 78 nor annexin (Polla et al., 1996). On the 
other hand, hsp 27 has been suggested to play a role in TNF-a resistance in HeLa 
cells. In fact, murine L929 fibroblasts transfected with hsp 27 altered the TNF-a 
activity by modifying the phosphorylation, intracellular distribution and 
oligomerization of hsp 27 (Mehlen et al,, 1995). 
L929-11E cells have resistance towards TNF-a. However, such resistance was 
destroyed, at least partially, upon hyperthermia treatment. Hyperthermia and its 
combined treatment with TNF-a were found to induce apoptosis, mitochondrial 
membrane depolarization, cyto c release, ROS production and elevation of in 
L929-11E cells as shown in Section 3.7. 
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It was found that L929-11E cells were more sensitive to hyperthermia treatment. 
The reversal of resistance may be firstly due to the involvement of p53-dependent 
apoptosis. It was observed in Figure 3.46 and 3.47 that untreated L929-11E cells but 
not L929 cells possessed certain basal levels of p53 protein. Moreover, only a slight 
decrease in the level of p53 was observed in hyperthermia-treated L929-11E cells 
(Figure 3.47) whereas p53 was expressed in L929 cells after hyperthermia treatment 
(Figure 3.47). It was suggested that hyperthermia enhanced the heat sensitivity in 
murine fibroblast cells and SAS cells through the induction of p53-dependent 
apoptosis (Matsumoto et al” 1997; Ota et al., 2000). With the expression of p53, the 
level of bax is upregulated and it can mediate the caspase-3 activation through the 
release of cyto c (Ohnishi and Ohnishi, 2001). Cyto c release can then bind to Apaf-1 
and this recruits pro-caspase-9 and allows its auto-activation, leading to the 
activation of the downstream caspase cascade and hence apoptosis occurs. Moreover, 
it was suggested that hyperthermia induced apoptosis through the activation of p53 
in certain tumor cells such as glioma cells (Fuse et al., 1998; Matsumoto et al., 1997). 
The accumulation of p53 maybe correlated with an increase in the level of heat 
shock proteins, hsp 70 or hsp 72 (Hayahi et al., 1999). 
Secondly, hyperthermia significantly enhanced the caspase-8 and caspase-3 
activities and caused the cleavage of Bid in L929-11E cells (Figure 3.58 and 3.68) 
might be of another possible reason. Although the mechanisms by which 
hyperthermia induced activation of caspase-8, caspase-3 and Bid cleavage were still 
unknown, it was found that the degree of such activation was higher and it correlated 
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with the enhanced sensitivity of L929-11E cells towards apoptosis as compared with 
L929 cells. 
Taken together, our results suggest that combined treatment could kill more 
tumour cells. In the combined treatment, TNF-a could kill L929 cells while 
hyperthermia could eliminate the TNF-a-insensitive L929-11E cells. Although the 
mechanism for their discrepancy in the signal pathway during apoptosis is not fully 
understood, combined treatment is a good therapeutic design to combat tumour and 
to counteract drug resistance. 
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4.6 Proposed Pathway in the TNF-a- and Hyperthermia-
mediated Apoptosis 
With the results from this project, it can be concluded that both TNF-a and 
hyperthermia induced apoptosis in L929 and L929-11E cells in a very similar way 
and both treatments involved mitochondria. 
Figure 4.1 shows a proposed model for the signaling of TNF-a in the induction 
of cell death in L929 cells. Generally, TNF-a binds to TNFRl and triggered the 
receptor trimerization. TNFRl can then interact with the adaptor proteins, 
TNFR-associated death domain protein (TRADD) (Seol et al., 2001; review: 
MacEwan, 2002; minireview: Green, 1998; Kaufmann and Hengartner, 2001). 
Signals are then transduced through the interaction of pro-caspase-8 after recruitment 
from the cytosol which becomes activated. The activated caspase-8 can then cleave 
the Bid protein and its truncated form can be translocated to mitochondria and 
stimulates the release of cyto c from mitochondria. Moreover, the level of ROS and 
calcium increase. After the release of cyto c, pro-caspase-3 is activated and 
subsequently, PARP is cleaved. p53 protein expression is also elevated at some point 
in the apoptotic pathway. All these changes lead to apoptosis. Figure 4.2 shows the 
proposed model for the signaling of hyperthermia in the induction of cell death in 
both L929 cells and L929-11E cells. The proposed pathway of hyperthermia is very 
similar to that triggered by TNF-a except that hyperthermia does not require cell 
surface receptors in the mediation of apoptosis. 
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Figure 4.1 
A proposed pathway for TNF-induced cell death in L929 cells. Generally, TNF-a 
binds to TNFRl and triggered receptor trimerization. Signals are then transduced 
through the activation pro-caspase-8. The activated caspase-8 then cleave the Bid 
protein and its truncated form is translocated to mitochondria and stimulates cyto c 
release from mitochondria. After the release of cyto c, pro-caspase-3 is activated and 
subsequently, PARP is cleaved. p53 protein expression is also elevated at some point 
in the apoptotic pathway. All these changes lead to apoptosis. 
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A proposed pathway for Hyperthermia-induced cell death in L929 and 
L929-11E cells. Hyperthermia was applied on both L929 and L929-11E cells. 
Signals are then transduced through the activation pro-caspase-8. The activated 
caspase-8 then cleave the Bid protein and its truncated form is translocated to 
mitochondria and stimulates cyto c release from mitochondria. After the release of 
cyto c, pro-caspase-3 is activated and subsequently, PARP is cleaved. p53 protein 
expression is also elevated at some point in the apoptotic pathway. All these changes 
lead to apoptosis. 
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4.7 Application of TNF-a and Hyperthermia on Clinical 
Cancer Treatment 
The efficacy of either TNF-a, hyperthermia or their combination on cancer 
treatment is a question under debate. In this project, recombinant murine TNF-a and 
hyperthermia was applied on transformed mouse fibroblasts, L929 and L929-11E. In 
vitro studies on the effect of murine TNF-a in apoptosis in mouse TNF-a sensitive 
cell line, L929 cells (Figure 3.10)，suggested that TNF-a may be useful in cancer 
treatment. Generally，the amino acid sequences of human and mouse TNF showed 
79% homology (Fiers et al., 1987) and the anti-tumour activity of TNF-a was not 
species-specific (Haranaka, et al., 1984;-Fransen et al., 1986; Haranaka, et al； 1987). 
Murine TNF-a was effective in mouse tumours as well as in human tumours 
heterotransplanted into nude mice (Haranaka, et al,, 1984). On the other hand, 
human TNF can act on mouse tumours on top of human tumours (Haranaka et al., 
1987). Various kinds of human cell lines such as HeLa D98, BT-20, MCF-7 and 
ME-180 are highly sensitive to cytotoxic action of TNF (Fiers et al., 1987). Studies 
also showed that picomolar concentrations of recombinant human TNF had 50% 
inhibition on human cervical cancer cells, ME-180 and breast cancer cells, BT-20 
(Baglioni et al., 1987). Clinical studies on the effect of recombinant human TNF 
were also carried out in phase II study. It was found that intratumorally 
administration of recombinant human TNF has 100% response rate for adult T-cell 
lymphoma, malignant angioendothelioma and fair effect on malignant melanoma and 
squamous cell carcinoma (Taguchi et aL, 1992). 
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Although TNF-a possessed anti-timour activities on certain tumour cells, it was 
found that 30 to 60% of human tumour cell lines had innate resistance to TNF-a 
with unknown mechanism (Spriggs et al., 1987). With this evidence, other cancer 
treatment modalities such as radiotherapy or hyperthermia were applied. 
Hyperthermia has been suggested to be a method to improve cancer treatment 
of chemotherapy or radiotherapy (Vernon and Hand, 1995). According to the 
experimental results, it was found that hyperthermia alone at 43 induced 
apoptosis in both L929 and L929-11E cells (Figure 3.18). Although hyperthermia 
alone at above 42 can kill tumour cells, acute treatment or repeated exposure of 
cells to hyperthermia usually induces thermotolerance that will lower the efficacy of 
further tumour treatment by heat (Vernon and Hand, 1995). Thus, hyperthermia is 
generally applied in combination with other treatment modalities bearing different 
cytotoxic mechanisms so as to enhance the therapeutic efficacy (Rong and Mack, 
2000;Ressel, et al, 2001). 
In this project, 50 ng/ml of TNF-a was applied in L929 and L929-11E cells 
after hyperthermia at 43 for 3 hr and apoptosis or late apoptosis/necrosis was 
observed in both cell lines (Figure 3.39 and 3.40). In terms of the treatment sequence, 
hyperthermia was applied prior to TNF-a. Such treatment sequence was selected to 
study whether hyperthermia induced cell death in L929-11E cells that had developed 
resistance towards TNF-a. Subsequently, TNF-a was added to find out whether 
extra TNF-a could induce cell death in L929-11E cells that normally resisted TNF-a 
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cytotoxicity. Others proposed that the reverse sequence of hyperthermia and TNF-a 
should be carried out as hyperthermia may induce heat shock proteins that protect 
tumour cells against TNF-a cytotoxicity (Tomasovic et aL, 1994) 
Generally, the cancer treatment strategies involve multimodal treatments with 
surgery followed by the systemic administration of drugs or radiation and with 
hyperthermia as an adjunct to the conventional treatment (Honess and Bleehen, 1988; 
Vernon and Hand, 1995; Ressel et al., 2002). As systemic administration of 
anticancer drugs usually lead to multi-drug resistance, hyperthermia may be applied 
in adjunct to chemotherapy so as to eliminate those MDR cells (Larrivee and Averill, 
2000). After the elimination, the remaining tumour cells were then repeatedly 
exposed to anticancer drugs or radiation and a loop of treatments with anticancer 
drugs or radiotherapy and then subsequently hyperthermia was performed until 
tumours are successfully eliminated. 
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Results in this study show that hyperthermia induced apoptosis and changed 
the mitochondrial activities in L929-11E cells. As hyperthermia mediates cell death 
through a non-receptor pathway, it is of interest to delineate the mechanism of how 
hyperthermia activates caspase-8 and Bid protein. Our results showed that 
hyperthermia was able to enhance the caspase-8 activity in intact L929-11E cells but 
not in the lysate of L929-11E cells. This suggested that certain molecules in the 
intact living cells were required for the activation of caspase-8. The decreased 
activity of caspase-8 after pre-treatment or co-treatment of cells with cycloheximide 
in both normal or hyperthermia treatment further supports this (Figure 3.69). One of 
the possible targets may be the heat shock proteins as the cells were under a stress or 
heat shock (Garrido et al., 2001). 
Heat shock proteins belong to a set of proteins that are highly conserved 
proteins. Some of them are constitutively expressed with cells such as hsp 90 and 
hsp 60, whereas some are induced in response to stress such as hsp 72 and hsp 70 
(Samali et al” 1999; Xanthoudakis and Nicholson, 2000). Recently, it has been 
found that the hsp 27 and hsp 70 possessed antiapoptotic activities whereas hsp 60 
and hsp 10 possessed proapoptotic activities (Garrido et al., 2001). Hsp 60 and hsp 
10 was found to complex with pro-caspase-3 in mitochondria in Jurkat cells (Samali 
et al., 1999). Upon the induction of apoptosis, hsp 60 and hsp 10 dissociated from 
pro-caspase-3 and both hsp 60 and hsp 10 released from mitochondria can accelerate 
the activation of caspase-3 through its chaperone functions (Samali et al., 1999). 
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Our preliminary results showed that hyperthermia decreased the expression 
of hsp 90 in L929 cells whereas a slight increase in the expression of hsp 90 was 
observed in L929-11E cells (Figure 3.71). Hsp 90 is a highly conserved 
stress-induced protein and it is abundantly expressed in most tissues under non-stress 
conditions. Overexpression of hsp 90 has been found to increase the rate of apoptosis 
in the monoblastoid cell line U937 after activation with TNF. Yet hsp 90 was found 
to inhibit apoptosis in staurosporine-induced cell death (Garrido et al., 2001). The 
role of hsp 90 in the mediation of cell death is still unknown. 
On the other hand, our preliminary results also indicated that there was a 
decrease in the expression of hsp 60 with time in L929 cells whereas an enhanced 
expression was found in L929-11E cells. Hsp 60 has been demonstrated to be 
involved in the induction of apoptosis as it acts as a proapoptotic protein (Garrido et 
al.’ 2001). Our results therefore showed contradictions in the expression of hsp 60 in 
L929 and L929-11E cells and further investigation in this regard is needed. 
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Figure 3.71 
Preliminary results on the effect of hyperthermia on hsp 60 and hsp 90 
expression in L929 and L929-11E cells. L929 and L929-11E cells in complete 
medium were seeded at 1 x 1 Orwell in complete medium in a 6-well plate and 
incubated at 37 5 % CO2 overnight. Cells were then washed twice with 
serum-free medium and then treated at 37 for 3 hr or at 43 for 1 to 3 hr as 
indicated. Cells were then harvested and 1x10^ cells were re-suspended in 100 j^ l of 
lysis buffer for 30 min to extract protein. Samples were boiled and centrifugation 
was then carried out at 20,817 x g (14,000 rpm, 9.5 cm, Eppendorf Centrifuge 
5417R) for 7 min. The supernatant was then collected and stored at -70 The 
protein content was determined with BCA assay. 25 |j.g of proteins were loaded for 
gel electrophoresis. Electroblotting and non-specific block of proteins were done. 
Anti-hsp 60 (1:200) and anti-hsp 90 (1:1000) antibodies were probed onto the 
membrane at room temperature for 1 hr and then with anti-mouse-HRP conjugated 
antibodies (1:1000) at room temperature for another hr. The ECL assay was then 
performed and signal was exposed on x-ray film. 
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